BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ, Weir HK. Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. J Natl Cancer Inst. 2017;109. [PMID: 28376154 DOI: 10.1093/jnci/djx030] [Cited by in Crossref: 748] [Cited by in F6Publishing: 848] [Article Influence: 124.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Li X, Bai H, Yang X, Mu J, Yan R, Wang S. Traditional uses, phytochemistry, pharmacology, and pharmacokinetics of the root bark of Paeonia x suffruticosa andrews: A comprehensive review. J Ethnopharmacol 2023;308:116279. [PMID: 36822345 DOI: 10.1016/j.jep.2023.116279] [Reference Citation Analysis]
2 Peng C, Yang F, Peng L, Zhang C, Lin Z, Chen C, Gao H, He J, Jin Z. Temporal trends and outcomes in acute ischaemic stroke patients with a current or historical diagnosis of cancer. Eur J Neurol 2023;30:951-62. [PMID: 36704907 DOI: 10.1111/ene.15699] [Reference Citation Analysis]
3 Millar MM, Herget KA, Ofori-Atta B, Codden RR, Edwards SL, Carter ME, Belnap B, Kirchhoff AC, Sweeney C. Cancer survivorship experiences in Utah: an evaluation assessing indicators of survivors' quality of life, health behaviors, and access to health services. Cancer Causes Control 2023;34:337-47. [PMID: 36723708 DOI: 10.1007/s10552-023-01671-5] [Reference Citation Analysis]
4 Karamitsou P, Skliris JP, Gougousis S, Karamitsou A, Poutoglidis A. Hepatocellular Carcinoma Metastasis to the Tonsil: A Case Report of a Rare Entity. Cureus 2023. [DOI: 10.7759/cureus.35943] [Reference Citation Analysis]
5 Deng Z, Jones MR, Wang MC, Wolff AC, Visvanathan K. Racial and ethnic disparities in mortality among breast cancer survivors after a second malignancy. J Natl Cancer Inst 2023;115:279-87. [PMID: 36529890 DOI: 10.1093/jnci/djac220] [Reference Citation Analysis]
6 van Deursen L, van der Vaart R, Alblas EE, Struijs JN, Chavannes NH, Aardoom JJ. Improving the colorectal cancer care pathway via e-health: a qualitative study among Dutch healthcare providers and managers. Support Care Cancer 2023;31:203. [PMID: 36872396 DOI: 10.1007/s00520-023-07653-2] [Reference Citation Analysis]
7 Abutorabi ES, Poursheikhani A, Kashani B, Shamsaiegahkani S, Haghpanah V, Bashash D, Mousavi SA, Momeny M, Ghaffari SH. The effects of Abemaciclib on cell cycle and apoptosis regulation in anaplastic thyroid cancer cells. Mol Biol Rep 2023. [PMID: 36877344 DOI: 10.1007/s11033-023-08255-1] [Reference Citation Analysis]
8 Gao T, Yang X, Fujisawa M, Ohara T, Wang T, Tomonobu N, Sakaguchi M, Yoshimura T, Matsukawa A. SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells. Int J Mol Sci 2023;24. [PMID: 36902429 DOI: 10.3390/ijms24054996] [Reference Citation Analysis]
9 Yang H, Xiang C, Mou Y, Zhou X, Li W, Duan Y, Hu B. The investigation of volatile organic compounds in diagnosing (early) esophageal squamous cell carcinoma and gastric adenocarcinoma. J Cancer Res Clin Oncol 2023. [PMID: 36859724 DOI: 10.1007/s00432-023-04595-4] [Reference Citation Analysis]
10 Wänman J, Kjartansdóttir S, Wolf O, Sundkvist J, Wennergren D, Mukka S. Age, sex, primary tumor type and site are associated with mortality after pathological fractures: an observational study of 1453 patients from the Swedish Fracture Register. J Orthop Surg Res 2023;18:150. [PMID: 36859299 DOI: 10.1186/s13018-023-03620-z] [Reference Citation Analysis]
11 Kumar D, Moghiseh M, Chitcholtan K, Mutreja I, Lowe C, Kaushik A, Butler A, Sykes P, Anderson N, Raja A. LHRH conjugated gold nanoparticles assisted efficient ovarian cancer targeting evaluated via spectral photon-counting CT imaging: a proof-of-concept research. J Mater Chem B 2023;11:1916-28. [PMID: 36744575 DOI: 10.1039/d2tb02416k] [Reference Citation Analysis]
12 Zhang P, Wang T, Liu H, She X, Chen K, Zhao Y, Ming Y. Acute rejection was observed in a combination therapy of CTLA-4 and PD-1 inhibitors before liver transplantation: A case report and literature review. iLIVER 2023. [DOI: 10.1016/j.iliver.2023.03.001] [Reference Citation Analysis]
13 Sabatier R, Rousseau F, Joly F, Cropet C, Montégut C, Frindte J, Cinieri S, Guerra Alía EM, Polterauer S, Yoshida H, Vergote I, Colombo N, Hietanen S, Largillier R, Canzler U, Gratet A, Marmé F, Favier L, Pujade-Lauraine E, Ray-Coquard I. Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial. Eur J Cancer 2023;181:42-52. [PMID: 36634389 DOI: 10.1016/j.ejca.2022.11.029] [Reference Citation Analysis]
14 Zhao FQ, Jiang YJ, Xing W, Pei W, Liang JW. The safety and prognosis of radical surgery in colorectal cancer patients over 80 years old. BMC Surg 2023;23:45. [PMID: 36855086 DOI: 10.1186/s12893-023-01938-3] [Reference Citation Analysis]
15 Lee AJ, Wu AG, Yew KC, Shelat VG. Does size matter for resection of giant versus non-giant hepatocellular carcinoma? A meta-analysis. World J Gastrointest Surg 2023; 15(2): 273-286 [DOI: 10.4240/wjgs.v15.i2.273] [Reference Citation Analysis]
16 Kumar P, Del Rosario M, Chang J, Ziogas A, Jafari MD, Bristow RE, Tanjasiri SP, Zell JA. Population-Based Analysis of National Comprehensive Cancer Network (NCCN) Guideline Adherence for Patients with Anal Squamous Cell Carcinoma in California. Cancers (Basel) 2023;15. [PMID: 36900256 DOI: 10.3390/cancers15051465] [Reference Citation Analysis]
17 Christodoulou I, Ukert B, Vavuranakis MA, Kum HC, Giannouchos TV. Adult Cancer-Related Emergency Department Utilization: An Analysis of Trends and Outcomes From Emergency Departments in Maryland and New York. JCO Oncol Pract 2023;:OP2200525. [PMID: 36827627 DOI: 10.1200/OP.22.00525] [Reference Citation Analysis]
18 Shi X, Wu M, Jia X, Bao J, Wang Y, Yang C, Yu M, Yang Y. Trends of Incidence, Mortality, and Risk Factors for Lower Respiratory Infections among Children under 5 Years in China from 2000 to 2019. Int J Environ Res Public Health 2023;20. [PMID: 36834242 DOI: 10.3390/ijerph20043547] [Reference Citation Analysis]
19 Allen I, Hassan H, Sofianopoulou E, Eccles D, Turnbull C, Tischkowitz M, Pharoah P, Antoniou AC. Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis. Breast Cancer Res 2023;25:18. [PMID: 36765408 DOI: 10.1186/s13058-023-01610-x] [Reference Citation Analysis]
20 Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev 2023. [PMID: 36729264 DOI: 10.1007/s10555-023-10084-4] [Reference Citation Analysis]
21 Van Doorn S, Heyden ML, Reimer M. The private life of CEOs; A strategic leadership perspective. The Leadership Quarterly 2023. [DOI: 10.1016/j.leaqua.2023.101679] [Reference Citation Analysis]
22 Tan CT, Soh NJH, Chang HC, Yu VC. p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities. FEBS J 2023;290:892-912. [PMID: 34882306 DOI: 10.1111/febs.16317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
23 Lei K, Fu L, Zhang Y, Sun X. The prognostic and clinicopathologic value of long noncoding RNA HEIH in human cancer: A review and meta-analysis. Asian J Surg 2023;46:992-3. [PMID: 35961904 DOI: 10.1016/j.asjsur.2022.07.101] [Reference Citation Analysis]
24 Nouhravesh N, Strange JE, Tønnesen J, Holt A, Andersen CF, Jensen MH, Al-Alak A, D'Souza M, Nielsen D, Kragholm K, Fosbøl EL, Schou M, Lamberts MK. Prognosis of acute coronary syndrome stratified by cancer type and status - a nationwide cohort study. Am Heart J 2023;256:13-24. [PMID: 36370886 DOI: 10.1016/j.ahj.2022.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Guo F, Sun DF, Feng Y, Yang L, Li JL, Sun ZL. Efficacy and safety of propofol target-controlled infusion combined with butorphanol for sedated colonoscopy. World J Clin Cases 2023; 11(3): 610-620 [PMID: 36793626 DOI: 10.12998/wjcc.v11.i3.610] [Reference Citation Analysis]
26 Zandi M. Synergistic Effect ofTaxolandVincristineAgainstMCF-7 Cell Line. Gene Cell Tissue 2023;In Press. [DOI: 10.5812/gct-126544] [Reference Citation Analysis]
27 Grant BM, Pugh TJ, Oza AM. Molecular Monitoring in Endometrial Cancer-Ready for Prime Time? Clin Cancer Res 2023;29:305-8. [PMID: 36354753 DOI: 10.1158/1078-0432.CCR-22-2781] [Reference Citation Analysis]
28 Ashley CW, Selenica P, Patel J, Wu M, Nincevic J, Lakhman Y, Zhou Q, Shah RH, Berger MF, Da Cruz Paula A, Brown DN, Marra A, Iasonos A, Momeni-Boroujeni A, Alektiar KM, Long Roche K, Zivanovic O, Mueller JJ, Zamarin D, Broach VA, Sonoda Y, Leitao MM, Friedman CF, Jewell E, Reis-Filho JS, Ellenson LH, Aghajanian C, Abu-Rustum NR, Cadoo K, Weigelt B. High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer. Clin Cancer Res 2023;29:410-21. [PMID: 36007103 DOI: 10.1158/1078-0432.CCR-22-1134] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Wang G, Zhang X, Zhou Z, Song C, Jin W, Zhang H, Wu W, Yi Y, Cui H, Zhang P, Liu X, Xu W, Shen X, Shen W, Wang X. Sphingosine 1-phosphate receptor 2 promotes the onset and progression of non-alcoholic fatty liver disease-related hepatocellular carcinoma through the PI3K/AKT/mTOR pathway. Discov Oncol 2023;14:4. [PMID: 36631680 DOI: 10.1007/s12672-023-00611-8] [Reference Citation Analysis]
30 Park JH, Myung JK, Lee SJ, Kim H, Kim S, Lee SB, Jang H, Jang WI, Park S, Yang H, Shim S, Kim MJ. ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway. Cells 2023;12. [PMID: 36672209 DOI: 10.3390/cells12020274] [Reference Citation Analysis]
31 Angeli A, Micheli L, Carta F, Ferraroni M, Pirali T, Fernandez Carvajal A, Ferrer Montiel A, Di Cesare Mannelli L, Ghelardini C, Supuran CT. First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy. J Med Chem 2023;66:1616-33. [PMID: 36626645 DOI: 10.1021/acs.jmedchem.2c01911] [Reference Citation Analysis]
32 Mohammed BA, Senan EM, Alshammari TS, Alreshidi A, Alayba AM, Alazmi M, Alsagri AN. Hybrid Techniques of Analyzing MRI Images for Early Diagnosis of Brain Tumours Based on Hybrid Features. Processes 2023;11:212. [DOI: 10.3390/pr11010212] [Reference Citation Analysis]
33 Cao SY, Fan Y, Zhang YF, Ruan JY, Mu Y, Li JK. Recurrence and survival of patients with stage III endometrial cancer after radical surgery followed by adjuvant chemo- or chemoradiotherapy: a systematic review and meta-analysis. BMC Cancer 2023;23:31. [PMID: 36624407 DOI: 10.1186/s12885-022-10482-x] [Reference Citation Analysis]
34 Zhou H, Chen J, Fan M, Cai H, Dong Y, Qiu Y, Zhuang Q, Lei Z, Li M, Ding X, Yan P, Lin A, Zheng S, Yan Q. KLF14 regulates the growth of hepatocellular carcinoma cells via its modulation of iron homeostasis through the repression of iron-responsive element-binding protein 2. J Exp Clin Cancer Res 2023;42:5. [PMID: 36600258 DOI: 10.1186/s13046-022-02562-4] [Reference Citation Analysis]
35 Zeng XL, Heneghan MB, Badawy SM. Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review. Curr Oncol 2023;30:720-48. [PMID: 36661705 DOI: 10.3390/curroncol30010056] [Reference Citation Analysis]
36 Qiu M, Liu Y, Lin Q, Jiang Y, Zhou Z, Wen Q, Liang X, Zhou X, Yu H. A functional variant in the RAD51 3′ UTR is associated with survival of hepatocellular carcinoma patients. Gene 2023;851:146964. [DOI: 10.1016/j.gene.2022.146964] [Reference Citation Analysis]
37 Sarna MJ, Giorgi M. Obesity and cancers of the liver, gallbladder, and pancreas. The Link Between Obesity and Cancer 2023. [DOI: 10.1016/b978-0-323-90965-5.00002-7] [Reference Citation Analysis]
38 Belciug S. A Survival Analysis Guide in Oncology. Intelligent Systems Reference Library 2023. [DOI: 10.1007/978-3-031-11170-9_2] [Reference Citation Analysis]
39 Su Y, Zhang T, Lu J, Qian L, Fei Y, Zhang L, Fan S, Zhou J, Tang J, Chen H, Liang C. Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response. Cells 2023;12. [PMID: 36611973 DOI: 10.3390/cells12010180] [Reference Citation Analysis]
40 Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, Razzazan M, Mirzaei S, Entezari M, Goharrizi MASB, Salimimoghadam S, Aref AR, Kalbasi A, Rajabi R, Rashidi M, Taheriazam A, Sethi G. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges. Pharmacol Res 2023;187:106553. [PMID: 36400343 DOI: 10.1016/j.phrs.2022.106553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Qin H, Sheng W, Zhang G, Yang Q, Yao S, Yue Y, Zhang P, Zhu Y, Wang Q, Chen Y, Zeng H, Weng J, Yu F, Yang J. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC. Front Genet 2023;14:1094793. [PMID: 36891150 DOI: 10.3389/fgene.2023.1094793] [Reference Citation Analysis]
42 Bandera EV, Hong C, Qin B. Impact of Obesity and Related Factors in Breast Cancer Survivorship Among Hispanic Women. Advancing the Science of Cancer in Latinos 2023. [DOI: 10.1007/978-3-031-14436-3_14] [Reference Citation Analysis]
43 Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023;73:17-48. [PMID: 36633525 DOI: 10.3322/caac.21763] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 41.0] [Reference Citation Analysis]
44 Ay C, Grilz E, Nopp S, Moik F, Königsbrügge O, Klimek P, Thurner S, Posch F, Pabinger I. Atrial fibrillation and cancer: prevalence and relative risk from a nationwide study. Res Pract Thromb Haemost 2023;7:100026. [PMID: 36891526 DOI: 10.1016/j.rpth.2022.100026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Zheng Z, Hu Y, Ren Y, Mo G, Wan H. Correlation between metastatic patterns and age in patients with metastatic primary liver cancer: A population-based study. PLoS One 2023;18:e0267809. [PMID: 36706100 DOI: 10.1371/journal.pone.0267809] [Reference Citation Analysis]
46 Ravindranath V, Menesgere AL, Wallin MT. Burden of neurological disease. Neurobiology of Brain Disorders 2023. [DOI: 10.1016/b978-0-323-85654-6.00019-8] [Reference Citation Analysis]
47 Shobeiri P, Seyedmirzaei H, Kalantari A, Mohammadi E, Rezaei N, Hanaei S. The Epidemiology of Brain and Spinal Cord Tumors. Adv Exp Med Biol 2023;1394:19-39. [PMID: 36587379 DOI: 10.1007/978-3-031-14732-6_2] [Reference Citation Analysis]
48 Shi K, Li P, Zhang Q, Zhang Y, Bi Y, Zeng X, Wang X. Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals. Front Oncol 2023;13:1128062. [PMID: 36874109 DOI: 10.3389/fonc.2023.1128062] [Reference Citation Analysis]
49 Botdorf J, Nates JL. Intensive Care Considerations of the Cancer Patient. Perioperative Care of the Cancer Patient 2023. [DOI: 10.1016/b978-0-323-69584-8.00039-6] [Reference Citation Analysis]
50 Rashid G, Khan NA, Elsori D, Rehman A, Tanzeelah, Ahmad H, Maryam H, Rais A, Usmani MS, Babker AM, Kamal MA, Hafez W. Non-steroidal anti-inflammatory drugs and biomarkers: A new paradigm in colorectal cancer. Front Med (Lausanne) 2023;10:1130710. [PMID: 36950511 DOI: 10.3389/fmed.2023.1130710] [Reference Citation Analysis]
51 Aljohani GF, Abolibda TZ, Alhilal M, Al-humaidi JY, Alhilal S, Ahmed HA, Gomha SM. Novel thiadiazole-thiazole hybrids: synthesis, molecular docking, and cytotoxicity evaluation against liver cancer cell lines. Journal of Taibah University for Science 2022;16:1005-15. [DOI: 10.1080/16583655.2022.2135805] [Reference Citation Analysis]
52 Shahidi S, Rostamizadeh K, Fathi M, Nedaei K, Ramazani A. Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells. BMC Complement Med Ther 2022;22:340. [PMID: 36575448 DOI: 10.1186/s12906-022-03787-8] [Reference Citation Analysis]
53 Zhang S, Bacon W, Peppelenbosch MP, van Kemenade F, Stubbs AP. Deciphering Tumour Microenvironment of Liver Cancer through Deconvolution of Bulk RNA-Seq Data with Single-Cell Atlas. Cancers (Basel) 2022;15. [PMID: 36612149 DOI: 10.3390/cancers15010153] [Reference Citation Analysis]
54 Wang J, Wu R, Sun JY, Lei F, Tan H, Lu X. An overview: Management of patients with advanced hepatocellular carcinoma. Biosci Trends 2022;16:405-25. [PMID: 36476621 DOI: 10.5582/bst.2022.01109] [Reference Citation Analysis]
55 Yang Z, Li X, Pan C, Li Y, Lin L, Jin Y, Zheng J, Yu Z. A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma. BMC Cancer 2022;22:1344. [PMID: 36550445 DOI: 10.1186/s12885-022-10463-0] [Reference Citation Analysis]
56 Jiang J, Diaz DA, Nuguru SP, Mittra A, Manne A. Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma. Cancers (Basel) 2022;15. [PMID: 36612046 DOI: 10.3390/cancers15010050] [Reference Citation Analysis]
57 Shi Y, Wang Y, Yang R, Zhang W, Zhang Y, Feng K, Lv Q, Niu K, Chen J, Li L, Zhang Y. Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making. Front Endocrinol (Lausanne) 2022;13:1090324. [PMID: 36605944 DOI: 10.3389/fendo.2022.1090324] [Reference Citation Analysis]
58 Tümen D, Heumann P, Gülow K, Demirci CN, Cosma LS, Müller M, Kandulski A. Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma. Biomedicines 2022;10. [PMID: 36551958 DOI: 10.3390/biomedicines10123202] [Reference Citation Analysis]
59 Li G, Xu S, Yang S, Wu C, Zhang L, Wang H. An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma. Front Genet 2022;13:1029576. [PMID: 36568382 DOI: 10.3389/fgene.2022.1029576] [Reference Citation Analysis]
60 Shannon AH, Ruff SM, Pawlik TM. Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress. JHC 2022;Volume 9:1247-1261. [DOI: 10.2147/jhc.s383922] [Reference Citation Analysis]
61 Islam MM, Poly TN, Walther BA, Yeh CY, Seyed-Abdul S, Li YJ, Lin MC. Deep Learning for the Diagnosis of Esophageal Cancer in Endoscopic Images: A Systematic Review and Meta-Analysis. Cancers (Basel) 2022;14. [PMID: 36497480 DOI: 10.3390/cancers14235996] [Reference Citation Analysis]
62 Guan J, Pan Y, Li H, Zhu Y, Gao Y, Wang J, Zhou Y, Guan Z, Yang Z. Activity and Tissue Distribution of Antisense Oligonucleotide CT102 Encapsulated with Cytidinyl/Cationic Lipid against Hepatocellular Carcinoma. Mol Pharm 2022;19:4552-64. [PMID: 35508302 DOI: 10.1021/acs.molpharmaceut.2c00026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Jaffe A, Taddei TH, Giannini EG, Ilagan-Ying YC, Colombo M, Strazzabosco M. Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook. Liver Int 2022;42:2607-19. [PMID: 36161463 DOI: 10.1111/liv.15432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Tang B, Zhu J, Wang Y, Chen W, Fang S, Mao W, Xu Z, Yang Y, Weng Q, Zhao Z, Chen M, Ji J. Targeted xCT-mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti-PD-1/L1 Response. Adv Sci (Weinh) 2023;10:e2203973. [PMID: 36442849 DOI: 10.1002/advs.202203973] [Reference Citation Analysis]
65 Zhou Q, Chen L, Yang L, Zhou H, Chen Y, Guo Y. Integrated systemic analysis of FAM72A to identify its clinical relevance, biological function, and relationship to drug sensitivity in hepatocellular carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1046473] [Reference Citation Analysis]
66 Myers DJ, Kriebel D. If Smoking Were Eliminated, Which US Counties Would Still Have High Rates of Smoking-Related Cancers? Int J Environ Res Public Health 2022;19. [PMID: 36430011 DOI: 10.3390/ijerph192215292] [Reference Citation Analysis]
67 Qi X, Guo J, Chen G, Fang C, Hu L, Li J, Zhang C. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. J Immunol Res 2022;2022:3393027. [PMID: 36438201 DOI: 10.1155/2022/3393027] [Reference Citation Analysis]
68 Gholipour AR, Jafari L, Ramezanpour M, Evazalipour M, Chavoshi M, Yousefbeyk F, Kargar Moghaddam SJ, Yekta Kooshali MH, Ramezanpour N, Daei P, Ghasemi S, Hamidi M. Apoptosis Effects of Oxalis corniculata L. Extract on Human MCF-7 Breast Cancer Cell Line:. Galen Med J 2022;11:e2484. [PMID: 36698692 DOI: 10.31661/gmj.v11i.2484] [Reference Citation Analysis]
69 Devis-Jauregui L, Vidal A, Plata-Peña L, Santacana M, García-Mulero S, Bonifaci N, Noguera-Delgado E, Ruiz N, Gil M, Dorca E, Llobet FJ, Coll-Iglesias L, Gassner K, Martinez-Iniesta M, Rodriguez-Barrueco R, Barahona M, Marti L, Viñals F, Ponce J, Sanz-Pamplona R, Piulats JM, Vivancos A, Matias-Guiu X, Villanueva A, Llobet-Navas D. Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer. Adv Sci (Weinh) 2022;10:e2204211. [PMID: 36373729 DOI: 10.1002/advs.202204211] [Reference Citation Analysis]
70 Guo Y, Hu HT, Xu SJ, Xia WL, Zhao Y, Zhao XH, Zhu WB, Li FT, Li HL. Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and inhibits cancer cell migration in vitro. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1023801] [Reference Citation Analysis]
71 da Silva Freire AK, Furtado de Mendonça Belmont T, Pinto Santiago EJ, Cristina Cordeiro Farias I, Palmeira do Ó K, Soares da Silva A, Richardson Silva Vasconcelos L. Potential role of circulating miR-21 in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Expert Rev Mol Diagn 2022;22:1037-52. [PMID: 36348568 DOI: 10.1080/14737159.2022.2145189] [Reference Citation Analysis]
72 Wang J, Chang J, Liu Y, Bennett DL, Poplack SP. A comparison of the imaging appearance of breast cancer in African American women with non-Latina white women. Clinical Imaging 2022. [DOI: 10.1016/j.clinimag.2022.11.004] [Reference Citation Analysis]
73 Ma XY, Hill BD, Hoang T, Wen F. Virus-inspired strategies for cancer therapy. Semin Cancer Biol 2022;86:1143-57. [PMID: 34182141 DOI: 10.1016/j.semcancer.2021.06.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
74 How GY, Pua U. Impact and the delivery of loco-regional treatment for hepatocellular carcinoma during the COVID-19 pandemic. Journal of Interventional Medicine 2022;5:180-183. [DOI: 10.1016/j.jimed.2022.09.004] [Reference Citation Analysis]
75 Donati G, Amati B. MYC and therapy resistance in cancer: risks and opportunities. Mol Oncol 2022;16:3828-54. [PMID: 36214609 DOI: 10.1002/1878-0261.13319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Aghayev T, Titerina EK, Khoreva MV, Gankovskaya LV. Role of cytokines in hepatocellular carcinoma. Med immunol 2022;24:889-902. [DOI: 10.15789/1563-0625-roc-2512] [Reference Citation Analysis]
77 Qiu A, Xu H, Mao L, Xu B, Fu X, Cheng J, Zhao R, Cheng Z, Liu X, Xu J, Zhou Y, Dong Y, Tian T, Tian G, Chu M. A Novel apaQTL-SNP for the Modification of Non-Small-Cell Lung Cancer Susceptibility across Histological Subtypes. Cancers (Basel) 2022;14. [PMID: 36358727 DOI: 10.3390/cancers14215309] [Reference Citation Analysis]
78 Kakar MU, Mehboob MZ, Akram M, Shah M, Shakir Y, Ijaz HW, Aziz U, Ullah Z, Ahmad S, Ali S, Yin Y, Li K. Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/4237633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Murgaski A, Kiss M, Van Damme H, Kancheva D, Vanmeerbeek I, Keirsse J, Hadadi E, Brughmans J, Arnouk SM, Hamouda AEI, Debraekeleer A, Bosteels V, Elkrim Y, Boon L, Hoves S, Vandamme N, Deschoemaeker S, Janssens S, Garg AD, Vande Velde G, Schmittnaegel M, Ries CH, Laoui D. Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages. Cancer Res 2022;82:3785-801. [PMID: 35979635 DOI: 10.1158/0008-5472.CAN-22-0094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
80 Yu C, Jiang L, Yang D, Dong X, Yu R, Yu H. Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year After Standard Treatment. Onco Targets Ther 2022;15:1221-8. [PMID: 36262804 DOI: 10.2147/OTT.S380615] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Huang EM, Ma N, Ma T, Zhou JY, Yang WS, Liu CX, Hou ZH, Chen S, Zong Z, Zeng B, Li YR, Zhou TC. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma. World J Gastrointest Oncol 2022; 14(10): 1981-2003 [DOI: 10.4251/wjgo.v14.i10.1981] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
82 Lovejoy LA, Shriver CD, Ellsworth RE. Cancer Incidence and Etiology in the Active Duty Population of U.S. Military. Mil Med 2022:usac297. [PMID: 36239575 DOI: 10.1093/milmed/usac297] [Reference Citation Analysis]
83 Wang J, Shen B, Liu X, Zhang S, Yang C, Zheng Q, Hao Y, Jiang J. An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-2139514/v1] [Reference Citation Analysis]
84 Qi J, Yin J, Ding G, Cao S. A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/9261339] [Reference Citation Analysis]
85 Song L, Xu C, Zhang T, Chen S, Hu S, Cheng B, Tong H, Li X. Clinical neutrophil-associated genes as reliable predictors of hepatocellular carcinoma. Front Genet 2022;13:989779. [DOI: 10.3389/fgene.2022.989779] [Reference Citation Analysis]
86 Li S, Yu G, Wei R, Wang X, Jiang Z. Development and validation of machine learning based models for predicting distant metastasis in colorectal cancer: a population-level study.. [DOI: 10.21203/rs.3.rs-2125523/v1] [Reference Citation Analysis]
87 Yan C, Niu Y, Ma L, Tian L, Ma J. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma. J Transl Med 2022;20:452. [PMID: 36195876 DOI: 10.1186/s12967-022-03630-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
88 Wang J, Shen B, Liu X, Jiang J. A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma. Front Genet 2022;13:985191. [DOI: 10.3389/fgene.2022.985191] [Reference Citation Analysis]
89 Gerstl JVE, Yearley AG, Kilgallon JL, Lassarén P, Robertson FC, Herdell V, Wang AY, Segar DJ, Bernstock JD, Laws ER, Ranganathan K, Smith TR. A national stratification of the global macroeconomic burden of central nervous system cancer. Journal of Neurosurgery 2022. [DOI: 10.3171/2022.9.jns221499] [Reference Citation Analysis]
90 Xiong R, Wang H, Li Y, Zheng J, Cheng Y, Liu S, Yang G. Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinoma. Front Genet 2022;13:1005271. [DOI: 10.3389/fgene.2022.1005271] [Reference Citation Analysis]
91 Bryant A, Hiu S, Kunonga PT, Gajjar K, Craig D, Vale L, Winter-Roach BA, Elattar A, Naik R. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Cochrane Database Syst Rev 2022;9:CD015048. [PMID: 36161421 DOI: 10.1002/14651858.CD015048.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Fan X, Yu L, Qi X, Lin X, Zhao J, Wang D, Zhang J, Liu L. Primary Investigation of Deep Learning Models for Japanese “Group Classification” of Whole-Slide Images of Gastric Endoscopic Biopsy. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/6899448] [Reference Citation Analysis]
93 Zhuang A, Zhuang A, Qin Z, Zhu D, Ren L, Wei Y, Zhou P, Yue X, He F, Xu J, Ding C. Proteomics Characteristics Reveal the Risk of T1 Colorectal Cancer Metastasis to Lymph Nodes.. [DOI: 10.1101/2022.09.22.508997] [Reference Citation Analysis]
94 Huang Y, Wang T, Chen M, Lin C, Chang C, Tai H, Hsu S, Chen Y. Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy. Front Oncol 2022;12:906498. [DOI: 10.3389/fonc.2022.906498] [Reference Citation Analysis]
95 Mori Y, Matsuda S, Sato M, Muraoka M, Suzuki Y, Tatsumi A, Nakayama Y, Inoue T, Maekawa S, Enomoto N. The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment. Intern Med 2022;61:2721-9. [DOI: 10.2169/internalmedicine.8456-21] [Reference Citation Analysis]
96 Zhou Y, Zhou X, Liu Q, Zhang Z, Zhang W, Ma J, Yang M, Yu J, Luo J, Yan Z, Mei J. Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/8973721] [Reference Citation Analysis]
97 Liang X, Zhang Y, He Y, Liu X, Ding Z, Zhang X, Dong M, Du R. A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma. Front Genet 2022;13:888601. [DOI: 10.3389/fgene.2022.888601] [Reference Citation Analysis]
98 Kenessey I, Szőke G, Dobozi M, Szatmári I, Wéber A, Fogarassy G, Nagy P, Kásler M, Polgár C, Vathy-fogarassy Á. Comparison of Cancer Survival Trends in Hungary in the Periods 2001–2005 and 2011–2015 According to a Population-Based Cancer Registry. Pathol Oncol Res 2022;28:1610668. [DOI: 10.3389/pore.2022.1610668] [Reference Citation Analysis]
99 Zhang L, Qi Q, Li Q, Ren S, Liu S, Mao B, Li X, Wu Y, Yang L, Liu L, Li Y, Duan S, Zhang L. Ultrasomics prediction for cytokeratin 19 expression in hepatocellular carcinoma: A multicenter study. Front Oncol 2022;12:994456. [DOI: 10.3389/fonc.2022.994456] [Reference Citation Analysis]
100 Zhang N, Liu S, Xu J, Ning T, Xie S, Min L, Zhu S, Zhang S, Zhu S. PGM3 regulates beta-catenin activity to promote colorectal cancer cell progression. Exp Biol Med (Maywood) 2022;247:1518-28. [PMID: 35723049 DOI: 10.1177/15353702221101810] [Reference Citation Analysis]
101 Xia H, Huang Z, Xu Y, Yam JWP, Cui Y. Reprogramming of central carbon metabolism in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2022;153:113485. [DOI: 10.1016/j.biopha.2022.113485] [Reference Citation Analysis]
102 Yang J, Ye J, Ma T, Tang F, Huang L, Liu Z, Tian S, Cheng X, Zhang L, Guo Z, Tu F, He M, Xu X, Lu X, Wu Y, Zeng X, Zou J, Wang X, Peng W, Zhang P. Tripartite motif-containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin-proteasome-mediated degradation of pleckstrin homology domain leucine-rich repeats protein phosphatase 1. Hepatology 2022;76:612-29. [PMID: 34767673 DOI: 10.1002/hep.32234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
103 Tao Q, Zhu K, Zhan Y, Zhang R, Lang Z, Yu Z, Wang M. Construction of a novel exosomes-related gene signature in hepatocellular carcinoma. Front Cell Dev Biol 2022;10:997734. [DOI: 10.3389/fcell.2022.997734] [Reference Citation Analysis]
104 Gao Z, Chen J, Zhou Y, Deng P, Sun L, Qi J, Zhang P, Zheng M. A Novel Metabolism-Related Gene Signature for Predicting the Prognosis of HBV-Infected Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/2391265] [Reference Citation Analysis]
105 Lei L, Tan L, Sui L. A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer. Front Genet 2022;13:957744. [DOI: 10.3389/fgene.2022.957744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
106 Donne R, Lujambio A. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology 2022. [PMID: 35989535 DOI: 10.1002/hep.32740] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
107 Xie W, Yu J, Yin Y, Zhang X, Zheng X, Wang X. OCT4 induces EMT and promotes ovarian cancer progression by regulating the PI3K/AKT/mTOR pathway. Front Oncol 2022;12:876257. [DOI: 10.3389/fonc.2022.876257] [Reference Citation Analysis]
108 Wang J, Wang Q, Du X, Zhu X, Nie C, Han X, Tian W, Li H, Zhou H. Risk factors associated with cardiovascular mortality among gastric cancer patients: a population-based analysis. Jpn J Clin Oncol 2022:hyac132. [PMID: 35946330 DOI: 10.1093/jjco/hyac132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Chen B, Yang Z, Lang Z, Tao Q, Zhang R, Zhan Y, Xu X, Zhu K, Zheng J, Yu Z, Yu S. M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma. BMC Cancer 2022;22:867. [PMID: 35941582 DOI: 10.1186/s12885-022-09925-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Burasakarn P, Thienhiran A, Fuengfoo P, Hongjinda S. Analysis of preoperative risk factors for early recurrence after curative pancreatoduodenectomy for resectable pancreatic adenocarcinoma. Innovative Surgical Sciences 2022;7:5-11. [DOI: 10.1515/iss-2021-0034] [Reference Citation Analysis]
111 Stagnoli S, Garro C, Ertekin O, Heid S, Seyferth S, Soria G, Mariano Correa N, Leal-egaña A, Boccaccini AR. Topical Systems for the Controlled Release of Antineoplastic Drugs: Oxidized Alginate-Gelatin Hydrogel/Unilamellar Vesicles. Journal of Colloid and Interface Science 2022. [DOI: 10.1016/j.jcis.2022.08.163] [Reference Citation Analysis]
112 Liu Y, Wang X, Zeng X, Wu Y, Liu X, Tan J, Li X. Bioinformatics-based analysis of SUMOylation-related genes in hepatocellular carcinoma reveals a role of upregulated SAE1 in promoting cell proliferation. Open Med (Wars) 2022;17:1183-202. [PMID: 35859792 DOI: 10.1515/med-2022-0510] [Reference Citation Analysis]
113 Javadian P, Xu C, Sjoelund V, Borden LE, Garland J, Benbrook DM. Identification of Candidate Biomarker and Drug Targets for Improving Endometrial Cancer Racial Disparities. Int J Mol Sci 2022;23. [PMID: 35887124 DOI: 10.3390/ijms23147779] [Reference Citation Analysis]
114 Teufel-shone NI, Goldtooth-begay C, Begay AB, Lazaro A, Yellowhair J, Todecheenie R, Begay D, Singer D, Briscoe C. Maintaining the Partnership Between a Tribal Breast and Cervical Cancer Program and a University-Based Cancer Prevention Center During COVID-19 Lock-Down Restrictions-A Case Study. Front Public Health 2022;10:902253. [DOI: 10.3389/fpubh.2022.902253] [Reference Citation Analysis]
115 Wang F, Shu X, Pal T, Berlin J, Nguyen SM, Zheng W, Bailey CE, Shu X. Racial/Ethnic Disparities in Mortality Related to Access to Care for Major Cancers in the United States. Cancers 2022;14:3390. [DOI: 10.3390/cancers14143390] [Reference Citation Analysis]
116 Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, Ettinger DS, Ferguson JS, Hou L, Kadaria D, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Mazzone P, Merritt RE, Midthun DE, Onaitis M, Pipavath S, Pratt C, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Studts JL, Tanoue L, Tong BC, Travis WD, Wei B, Westover K, Yang SC, McCullough B, Hughes M. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. J Natl Compr Canc Netw 2022;20:754-64. [PMID: 35830884 DOI: 10.6004/jnccn.2022.0036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
117 Griffiths CD, Zhang B, Tywonek K, Meyers BM, Serrano PE. Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. JAMA Netw Open 2022;5:e2222721. [PMID: 35849393 DOI: 10.1001/jamanetworkopen.2022.22721] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Roubidoux MA, Kaur JS, Rhoades DA. Health Disparities in Cancer Among American Indians and Alaska Natives. Acad Radiol 2022;29:1013-21. [PMID: 34802904 DOI: 10.1016/j.acra.2021.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
119 Nixon AB, Sibley AB, Liu Y, Hatch AJ, Jiang C, Mulkey F, Starr MD, Brady JC, Niedzwiecki D, Venook AP, Baez-Diaz L, Lenz HJ, O'Neil BH, Innocenti F, Meyerhardt JA, O'Reilly EM, Owzar K, Hurwitz HI. Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance). Clin Cancer Res 2022;28:2779-88. [PMID: 34965954 DOI: 10.1158/1078-0432.CCR-21-2389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
120 Huang E, Ma T, Zhou J, Ma N, Yang W, Liu C, Hou Z, Chen S, de Castria TB, Zeng B, Zong Z, Zhou T. The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma. Ann Transl Med 2022;10:766. [PMID: 35965795 DOI: 10.21037/atm-22-3348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Rallis KS, Makrakis D, Ziogas IA, Tsoulfas G. Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances. World J Clin Oncol 2022; 13(6): 448-472 [DOI: 10.5306/wjco.v13.i6.448] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
122 Liu P, Zhou Q, Li J. Integrated Multi-Omics Data Analysis Reveals Associations Between Glycosylation and Stemness in Hepatocellular Carcinoma. Front Oncol 2022;12:913432. [DOI: 10.3389/fonc.2022.913432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Chen R, Hou B, Qiu S, Shao S, Yu Z, Zhou F, Guo B, Li Y, Zhang Y, Han T. Development and Validation of Nomogram for Predicting Survival of Primary Liver Cancers Using Machine Learning. Front Oncol 2022;12:926359. [DOI: 10.3389/fonc.2022.926359] [Reference Citation Analysis]
124 Nakhla M, Eakin CM, Mandelbaum A, Karlan B, Benharash P, Salani R, Cohen JG. Frailty is independently associated with worse outcomes and increased resource utilization following endometrial cancer surgery. Int J Gynecol Cancer 2022:ijgc-2022-003484. [PMID: 35725031 DOI: 10.1136/ijgc-2022-003484] [Reference Citation Analysis]
125 Song D, Zhou Z, Zhang D, Wu J, Hao Q, Zhao L, Ren H, Zhang B. Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma. Front Genet 2022;13:850200. [PMID: 35711939 DOI: 10.3389/fgene.2022.850200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Soto-feliciano YM, Zhu C, Morris JP, Huang C, Koche RP, Ho Y, Banito A, Chen C, Shroff A, Tian S, Livshits G, Chen C, Fennell M, Armstrong SA, Allis CD, Tschaharganeh DF, Lowe SW. MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer.. [DOI: 10.1101/2022.06.07.495174] [Reference Citation Analysis]
127 Liu HH, Wang J, Zhang Y, Fan YC, Wang K. Prognostic potential of the small GTPase Ran and its methylation in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2022;21:248-56. [PMID: 35367146 DOI: 10.1016/j.hbpd.2022.03.011] [Reference Citation Analysis]
128 Mao D, Lau ESH, Wu H, Yang A, Fan B, Shi M, Tam CHT, Chow E, Kong APS, Ma RCW, Luk A, Chan JCN. Risk Associations of Glycemic Burden and Obesity With Liver Cancer-A 10-Year Analysis of 15,280 Patients With Type 2 Diabetes. Hepatol Commun 2022;6:1350-60. [PMID: 35044101 DOI: 10.1002/hep4.1891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
129 Prieto Ortíz JE, Garzón Orjuela N, Sanchez Pardo S, Prieto Ortíz RG, Eslava Schmalbach JH. Hepatocarcinoma: experiencia de la vida real en un centro especializado de Bogotá, Colombia. Rev colomb Gastroenterol 2022;37:163-173. [DOI: 10.22516/25007440.823] [Reference Citation Analysis]
130 Peng Q, Yan Y, Qian L, Suo S, Guo Y, Xu J, Wang Y. Liver tumor segmentation and classification using FLAS-UNet++ and an improved DenseNet. Technol Health Care 2022. [PMID: 35661035 DOI: 10.3233/THC-213655] [Reference Citation Analysis]
131 Huang S, Li D, Zhuang L, Zhang J, Wu J. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients. Front Med 2022;9:850343. [DOI: 10.3389/fmed.2022.850343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Li C, Wang H, Jiang Y, Fu W, Liu X, Zhong R, Cheng B, Zhu F, Xiang Y, He J, Liang W. Advances in lung cancer screening and early detection. Cancer Biol Med 2022;19:591-608. [PMID: 35535966 DOI: 10.20892/j.issn.2095-3941.2021.0690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Wu Y, Xu X, Liu M, Qin X, Wu Q, Ding H, Zhao Q. DZW-310, a novel phosphoinositide 3-kinase inhibitor, attenuates the angiogenesis and growth of hepatocellular carcinoma cells via PI3K/AKT/mTOR axis. Biochem Pharmacol 2022;:115093. [PMID: 35580648 DOI: 10.1016/j.bcp.2022.115093] [Reference Citation Analysis]
134 Pollock AE, Remick JS, Mohindra P. Gynecologic Cancers. Principles and Practice of Particle Therapy 2022. [DOI: 10.1002/9781119707530.ch23] [Reference Citation Analysis]
135 Eltelbany A, Khoudari G, Al-khadra Y, Mccullough A, Alkhouri N. Lower Rates of Hepatocellular Carcinoma Observed Among Cannabis Users: A Population-Based Study. Cureus 2022. [DOI: 10.7759/cureus.24576] [Reference Citation Analysis]
136 Karpel HC, Chern JY, Smith J M, Smith A J, Pothuri B. Utility of germline multi-gene panel testing in patients with endometrial cancer. Gynecol Oncol 2022:S0090-8258(22)00216-5. [PMID: 35483985 DOI: 10.1016/j.ygyno.2022.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
137 Lin A, De Backer J, Quatannens D, Cuypers B, Verswyvel H, De La Hoz EC, Ribbens B, Siozopoulou V, Van Audenaerde J, Marcq E, Lardon F, Laukens K, Vanlanduit S, Smits E, Bogaerts A. The effect of local non‐thermal plasma therapy on the cancer‐immunity cycle in a melanoma mouse model. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Paro A, Dalmacy D, Tslimigras DI, Cloyd J, Ejaz A, Pawlik TM. Association of County-Level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment among Patients with Hepatocellular Carcinoma. Ann Surg Oncol 2022. [PMID: 35441305 DOI: 10.1245/s10434-022-11726-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Feng LS, Su WQ, Cheng JB, Xiao T, Li HZ, Chen DA, Zhang ZL. Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021). Arch Pharm (Weinheim) 2022;:e2200051. [PMID: 35385159 DOI: 10.1002/ardp.202200051] [Reference Citation Analysis]
140 Bychkovsky B, Laws A, Katlin F, Hans M, Knust Graichen M, Pace LE, Scheib R, Garber JE, King TA. Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen. Breast Cancer Res Treat 2022. [PMID: 35378642 DOI: 10.1007/s10549-022-06577-5] [Reference Citation Analysis]
141 Cui M, Wang Z, Huang L, Wang J. Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis. BMC Complement Med Ther 2022;22. [DOI: 10.1186/s12906-022-03579-0] [Reference Citation Analysis]
142 Boome IT, Somers AM, Graupner C, Kimman ML, Gidding- Slok AH, Breukink SO. Development and content validation of the assessment of burden of ColoRectal cancer (ABCRC)-tool. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.04.002] [Reference Citation Analysis]
143 Schneider M, Linge A, Krause M, Baumann M. Importance of long-term follow up to address long-term effectiveness and toxicity of radiotherapy. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.04.014] [Reference Citation Analysis]
144 Zhou Z, Wang T, Du Y, Deng J, Gao G, Zhang J. Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm. Front Genet 2022;13:823728. [PMID: 35356430 DOI: 10.3389/fgene.2022.823728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Singh J, Wozniak A, Cotler SJ, Dhanarajan A, Aldrich D, Park D, Kasia C, Schmidt B, Scaglione S. Combined Use of Aspirin and Statin is Associated With a Decreased Incidence of Hepatocellular Carcinoma. J Clin Gastroenterol 2022;56:369-73. [PMID: 33883511 DOI: 10.1097/MCG.0000000000001546] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
146 Shi L, Qu Z, Yang Y, Zhang Y, Sun D. Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma. Comput Math Methods Med 2022;2022:8195512. [PMID: 35356664 DOI: 10.1155/2022/8195512] [Reference Citation Analysis]
147 Lei D, Wang T, Zhong WL. circSYPL1 Promotes the Proliferation and Metastasis of Hepatocellular Carcinoma via the Upregulation of EZH2 Expression by Competing with hsa-miR-506-3p. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/2659563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Michaeli JC, Michaeli DT, Boch T, Albers S, Michaeli T. Socio-economic burden of disease: Survivorship costs for renal cell carcinoma. Eur J Cancer Care (Engl) 2022. [PMID: 35293070 DOI: 10.1111/ecc.13569] [Reference Citation Analysis]
149 Chong N, Schoenberger H, Yekkaluri S, Fetzer DT, Rich NE, Yokoo T, Gopal P, Manwaring C, Quirk L, Singal AG. Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study. Aliment Pharmacol Ther 2022;55:683-90. [PMID: 35170052 DOI: 10.1111/apt.16779] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
150 Yao F, Zhao Y, Ma L. LIF-ting ferroptosis to improve liver cancer therapy. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.02.013] [Reference Citation Analysis]
151 Liu S, He L, Bannister OB, Schnegelberger RD, Tao J, Althouse AD, Schopfer FJ, Wahlang B, Cave MC, Monga SP, Zhang X, Arteel GE, Beier JI. Western diet unmasks transient low-level vinyl chloride exposure-induced tumorigenesis; potential role of the (epi-)transcriptome.. [DOI: 10.1101/2022.02.24.481808] [Reference Citation Analysis]
152 Cirmena G, Ferrando L, Ravera F, Garuti A, Dameri M, Gallo M, Barbero V, Ferrando F, Del Mastro L, Garlaschi A, Friedman D, Fregatti P, Ballestrero A, Zoppoli G. Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer. JCO Precis Oncol 2022;6:e2100198. [PMID: 35201850 DOI: 10.1200/PO.21.00198] [Reference Citation Analysis]
153 Joshi S, Raj KA, Rao MR, Ghosh R. An electronic biosensor based on semiconducting tetrazine polymer immobilizing matrix coated on rGO for carcinoembryonic antigen. Sci Rep 2022;12:3006. [PMID: 35194116 DOI: 10.1038/s41598-022-06976-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Guangshun S, Guoqiang S, Xin C, Xiangyi K, Wubin Z, Zhitao L, Zhiying Z, Hongyong C, Chengyu L, Yongxiang X, Weiwei T, Kanjoormana Aryan M. Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/4598573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Gokcen P, Guzelbulut F, Adali G, Degirmenci Salturk AG, Ozturk O, Bahadir O, Kanatsiz E, Kiyak M, Ozdil K, Doganay HL. Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment. World J Gastroenterol 2022; 28(6): 665-674 [DOI: 10.3748/wjg.v28.i6.665] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Tan X, Liu S, Yao L, Cui G, Liu J, Ding J, Cao S. Comprehensive Analysis of a Novel Lipid Metabolism-Related Gene Signature for Predicting the Prognosis and Immune Landscape in Uterine Corpus Endometrial Carcinoma. Journal of Oncology 2022;2022:1-22. [DOI: 10.1155/2022/8028825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Richards J, Begay T, Chambers RA, Patel H, Mayhew J, Allison-burbank J, Gishie L, Tsingine N, Badoni J, Staley L, Harvey B, Tsosie A, Begay M, Mitchell K, Tingey L. Azhe'é Bidziil (Strong Fathers): Study Protocol for the Pilot Evaluation of an American Indian Fatherhood Program to Improve the Health and Wellbeing of Diné (Navajo) Fathers. Front Public Health 2022;9:790024. [DOI: 10.3389/fpubh.2021.790024] [Reference Citation Analysis]
158 Curry L, Limaye W, Ramjeesingh R. Spontaneous regression of metastatic hepatocellular carcinoma following 3 weeks of lenvatinib. BMJ Case Rep 2022;15:e247212. [PMID: 35140091 DOI: 10.1136/bcr-2021-247212] [Reference Citation Analysis]
159 Levkovich I, Hamama-Raz Y, Shinan-Altman S. "A kaleidoscope of relationships" - cervical cancer survivors' perspectives on their intimate relationships: A qualitative study. Palliat Support Care 2022;:1-10. [PMID: 35130992 DOI: 10.1017/S147895152100198X] [Reference Citation Analysis]
160 Kong J, Yu G, Si W, Li G, Chai J, Liu Y, Liu J. Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09209-9] [Reference Citation Analysis]
161 Constantin N, Sina AAI, Korbie D, Trau M. Opportunities for Early Cancer Detection: The Rise of ctDNA Methylation-Based Pan-Cancer Screening Technologies. Epigenomes 2022;6:6. [DOI: 10.3390/epigenomes6010006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
162 Wan Z, Wang X. Role of SLC39A6 in the development and progression of liver cancer. Oncol Lett 2022;23:77. [PMID: 35111246 DOI: 10.3892/ol.2022.13197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Kumar A, Naithani M, Kumar N, Singh N, Agrawal S, Sharma A, Thapliyal S, Singh J, Handu S. Piperlongumine inhibits diethylnitrosamine induced hepatocellular carcinoma in rats. Hum Exp Toxicol 2022;41:9603271211073593. [PMID: 35113675 DOI: 10.1177/09603271211073593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Levitch CF, Holland AA, Bledsoe J, Kim SY, Barnett M, Ramjan S, Sands SA. Comparison of neuropsychological functioning in pediatric posterior fossa tumor survivors: Medulloblastoma, low-grade astrocytoma, and healthy controls. Pediatr Blood Cancer 2022;69:e29491. [PMID: 34842359 DOI: 10.1002/pbc.29491] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
165 Gao Y, Qiu J, Gu L, Yang Y, Kang H, Zhang Y, Zhang S, Zhang Y, Wang H, Zhang Y, Qian J. Secondary primary lung cancer after esophageal cancer: a population-based study of 44,172 patients. Scand J Gastroenterol 2022;57:222-31. [PMID: 34726133 DOI: 10.1080/00365521.2021.1994639] [Reference Citation Analysis]
166 Yang Y, Huang Q, Xiao Z, Liu M, Zhu Y, Chen Q, Li Y, Ai K. Nanomaterial-based biosensor developing as a route toward in vitro diagnosis of early ovarian cancer. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100218] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
167 Hu J, Tan J, Dong F, Zhang X, Ming J, Huang T. The Effect of Post-Mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: A Propensity Score-Matched Analysis of the SEER Database. Front Oncol 2021;11:593121. [PMID: 35096554 DOI: 10.3389/fonc.2021.593121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Kendal JK, Heard BJ, Abbott AG, Moorman SW, Saini R, Puloski SKT, Monument MJ. Does surgical technique influence the burden of lung metastases in patients with pathologic long bone fractures? BMC Musculoskelet Disord 2022;23:102. [PMID: 35101024 DOI: 10.1186/s12891-022-05067-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Wang L, Shi C, Yu J, Xu Y. FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-021-02372-2] [Reference Citation Analysis]
170 Zhao Z, Wang C, Chu P, Lu X. Key Genes Associated with Tumor-Infiltrating Non-regulatory CD4- and CD8-Positive T Cells in Microenvironment of Hepatocellular Carcinoma. Biochem Genet. [DOI: 10.1007/s10528-021-10175-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
171 Gąska W, Lohk C, Verduin M, Hubert C, Vooijs M, Cavill R, Staňková K. How to use transcriptomic data for game-theoretic modeling of treatment-induced resistance in cancer cells? A case study in patient-derived glioblastoma organoids.. [DOI: 10.1101/2022.01.26.477755] [Reference Citation Analysis]
172 Zhang Y, Xu Y, Ma W, Wu H, Xu G, Chekhonin VP, Peltzer K, Wang X, Wang G, Zhang C. The homogeneity and heterogeneity of occurrence, characteristics, and prognosis in hepatocellular carcinoma patients with synchronous and metachronous bone metastasis. J Cancer 2022;13:393-400. [PMID: 35069889 DOI: 10.7150/jca.65308] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
173 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7-33. [PMID: 35020204 DOI: 10.3322/caac.21708] [Cited by in Crossref: 1857] [Cited by in F6Publishing: 1933] [Article Influence: 1857.0] [Reference Citation Analysis]
174 Chen J, Tao Q, Lang Z, Gao Y, Jin Y, Li X, Wang Y, Zhang Y, Yu S, Lv B, Yu Z, Lin C, Duan B. Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/4494713] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
175 Huang S, Zhang J, Lai X, Zhuang L, Wu J. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients. Front Mol Biosci 2021;8:781307. [PMID: 35004851 DOI: 10.3389/fmolb.2021.781307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
176 Nagasaka M, Al-share B, Shao YF, Sexton R, Al Hallak MN, Azmi AS, Sukari A. The Gut Microbiome and Cancer: A Comprehensive Review of Melanoma, Lung, Head and Neck and Gastrointestinal Tumors. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00047-4] [Reference Citation Analysis]
177 Orhan A. The Tumor Microenvironment in Pancreatic Cancer and Challenges to Immunotherapy. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_65] [Reference Citation Analysis]
178 Payne CF, Kobayashi LC. Changes in Life Expectancy and Disability-Free Life Expectancy in Successive Birth Cohorts of Older Cancer Survivors: A Longitudinal Modeling Analysis of the US Health and Retirement Study. Am J Epidemiol 2022;191:104-14. [PMID: 34613389 DOI: 10.1093/aje/kwab241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
179 Poghosyan H, Mello S, Robinson KN, Tan ASL. Worry About the Future Health Issues of Smoking and Intention to Screen for Lung Cancer With Low-Dose Computed Tomography. Cancer Nurs 2022;45:E146-52. [PMID: 34870941 DOI: 10.1097/NCC.0000000000000897] [Reference Citation Analysis]
180 Liu L, Liu Z, Meng L, Li L, Gao J, Yu S, Hu B, Yang H, Guo W, Zhang S. An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma. Front Mol Biosci 2021;8:766609. [PMID: 34970594 DOI: 10.3389/fmolb.2021.766609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
181 Castillo M. Thoracic Anesthesia for the Geriatric Patient. Cohen's Comprehensive Thoracic Anesthesia 2022. [DOI: 10.1016/b978-0-323-71301-6.00038-x] [Reference Citation Analysis]
182 Ahmed A, Ata F, Gaber M, Petkar M, Mahfouz A, Schirmacher P, Musa S, Hashim A. Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review. Current Problems in Cancer: Case Reports 2022. [DOI: 10.1016/j.cpccr.2022.100141] [Reference Citation Analysis]
183 Orhan A. Cancer Immunodiagnosis in Upper Gastrointestinal Cancers. Handbook of Cancer and Immunology 2022. [DOI: 10.1007/978-3-030-80962-1_147-1] [Reference Citation Analysis]
184 Semiz HS, Öztop İ. Systemic Treatments and Related Side Effects in Liver Tumors. Radionuclide Therapy 2022. [DOI: 10.1007/978-3-030-97220-2_14] [Reference Citation Analysis]
185 Dhandayuthapani S, Bhagat T. Triple-negative breast cancer in young aged Indian women - An overview. Santosh Univ J Health Sci 2022;8:108. [DOI: 10.4103/sujhs.sujhs_32_22] [Reference Citation Analysis]
186 Marchese V, Rock K, York T, Ruble K, Gray VL. The Efficacy of Targeted Exercise on Gross Motor and Neuromuscular Performance in Survivors of Childhood Leukemia: A Pilot Study. Front Pediatr 2022;10:891650. [PMID: 35633967 DOI: 10.3389/fped.2022.891650] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Meltzer C, Skaane P. Mammography Screening. Breast Imaging 2022. [DOI: 10.1007/978-3-030-94918-1_3] [Reference Citation Analysis]
188 Howard D, James D, Garcia-Parra J, Pan-Castillo B, Worthington J, Williams N, Coombes Z, Rees SC, Lutchman-Singh K, Francis LW, Rees P, Margarit L, Conlan RS, Gonzalez D. Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer. Front Oncol 2022;12:1014280. [PMID: 36505806 DOI: 10.3389/fonc.2022.1014280] [Reference Citation Analysis]
189 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA A Cancer J Clinicians 2022;72:7-33. [DOI: 10.3322/caac.21708] [Cited by in Crossref: 1983] [Cited by in F6Publishing: 1] [Article Influence: 1983.0] [Reference Citation Analysis]
190 Díaz SP, Barreiro VB, Pillado MTS, Alhayek-aí M, Santamaría PG, Martín CG. Prognosis and follow-up of CRC patients: Role of diagnostic and therapeutic delay. Foundations of Colorectal Cancer 2022. [DOI: 10.1016/b978-0-323-90055-3.00011-9] [Reference Citation Analysis]
191 Dunn M, Milius L, Ivarra A, Cooper M, Bhakta N. Motivations and Experiences in a Physical Activity Program for Cancer Survivors: Findings from Key Informant Interviews. Am J Health Promot 2021;:8901171211061939. [PMID: 34969306 DOI: 10.1177/08901171211061939] [Reference Citation Analysis]
192 Yammine K, Akiki S, Assi C, Hayek Md F. Amputation as a First Treatment is Highly Associated With Late Presentation: An Underestimated Modifiable Major Risk Factor for Diabetic Foot Ulcer. Foot Ankle Spec 2021;:19386400211067625. [PMID: 34967230 DOI: 10.1177/19386400211067625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
193 Xia X, Tang P, Liu H, Li Y. Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma. J Clin Transl Hepatol 2021;9:798-808. [PMID: 34966643 DOI: 10.14218/JCTH.2021.00017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
194 Murgaski A, Kiss M, Van Damme H, Kancheva D, Vanmeerbeek I, Keirsse J, Hadadi E, Brughmans J, Arnouk SM, Hamouda AEI, Debraekeleer A, Bosteels V, Elkrim Y, Boon L, Hoves S, Vandamme N, Deschoemaeker S, Janssens S, Garg AD, Schmittnägel M, Ries CH, Laoui D. Distinct cDC subsets co-operate in CD40 agonist response while suppressive microenvironments and lack of antigens subvert efficacy.. [DOI: 10.1101/2021.12.25.474021] [Reference Citation Analysis]
195 Maitra R, Malik P, Mukherjee TK. Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A Perspective. Cancers (Basel) 2021;14:80. [PMID: 35008242 DOI: 10.3390/cancers14010080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Yao F, Deng Y, Zhao Y, Mei Y, Zhang Y, Liu X, Martinez C, Su X, Rosato RR, Teng H, Hang Q, Yap S, Chen D, Wang Y, Chen MM, Zhang M, Liang H, Xie D, Chen X, Zhu H, Chang JC, You MJ, Sun Y, Gan B, Ma L. A targetable LIFR-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nat Commun 2021;12:7333. [PMID: 34921145 DOI: 10.1038/s41467-021-27452-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 20.5] [Reference Citation Analysis]
197 Ojinnaka CO, Bruening M. Black-White racial disparities in health care utilization and self-reported health among cancer survivors: The role of food insecurity. Cancer 2021;127:4620-7. [PMID: 34415573 DOI: 10.1002/cncr.33871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
198 Mouchli M, Reddy S, Gerrard M, Boardman L, Rubio M. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article. Ann Hepatol 2021;22:100249. [PMID: 32896610 DOI: 10.1016/j.aohep.2020.08.067] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
199 Zhao LX, Zhang K, Shen BB, Li JN. Mesenchymal stem cell-derived exosomes for gastrointestinal cancer. World J Gastrointest Oncol 2021; 13(12): 1981-1996 [DOI: 10.4251/wjgo.v13.i12.1981] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
200 Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, Carver J, Dent S, Ky B, Lyon AR, López-Fernández T, Fradley MG, Ganatra S, Curigliano G, Mitchell JD, Minotti G, Lang NN, Liu JE, Neilan TG, Nohria A, O'Quinn R, Pusic I, Porter C, Reynolds KL, Ruddy KJ, Thavendiranathan P, Valent P. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J 2022;43:280-99. [PMID: 34904661 DOI: 10.1093/eurheartj/ehab674] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 30.0] [Reference Citation Analysis]
201 Conci S, D'Onofrio M, Bianco A, Campagnaro T, Martone E, De Bellis M, Longo C, Dedoni S, Vittoria D'Addetta M, Ciangherotti A, Pedrazzani C, Dalbeni A, Campagnola P, Mansueto G, Guglielmi A, Ruzzenente A. Ablation Difficulty Score: Proposal of a new tool to predict success rate of percutaneous ablation for hepatocarcinoma. Eur J Radiol 2022;146:110097. [PMID: 34896959 DOI: 10.1016/j.ejrad.2021.110097] [Reference Citation Analysis]
202 Islami F, Guerra CE, Minihan A, Yabroff KR, Fedewa SA, Sloan K, Wiedt TL, Thomson B, Siegel RL, Nargis N, Winn RA, Lacasse L, Makaroff L, Daniels EC, Patel AV, Cance WG, Jemal A. American Cancer Society's report on the status of cancer disparities in the United States, 2021. CA Cancer J Clin 2021. [PMID: 34878180 DOI: 10.3322/caac.21703] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
203 Wu Q, Jiang S, Cheng T, Xu M, Lu B. A Novel Pyroptosis-related Prognostic Model for Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:770301. [PMID: 34869364 DOI: 10.3389/fcell.2021.770301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
204 Galinski B, Alexander TB, Mitchell DA, Chatwin HV, Awah C, Green AL, Weiser DA. Therapeutic Targeting of Exportin-1 in Childhood Cancer. Cancers (Basel) 2021;13:6161. [PMID: 34944778 DOI: 10.3390/cancers13246161] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
205 Gierz K, Park K. Detection of multiple change points in a Weibull accelerated failure time model using sequential testing. Biom J 2021. [PMID: 34873728 DOI: 10.1002/bimj.202000262] [Reference Citation Analysis]
206 Idrees BS, Wang Q, Khan MN, Teng G, Cui X, Xiangli W, Wei K. In-vitro study on the identification of gastrointestinal stromal tumor tissues using laser-induced breakdown spectroscopy with chemometric methods. Biomed Opt Express 2022;13:26. [DOI: 10.1364/boe.442489] [Reference Citation Analysis]
207 Jones TH, Song JW, Abushahin L. Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers. Transl Oncol 2022;15:101296. [PMID: 34847422 DOI: 10.1016/j.tranon.2021.101296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
208 Beier JI, Arteel GE. Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns. Acta Pharm Sin B 2021;11:3768-78. [PMID: 35024305 DOI: 10.1016/j.apsb.2021.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
209 Zhang H, Xia P, Liu J, Chen Z, Ma W, Yuan Y. ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival. Int J Biol Sci 2021;17:4442-58. [PMID: 34803509 DOI: 10.7150/ijbs.65669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
210 Sun W, Hu C, Wang T, Wang J, Zhang J, Gao F, Ou Q, Tian H, Jin C, Xu J, Zhang J, Xu GT, Lu L. Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Front Oncol 2021;11:744331. [PMID: 34796110 DOI: 10.3389/fonc.2021.744331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
211 Cheng YX, Tao W, Liu XY, Yuan C, Zhang B, Zhang W, Peng D. The outcome of young vs. old gastric cancer patients following gastrectomy: a propensity score matching analysis. BMC Surg 2021;21:399. [PMID: 34798854 DOI: 10.1186/s12893-021-01401-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 Du K, Li L, Wang Q, Zou J, Yu Z, Li J, Zheng Y. Development and application of a dynamic prediction model for esophageal cancer. Ann Transl Med 2021;9:1546. [PMID: 34790752 DOI: 10.21037/atm-21-4964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
213 Li L, Lu J, Dai X, Ma L, Wang C, Feng L. The lag effect of 24-year tobacco consumption on lung cancer mortality in Henan Province, China, 1992 to 2016. Environ Sci Pollut Res Int 2021. [PMID: 34787807 DOI: 10.1007/s11356-021-17302-y] [Reference Citation Analysis]
214 Boakye D, Günther K, Niedermaier T, Haug U, Ahrens W, Nagrani R. Associations between comorbidities and advanced stage diagnosis of lung, breast, colorectal, and prostate cancer: A systematic review and meta-analysis. Cancer Epidemiol 2021;75:102054. [PMID: 34773768 DOI: 10.1016/j.canep.2021.102054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
215 Lee J, Nair N. The Current and Future States of Screening in Gynecologic Cancers. Obstet Gynecol Clin North Am 2021;48:705-22. [PMID: 34756291 DOI: 10.1016/j.ogc.2021.06.001] [Reference Citation Analysis]
216 Sükei T, Palma E, Urbani L. Interplay between Cellular and Non-Cellular Components of the Tumour Microenvironment in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:5586. [PMID: 34771746 DOI: 10.3390/cancers13215586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
217 Abbott A, Kendal JK, Hewison C, Puloski S, Monument M. Longitudinal survival trends of patients with cancer with surgically managed appendicular metastatic bone disease: systematic review. Can J Surg 2021;64:E550-60. [PMID: 34728520 DOI: 10.1503/cjs.015520] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
218 Ma B, Cao L, Li Y. A novel 10-gene immune-related lncRNA signature model for the prognosis of colorectal cancer. Math Biosci Eng 2021;18:9743-60. [PMID: 34814366 DOI: 10.3934/mbe.2021477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
219 Hernandez-Meza G, Vietti Violi N, Said D, Novogrodsky E, Villavisanis D, Maron SZ, Frere J, Schiano TD, Friedman S, Boffetta P, Branch A, Taouli B. MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center. Abdom Radiol (NY) 2021;46:5142-51. [PMID: 34283266 DOI: 10.1007/s00261-021-03212-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
220 Reno JE, Dempsey AF. Testing Messages on Facebook to Promote Use of an HPV Educational Web-Intervention. Front Digit Health 2021;3:648555. [PMID: 34713120 DOI: 10.3389/fdgth.2021.648555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
221 Chen CT, Wu PH, Hu CC, Nien HC, Wang JT, Sheu JC, Chow LP. Aberrant Upregulation of Indoleamine 2,3-Dioxygenase 1 Promotes Proliferation and Metastasis of Hepatocellular Carcinoma Cells via Coordinated Activation of AhR and β-Catenin Signaling. Int J Mol Sci 2021;22:11661. [PMID: 34769098 DOI: 10.3390/ijms222111661] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
222 Mahbub F, Islam R, Akash SB, Ali MT, Islam S. Design and Implementation of a Microstrip Patch Antenna for the Detection of Cancers and Tumors in Skeletal Muscle of the Human Body Using ISM Band. 2021 IEEE 12th Annual Information Technology, Electronics and Mobile Communication Conference (IEMCON) 2021. [DOI: 10.1109/iemcon53756.2021.9623236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
223 Warren ML, Schneider VV, Qing Y, Feng L, Campbell JY, Myers JW, Von-Maszewski M, Gutierrez C. Short- and Long-Term Outcomes of Hematologic Malignancy Patients After Cardiopulmonary Resuscitation: Experience of a Large Oncology Center. J Adv Pract Oncol 2021;12:705-14. [PMID: 34671500 DOI: 10.6004/jadpro.2021.12.7.4] [Reference Citation Analysis]
224 Lam M, Zhu JW, Hu A, Beecker J. Racial Differences in the Prognosis and Survival of Cutaneous Melanoma From 1990 to 2020 in North America: A Systematic Review and Meta-Analysis. J Cutan Med Surg 2021;:12034754211052866. [PMID: 34676795 DOI: 10.1177/12034754211052866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
225 Ambinder EB, Oluyemi E, Kong X, Nguyen DL, Visvanathan K. Disparities in the uptake of digital breast tomosynthesis for breast cancer screening: A retrospective cohort study. Breast J 2021. [PMID: 34668275 DOI: 10.1111/tbj.14292] [Reference Citation Analysis]
226 Zheng G, Chattopadhyay S, Sundquist K, Sundquist J, Försti A, Hemminki A, Hemminki K. Types of second primary cancer influence overall survival in cutaneous melanoma. BMC Cancer 2021;21:1123. [PMID: 34663263 DOI: 10.1186/s12885-021-08845-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
227 Gong X, Pu X, Wang J, Yang L, Cui Y, Li L, Sun X, Liu J, Bai J, Wang Y. Enhancing of Nanocatalyst-Driven Chemodynaminc Therapy for Endometrial Cancer Cells Through Inhibition of PINK1/Parkin-Mediated Mitophagy. Int J Nanomedicine 2021;16:6661-79. [PMID: 34616150 DOI: 10.2147/IJN.S329341] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
228 Gepner Y, Lev-Ari S, Goldbourt U. Excess Body Weight and Long-Term Incidence of Lung and Colon Cancer in Men; Follow-Up Study of 43 Years. Int J Environ Res Public Health 2021;18:10418. [PMID: 34639717 DOI: 10.3390/ijerph181910418] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
229 Chen H, Yan L, Pu S, Zhu L, Zhang H, Zhou C. Research on Effectiveness of Prior Cancer on Survival Outcomes for Patients with Nonmetastatic Triple-Negative Breast Cancer: A Competing Risk Analysis and Propensity Score Matching Analysis of the SEER Database. J Oncol 2021;2021:9988624. [PMID: 34580591 DOI: 10.1155/2021/9988624] [Reference Citation Analysis]
230 Ailioaie LM, Ailioaie C, Litscher G. Latest Innovations and Nanotechnologies with Curcumin as a Nature-Inspired Photosensitizer Applied in the Photodynamic Therapy of Cancer. Pharmaceutics 2021;13:1562. [PMID: 34683855 DOI: 10.3390/pharmaceutics13101562] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
231 Liu Y, Chen Y, Fei W, Zheng C, Zheng Y, Tang M, Qian Y, Zhang X, Zhao M, Zhang M, Wang F. Silica-Based Nanoframeworks Involved Hepatocellular Carcinoma Theranostic. Front Bioeng Biotechnol 2021;9:733792. [PMID: 34557478 DOI: 10.3389/fbioe.2021.733792] [Reference Citation Analysis]
232 Shadbad MA, Asadzadeh Z, Derakhshani A, Hosseinkhani N, Mokhtarzadeh A, Baghbanzadeh A, Hajiasgharzadeh K, Brunetti O, Argentiero A, Racanelli V, Silvestris N, Baradaran B. A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery. Biomed Pharmacother 2021;143:112213. [PMID: 34560556 DOI: 10.1016/j.biopha.2021.112213] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
233 Zhao H, Zhang X, Guo L, Shi S, Lu C. A Robust Seven-Gene Signature Associated With Tumor Microenvironment to Predict Survival Outcomes of Patients With Stage III-IV Lung Adenocarcinoma. Front Genet 2021;12:684281. [PMID: 34552612 DOI: 10.3389/fgene.2021.684281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
234 Lu X, Song X, Hao X, Liu X, Zhang X, Yuan N, Ma H, Zhang Z. miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway. Bioengineered 2021;12:7079-92. [PMID: 34551673 DOI: 10.1080/21655979.2021.1977053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
235 Voshedskiy VI, Sakun PG, Genkova EA, Pushkin AA, Sitkovskaya AO, Mezhevova IV, Vlasov SG, Rogova TS. Molecular alterations in the culture of lung cancer cells H1299 after exposure to high doses of ionizing radiation. Innovacionnaâ medicina Kubani 2021. [DOI: 10.35401/2500-0268-2021-23-3-19-23] [Reference Citation Analysis]
236 Li JJ, Liang Q, Sun GC. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. J Integr Med 2021;19:469-77. [PMID: 34538644 DOI: 10.1016/j.joim.2021.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
237 Monda E, Lioncino M, Pacileo R, Rubino M, Cirillo A, Fusco A, Esposito A, Verrillo F, Di Fraia F, Mauriello A, Tessitore V, Caiazza M, Cesaro A, Calabrò P, Russo MG, Limongelli G. Advanced Heart Failure in Special Population-Pediatric Age. Heart Fail Clin 2021;17:673-83. [PMID: 34511214 DOI: 10.1016/j.hfc.2021.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
238 Metzger K, Mrosek J, Zittel S, Pilz M, Held T, Adeberg S, Ristow O, Hoffmann J, Engel M, Freudlsperger C, Moratin J. Treatment delay and tumor size in patients with oral cancer during the first year of the COVID-19 pandemic. Head Neck 2021;43:3493-7. [PMID: 34494330 DOI: 10.1002/hed.26858] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
239 Ogawa S, Kubo H, Murayama Y, Kubota T, Yubakami M, Matsumoto T, Yamamoto Y, Morimura R, Ikoma H, Okamoto K, Kamiya M, Urano Y, Otsuji E. Rapid fluorescence imaging of human hepatocellular carcinoma using the β-galactosidase-activatable fluorescence probe SPiDER-βGal. Sci Rep 2021;11:17946. [PMID: 34504174 DOI: 10.1038/s41598-021-97073-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
240 Pang Y, Tan G, Yang X, Lin Y, Chen Y, Zhang J, Xie T, Zhou H, Fang J, Zhao Q, Ren X, Li J, Lyu J, Wang Z. Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma. Cancer Cell Int 2021;21:463. [PMID: 34488769 DOI: 10.1186/s12935-021-02131-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
241 Bryant A, Hiu S, Kunonga P, Gajjar K, Craig D, Vale L, Winter-roach BA, Elattar A, Naik R; Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Cochrane Database of Systematic Reviews 2021;2021. [DOI: 10.1002/14651858.cd015048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
242 Fattakhov TA, Mironova AA, Pyankova AI, Shahzadova AO. CANCER MORTALITY IN RUSSIA FOR THE PERIOD OF 1965–2019: MAIN STRUCTURAL CHANGES AND TRENDS. Sib onkol ž 2021;20:5-20. [DOI: 10.21294/1814-4861-2021-20-4-5-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
243 Borgia M, Dal Bo M, Toffoli G. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4387. [PMID: 34503196 DOI: 10.3390/cancers13174387] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
244 Lin H, Chen H, Weng L, Shao J, Lin J. Automatic detection of oral cancer in smartphone-based images using deep learning for early diagnosis. J Biomed Opt 2021;26. [PMID: 34453419 DOI: 10.1117/1.JBO.26.8.086007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
245 Xie L, Zhu G, Shang J, Chen X, Zhang C, Ji X, Zhang Q, Wei Y. An overview on the biological activity and anti-cancer mechanism of lovastatin. Cell Signal 2021;87:110122. [PMID: 34438015 DOI: 10.1016/j.cellsig.2021.110122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
246 Xu JH, Guan YJ, Zhang YC, Qiu ZD, Zhou Y, Chen C, Yu J, Wang WX. ADAM15 correlates with prognosis, immune infiltration and apoptosis in hepatocellular carcinoma. Aging (Albany NY) 2021;13:20395-417. [PMID: 34426560 DOI: 10.18632/aging.203425] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
247 Zheng Y, Zhang X, Lu J, Liu S, Qian Y. Association between socioeconomic status and survival in patients with hepatocellular carcinoma. Cancer Med 2021;10:7347-59. [PMID: 34414679 DOI: 10.1002/cam4.4223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
248 Xie Y, Tian H, Xiang B, Zhang Y, Liu J, Cai Z, Xiang H. Transarterial chemoembolization plus sorafenib versus sorafenib for intermediate-advanced hepatocellular carcinoma: A meta-analysis comparing clinical outcomes. Medicine (Baltimore) 2021;100:e26958. [PMID: 34414963 DOI: 10.1097/MD.0000000000026958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
249 Benedict C, Wang J, Reppucci M, Schleien CL, Fish JD. Cost of survivorship care and adherence to screening-aligning the priorities of health care systems and survivors. Transl Behav Med 2021;11:132-42. [PMID: 31907549 DOI: 10.1093/tbm/ibz182] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
250 Wang A, Chen X, Li D, Yang L, Jiang J. METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis. J Clin Lab Anal 2021;35:e23931. [PMID: 34398984 DOI: 10.1002/jcla.23931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
251 Ilyas FZ, Beane JD, Pawlik TM. The State of Immunotherapy in Hepatobiliary Cancers. Cells 2021;10:2096. [PMID: 34440865 DOI: 10.3390/cells10082096] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
252 Arbour C, Tremblay M, Ogez D, Martineau-Lessard C, Lavigne G, Rainville P. Feasibility and acceptability of hypnosis-derived communication administered by trained nurses to improve patient well-being during outpatient chemotherapy: a pilot-controlled trial. Support Care Cancer 2021. [PMID: 34374847 DOI: 10.1007/s00520-021-06481-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
253 Gu JH, Zhao QY, He C, Ye ZD, Xu M, Jiang TA. Fusion imaging-guided radiofrequency ablation for residual hepatocellular carcinoma invisible on ultrasound after transcatheter arterial chemoembolization. Int J Hyperthermia 2021;38:1092-8. [PMID: 34296656 DOI: 10.1080/02656736.2021.1943545] [Reference Citation Analysis]
254 Masic S, Strother M, Kidd LC, Egleston B, Braun A, Srivastava A, Smaldone M, Milestone B, Parsons R, Viterbo R, Greenberg R, Chen D, Kutikov A, Uzzo R. Feasibility and Outcomes of Renal Mass Biopsy for Anatomically Complex Renal Tumors. Urology 2021:S0090-4295(21)00732-9. [PMID: 34380055 DOI: 10.1016/j.urology.2021.07.026] [Reference Citation Analysis]
255 Elfadaly AN, Tsilimigras DI, Hyer JM, Paro A, Bagante F, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM. Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis. World J Surg 2021. [PMID: 34341844 DOI: 10.1007/s00268-021-06265-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
256 Al-Malki AL, Bakkar A, Huwait EA, Barbour EK, Abulnaja KO, Kumosani TA, Moselhy SS. Strigol1/albumin/chitosan nanoparticles decrease cell viability, induce apoptosis and alter metabolomics profile in HepG2 cancer cell line. Biomed Pharmacother 2021;142:111960. [PMID: 34352718 DOI: 10.1016/j.biopha.2021.111960] [Reference Citation Analysis]
257 Zhang L, Hu J, Hou J, Jiang X, Guo L, Tian L. Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection. Abdom Radiol (NY) 2021;46:3845-54. [PMID: 33733337 DOI: 10.1007/s00261-021-03034-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
258 Elmohr MM, Chernyak V, Sirlin CB, Elsayes KM. Liver Imaging Reporting and Data System Comprehensive Guide: MR Imaging Edition. Magn Reson Imaging Clin N Am 2021;29:375-87. [PMID: 34243924 DOI: 10.1016/j.mric.2021.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
259 Bastian TD, Burhansstipanov L. Sharing Wisdom, Sharing Hope: Strategies Used by Native American Cancer Survivors to Restore Quality of Life. JCO Glob Oncol 2020;6:161-6. [PMID: 32031445 DOI: 10.1200/JGO.19.00215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
260 Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Roselind FS; ICMR-NCDIR-NCRP Investigator Group. Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. JCO Glob Oncol 2020;6:1063-75. [PMID: 32673076 DOI: 10.1200/GO.20.00122] [Cited by in Crossref: 220] [Cited by in F6Publishing: 248] [Article Influence: 110.0] [Reference Citation Analysis]
261 Liu SR, Yan Q, Lin HM, Shi GZ, Cao Y, Zeng H, Liu C, Zhang R. Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports. World J Clin Cases 2021; 9(21): 5988-5998 [PMID: 34368318 DOI: 10.12998/wjcc.v9.i21.5988] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
262 Bae JH, Kim JH, Lee J, Kye BH, Lee SC, Lee IK, Kang WK, Cho HM, Lee YS. Addition of V-Stage to Conventional TNM Staging to Create the TNVM Staging System for Accurate Prediction of Prognosis in Colon Cancer: A Multi-Institutional Retrospective Cohort Study. Biomedicines 2021;9:888. [PMID: 34440092 DOI: 10.3390/biomedicines9080888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
263 Villalobos A, Wagstaff W, Guo M, Zhang J, Bercu Z, Whitmore MJ, Cristescu MM, Majdalany BS, Wedd J, Akce M, Magliocca J, Kokabi N. Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma. Can J Gastroenterol Hepatol 2021;2021:9926704. [PMID: 34336728 DOI: 10.1155/2021/9926704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
264 Qi L, Wang W, Wu T, Zhu L, He L, Wang X. Multi-Omics Data Fusion for Cancer Molecular Subtyping Using Sparse Canonical Correlation Analysis. Front Genet 2021;12:607817. [PMID: 34367231 DOI: 10.3389/fgene.2021.607817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
265 Ye C, Wang X, Sun Y, Deng Y, Huang Y, Chi P. A nomogram predicting the difficulty of laparoscopic surgery for rectal cancer. Surg Today 2021. [PMID: 34296313 DOI: 10.1007/s00595-021-02338-x] [Reference Citation Analysis]
266 Pinheiro PS, Medina HN, Koru-Sengul T, Qiao B, Schymura M, Kobetz EN, Schlumbrecht MP. Endometrial Cancer Type 2 Incidence and Survival Disparities Within Subsets of the US Black Population. Front Oncol 2021;11:699577. [PMID: 34354948 DOI: 10.3389/fonc.2021.699577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
267 Schatz-Siemers N, Chen YT, Chen Z, Wang D, Ellenson LH, Du YN. Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression. Appl Immunohistochem Mol Morphol 2020;28:453-9. [PMID: 30920393 DOI: 10.1097/PAI.0000000000000763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
268 Rhoades DA, Farley J, Schwartz SM, Malloy KM, Wang W, Best LG, Zhang Y, Ali T, Yeh F, Rhoades ER, Lee E, Howard BV. Cancer mortality in a population-based cohort of American Indians - The strong heart study. Cancer Epidemiol 2021;74:101978. [PMID: 34293639 DOI: 10.1016/j.canep.2021.101978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
269 Zhan K, Bai Y, Liao S, Chen H, Kuang L, Luo Q, Lv L, Qiu L, Mei Z. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma. Mol Med Rep 2021;24:650. [PMID: 34278494 DOI: 10.3892/mmr.2021.12289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
270 Oskarsson T, Duun-Henriksen AK, Bautz A, Montgomery S, Harila-Saari A, Petersen C, Niinimäki R, Madanat-Harjuoja L, Tryggvadóttir L, Holmqvist AS, Hasle H, Heyman M, Winther JF; ALiCCS study group. Skeletal adverse events in childhood cancer survivors: An Adult Life after Childhood Cancer in Scandinavia cohort study. Int J Cancer 2021. [PMID: 34278568 DOI: 10.1002/ijc.33741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
271 Li G, Du X, Wu X, Wu S, Zhang Y, Xu J, Wang H, Chen T. Large-Scale Transcriptome Analysis Identified a Novel Cancer Driver Genes Signature for Predicting the Prognostic of Patients With Hepatocellular Carcinoma. Front Pharmacol 2021;12:638622. [PMID: 34335239 DOI: 10.3389/fphar.2021.638622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
272 George Notas, Athanasios Panagiotopoulos, Rodanthi Vamvoukaki, Konstantina Kalyvianaki, Foteini Kiagiadaki, Alexandra Deli, Marilena Kampa, Elias Castanas. ERα36–GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells. Int J Mol Sci 2021;22:7603. [PMID: 34299224 DOI: 10.3390/ijms22147603] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
273 Qureshi A, Michel M, Lerner J, Dasanu CA. Evolving therapeutic strategies for advanced hepatocellular carcinoma. Expert Opin Pharmacother 2021;:1-12. [PMID: 34252328 DOI: 10.1080/14656566.2021.1953473] [Reference Citation Analysis]
274 Xia H, Huang Z, Liu S, Zhao X, He R, Wang Z, Shi W, Chen W, Li Z, Yu L, Huang P, Kang P, Su Z, Xu Y, Yam JWP, Cui Y. LncRNA DiGeorge syndrome critical region gene 5: A crucial regulator in malignant tumors. Biomed Pharmacother 2021;141:111889. [PMID: 34323697 DOI: 10.1016/j.biopha.2021.111889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
275 Fang Y, Chen G, Chen F, Hu E, Dong X, Li Z, He L, Sun Y, Qiu L, Xu H, Cai Z, Liu X. Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma. Cancer Sci 2021. [PMID: 34255396 DOI: 10.1111/cas.15058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
276 Zhang B, Chen M, Cao J, Liang Y, Tu T, Hu J, Li T, Cai Y, Li S, Liu B, Xu J, Liang B, Ye X, Cai X. An integrated electrochemical POCT platform for ultrasensitive circRNA detection towards hepatocellular carcinoma diagnosis. Biosens Bioelectron 2021;192:113500. [PMID: 34280653 DOI: 10.1016/j.bios.2021.113500] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
277 Liu G, Ma JY, Hu G, Jin H. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients. PLoS One 2021;16:e0254368. [PMID: 34252149 DOI: 10.1371/journal.pone.0254368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
278 Liu B, Ornstein KA, Alpert N, Schwartz RM, Dharmarajan KV, Kelley AS, Taioli E. Trends of hospitalizations among patients with both cancer and dementia diagnoses in New York 2007-2017. Healthc (Amst) 2021;9:100565. [PMID: 34252707 DOI: 10.1016/j.hjdsi.2021.100565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
279 Price SN, Flores M, Hamann HA, Ruiz JM. Ethnic Differences in Survival Among Lung Cancer Patients: A Systematic Review. JNCI Cancer Spectr 2021;5. [PMID: 34485813 DOI: 10.1093/jncics/pkab062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
280 Ogawa S, Kubo H, Murayama Y, Kubota T, Yubakami M, Matsumoto T, Ohashi T, Okamoto K, Kuriki Y, Hanaoka K, Urano Y, Otsuji E. Matrix metalloprotease-14 is a target enzyme for detecting peritoneal metastasis in gastric cancer. Photodiagnosis Photodyn Ther 2021;35:102420. [PMID: 34242818 DOI: 10.1016/j.pdpdt.2021.102420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
281 Jiang T, Sánchez-Rivera FJ, Soto-Feliciano YM, Yang Q, Song CQ, Bhuatkar A, Haynes CM, Hemann MT, Xue W. Targeting the De Novo Purine Synthesis Pathway Through Adenylosuccinate Lyase Depletion Impairs Liver Cancer Growth by Perturbing Mitochondrial Function. Hepatology 2021;74:233-47. [PMID: 33336367 DOI: 10.1002/hep.31685] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
282 Afifi AM, Elmehrath AO, Ruhban IA, Saad AM, Gad MM, Al-Husseini MJ, Bekaii-Saab T, Sonbol MB. Causes of Death Following Nonmetastatic Colorectal Cancer Diagnosis in the U.S.: A Population-Based Analysis. Oncologist 2021;26:733-9. [PMID: 34101294 DOI: 10.1002/onco.13854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
283 Xu Y, Yuan X, Zhang X, Hu W, Wang Z, Yao L, Zong L. Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma. Medicine (Baltimore) 2021;100:e26506. [PMID: 34160470 DOI: 10.1097/MD.0000000000026506] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
284 Craig AJ, Garcia-Lezana T, Ruiz de Galarreta M, Villacorta-Martin C, Kozlova EG, Martins-Filho SN, von Felden J, Ahsen ME, Bresnahan E, Hernandez-Meza G, Labgaa I, D'Avola D, Schwartz M, Llovet JM, Sia D, Thung S, Losic B, Lujambio A, Villanueva A. Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. PLoS Genet 2021;17:e1009589. [PMID: 34166362 DOI: 10.1371/journal.pgen.1009589] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
285 Cho DY, Park J, Kim DS. The impact of expanding health insurance coverage for anti-cancer drugs on cancer survival in Korea. Cancer Med 2021;10:4555-63. [PMID: 34145980 DOI: 10.1002/cam4.3979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
286 Delaney LJ, Tantawi M, Wessner CE, Machado P, Forsberg F, Lyshchik A, O'Kane P, Liu JB, Civan J, Tan A, Anton K, Shaw CM, Eisenbrey JR. Predicting Long-Term Hepatocellular Carcinoma Response to Transarterial Radioembolization Using Contrast-Enhanced Ultrasound: Initial Experiences. Ultrasound Med Biol 2021;47:2523-31. [PMID: 34130880 DOI: 10.1016/j.ultrasmedbio.2021.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
287 Yun JP, Choi EK, Han KD, Park SH, Jung JH, Park SH, Ahn HJ, Lim JH, Lee SR, Oh S. Risk of Atrial Fibrillation According to Cancer Type: A Nationwide Population-Based Study. JACC CardioOncol 2021;3:221-32. [PMID: 34396327 DOI: 10.1016/j.jaccao.2021.03.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
288 Junqueira MZ, Rocha NH, Sapienza MT. 68Ga-PSMA PET/CT: effect of external cooling on salivary gland uptake. Radiol Bras 2021;54:171-6. [PMID: 34108764 DOI: 10.1590/0100-3984.2020.0044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
289 Chen H, Kong M, Chen Y, Jiang Y, Wen M, Zhang X. Prognostic significance of miR-203 and ZEB1 expression in early-stage hepatocellular carcinoma. J Cancer 2021;12:4810-8. [PMID: 34234851 DOI: 10.7150/jca.57819] [Reference Citation Analysis]
290 Grassi T, Harris FR, Smadbeck JB, Murphy SJ, Block MS, Multinu F, Schaefer Klein JL, Zhang P, Karagouga G, Liu MC, Larish A, Lemens MA, Sommerfield MKS, Cappuccio S, Cheville JC, Vasmatzis G, Mariani A. Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer. PLoS One 2021;16:e0252390. [PMID: 34111149 DOI: 10.1371/journal.pone.0252390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
291 Saung MT, Pelosof L, Casak S, Donoghue M, Lemery S, Yuan M, Rodriguez L, Schotland P, Chuk M, Davis G, Goldberg KB, Theoret MR, Pazdur R, Fashoyin-Aje L. FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with Sorafenib. Oncologist 2021;26:797-806. [PMID: 33973307 DOI: 10.1002/onco.13819] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
292 Ding Y, Sun Z, Zhang S, Li Y, Han X, Xu Q, Zhou L, Xu H, Bai Y, Xu C, Ding H, Ge Y, Wang W. Downregulation of snoRNA SNORA52 and Its Clinical Significance in Hepatocellular Carcinoma. Biomed Res Int 2021;2021:7020637. [PMID: 34195281 DOI: 10.1155/2021/7020637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
293 Wu J, Zhou X, Li P, Lin X, Wang J, Hu Z, Zhang P, Chen D, Cai H, Niessner R, Haisch C, Sun P, Zheng Y, Jiang Z, Zhou H. Ultrasensitive and Simultaneous SERS Detection of Multiplex MicroRNA Using Fractal Gold Nanotags for Early Diagnosis and Prognosis of Hepatocellular Carcinoma. Anal Chem 2021;93:8799-809. [PMID: 34076420 DOI: 10.1021/acs.analchem.1c00478] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 10.5] [Reference Citation Analysis]
294 Noyd DH, Neely NB, Schroeder KM, Lantos PM, Power S, Kreissman SG, Oeffinger KC. Integration of cancer registry and electronic health record data to construct a childhood cancer survivorship cohort, facilitate risk stratification for late effects, and assess appropriate follow-up care. Pediatr Blood Cancer 2021;68:e29014. [PMID: 33742534 DOI: 10.1002/pbc.29014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
295 Sasaki T, Shigeta K, Okabayashi K, Tsuruta M, Seishima R, Matsui S, Kitagawa Y. Horizontal spread of pericolic lymph node metastasis as a prognostic factor for recurrence in Stage III colorectal cancer. Colorectal Dis 2021;23:1370-8. [PMID: 33590648 DOI: 10.1111/codi.15586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
296 Kuo SC, Lin CN, Lin YJ, Chen WY, Hwang JS, Wang JD. Optimal Intervals of Ultrasonography Screening for Early Diagnosis of Hepatocellular Carcinoma in Taiwan. JAMA Netw Open 2021;4:e2114680. [PMID: 34165580 DOI: 10.1001/jamanetworkopen.2021.14680] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
297 Lehmann J, Cofala T, Tschuggnall M, Giesinger JM, Rumpold G, Holzner B. Machine Learning in der Onkologie – Perspektiven in der Patient-Reported-Outcome-Forschung. Onkologe 2021;27:587-594. [DOI: 10.1007/s00761-021-00917-8] [Reference Citation Analysis]
298 Nurfauzi R, Nugroho H, Ardiyanto I, Frannita E. Autocorrection of lung boundary on 3D CT lung cancer images. Journal of King Saud University - Computer and Information Sciences 2021;33:518-527. [DOI: 10.1016/j.jksuci.2019.02.009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
299 Yoon J, Park SB, Lee JY, Kim EH, Yoon SW. A Case Report of Chemotherapy-Induced Peripheral Neuropathy Treated with Warm Needling. J Int Korean Med 2021;42:114-121. [DOI: 10.22246/jikm.2021.42.2.114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
300 Kong S, Lee JK, Kang D, Kim N, Shim YM, Park W, Choi D, Cho J. Comparing the Effectiveness of a Wearable Activity Tracker in Addition to Counseling and Counseling Only to Reinforce Leisure-Time Physical Activity among Breast Cancer Patients: A Randomized Controlled Trial. Cancers (Basel) 2021;13:2692. [PMID: 34070937 DOI: 10.3390/cancers13112692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
301 Kwok CS, Wong CW, Kontopantelis E, Barac A, Brown SA, Velagapudi P, Hilliard AA, Bharadwaj AS, Chadi Alraies M, Mohamed M, Bhatt DL, Mamas MA. Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA. Eur Heart J 2021;42:1019-34. [PMID: 33681960 DOI: 10.1093/eurheartj/ehaa1032] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
302 Lin JC, Liu CL, Chang YC, Cheng SP, Huang WC, Lin CH, Wu CY, Chen MJ. Trilostane, a 3β-hydroxysteroid dehydrogenase inhibitor, suppresses growth of hepatocellular carcinoma and enhances anti-cancer effects of sorafenib. Invest New Drugs 2021. [PMID: 34031786 DOI: 10.1007/s10637-021-01132-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Li L, Xia S, Shi X, Chen X, Shang D. The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma. Sci Rep 2021;11:10728. [PMID: 34021184 DOI: 10.1038/s41598-021-89747-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
304 Chen Y, Xie H, Xie T, Yang X, Pang Y, Ye S. Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular Carcinoma. Front Genet 2021;12:669928. [PMID: 34093661 DOI: 10.3389/fgene.2021.669928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
305 Jacob JB, Jacob MK, Parajuli P. Review of immune checkpoint inhibitors in immuno-oncology. Adv Pharmacol 2021;91:111-39. [PMID: 34099106 DOI: 10.1016/bs.apha.2021.01.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
306 Liang PS, Mayer JD, Wakefield J, Trinh-Shevrin C, Kwon SC, Sherman SE, Ko CW. Trends in Sociodemographic Disparities in Colorectal Cancer Staging and Survival: A SEER-Medicare Analysis. Clin Transl Gastroenterol 2020;11:e00155. [PMID: 32352722 DOI: 10.14309/ctg.0000000000000155] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
307 Xu J, Ji L, Ruan Y, Wan Z, Lin Z, Xia S, Tao L, Zheng J, Cai L, Wang Y, Liang X, Cai X. UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma. Signal Transduct Target Ther 2021;6:190. [PMID: 34001851 DOI: 10.1038/s41392-021-00594-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
308 Ciurea AM, Gheonea DI, Schenker M, Mehedințeanu AM, Târtea GC, Vere CC. The Prognostic Correlation of Heart Rate Variability at Diagnosis with Survival of Patients with Hepatocellular Carcinoma. Diagnostics (Basel) 2021;11:890. [PMID: 34067711 DOI: 10.3390/diagnostics11050890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
309 Wang J, Li T, Ma L, Liu G, Wang G, Kang J. NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma. Open Med (Wars) 2021;16:742-8. [PMID: 34013046 DOI: 10.1515/med-2021-0268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
310 Pezzilli R. Editorial for "Does Training in LI-RADS Version 2018 Improve Readers' Agreement With the Expert Consensus and Inter-Reader Agreement in MRI Interpretation?". J Magn Reson Imaging 2021;54:1935-6. [PMID: 33960062 DOI: 10.1002/jmri.27687] [Reference Citation Analysis]
311 Lapke N, Chen CH, Chang TC, Chao A, Lu YJ, Lai CH, Tan KT, Chen HC, Lu HY, Chen SJ. Genetic alterations and their therapeutic implications in epithelial ovarian cancer. BMC Cancer 2021;21:499. [PMID: 33947352 DOI: 10.1186/s12885-021-08233-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
312 Gallaway MS, Idaikkadar N, Tai E, Momin B, Rohan EA, Townsend J, Puckett M, Stewart SL. Emergency department visits among people with cancer: Frequency, symptoms, and characteristics. J Am Coll Emerg Physicians Open 2021;2:e12438. [PMID: 33969353 DOI: 10.1002/emp2.12438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
313 Xie G, Qi C, Yang W, Wang R, Yang L, Shang L, Huang L, Chung MC. Competing risk nomogram predicting cancer-specific mortality for endometrial cancer patients treated with hysterectomy. Cancer Med 2021;10:3205-13. [PMID: 33932121 DOI: 10.1002/cam4.3887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
314 Gallage S, García-beccaria M, Szydlowska M, Rahbari M, Mohr R, Tacke F, Heikenwalder M. The therapeutic landscape of hepatocellular carcinoma. Med 2021;2:505-52. [DOI: 10.1016/j.medj.2021.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
315 Woodrell CD, Goldstein NE, Moreno JR, Schiano TD, Schwartz ME, Garrido MM. Inpatient Specialty-Level Palliative Care Is Delivered Late in the Course of Hepatocellular Carcinoma and Associated With Lower Hazard of Hospital Readmission. J Pain Symptom Manage 2021;61:940-947.e3. [PMID: 33035651 DOI: 10.1016/j.jpainsymman.2020.09.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
316 Engels EA, Haber G, Hart A, Lynch CF, Li J, Pawlish KS, Qiao B, Yu KJ, Pfeiffer RM. Solid Organ Transplantation and Survival among Individuals with a History of Cancer. Cancer Epidemiol Biomarkers Prev 2021;30:1312-9. [PMID: 33926864 DOI: 10.1158/1055-9965.EPI-21-0044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
317 Carr J, Cha DE, Shaltiel T, Zheng S, Siderides C, Golas B, Labow D, Magge D, Cohen N, Branch A, Sarpel U. African Immigrants in New York City with Hepatitis B-Related Hepatocellular Carcinoma Demonstrate High Morbidity and Mortality. J Immigr Minor Health 2021. [PMID: 33907933 DOI: 10.1007/s10903-021-01205-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
318 Owoyemi O, Aakhus E. Underrepresentation in Oncology: Identifying and Addressing Structural Barriers. Oncologist 2021;26:630-4. [PMID: 33797155 DOI: 10.1002/onco.13771] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
319 Javadian P, Washington C, Mukasa S, Benbrook DM. Histopathologic, Genetic and Molecular Characterization of Endometrial Cancer Racial Disparity. Cancers (Basel) 2021;13:1900. [PMID: 33920951 DOI: 10.3390/cancers13081900] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
320 Zhang R, Wu T, Zheng P, Liu M, Xu G, Xi M, Yu J. Thymoquinone sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis via oxidative DNA damage. DNA Repair (Amst) 2021;103:103117. [PMID: 33990030 DOI: 10.1016/j.dnarep.2021.103117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
321 Kim KH, Lee SY, Baek JH, Lee SY, Kim JY, Yoo JS. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring. Proteomics Clin Appl 2021;15:e2000096. [PMID: 33764665 DOI: 10.1002/prca.202000096] [Reference Citation Analysis]
322 Yu S, Cai L, Liu C, Gu R, Cai L, Zhuo L. Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma. Mol Med 2021;27:36. [PMID: 33832428 DOI: 10.1186/s10020-021-00294-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
323 Chen Y, Xia Y, Tolat PP, Long L, Jiang Z, Huang Z, Tang Q. Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion. AJR Am J Roentgenol 2021;216:1510-20. [PMID: 33826360 DOI: 10.2214/AJR.20.23255] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
324 Jian F, Che X, Zhang J, Liu C, Liu G, Tang Y, Feng W. The long-noncoding RNA SOCS2-AS1 suppresses endometrial cancer progression by regulating AURKA degradation. Cell Death Dis 2021;12:351. [PMID: 33824269 DOI: 10.1038/s41419-021-03595-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
325 Schwarze V, Marschner C, Völckers W, Grosu S, Negrão de Figueiredo G, Rübenthaler J, Clevert DA. Diagnostic value of contrast-enhanced ultrasound versus computed tomography for hepatocellular carcinoma: a retrospective, single-center evaluation of 234 patients. J Int Med Res 2020;48:300060520930151. [PMID: 32529869 DOI: 10.1177/0300060520930151] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
326 Tapia-sosa R, Hernández-cabral F, Gabutti A, Páez-zayas V, García-juárez I. Hepatocellular carcinoma associated with direct-acting antiviral therapy for hepatitis C virus: A report of two cases. Revista de Gastroenterología de México (English Edition) 2021;86:197-9. [DOI: 10.1016/j.rgmxen.2020.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
327 Tapia-Sosa R, Hernández-Cabral F, Gabutti A, Páez-Zayas VM, García-Juárez I. Hepatocellular carcinoma associated with direct-acting antiviral therapy for hepatitis C virus: A report of two cases. Rev Gastroenterol Mex (Engl Ed). 2021;86:197-199. [PMID: 33187768 DOI: 10.1016/j.rgmx.2020.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
328 Zhang T, Merle P, Wang H, Zhao H, Kudo M. Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel? Hepatobiliary Surg Nutr 2021;10:180-92. [PMID: 33898559 DOI: 10.21037/hbsn-2021-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
329 Singh B, Kaur P, Maroules M. Hyperprogression in a Patient With Hepatocellular Cancer Treated With Atezolizumab and Bevacizumab: A Case Report and Review of Literature. J Investig Med High Impact Case Rep 2021;9:2324709621992207. [PMID: 33787380 DOI: 10.1177/2324709621992207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
330 Hanson LC, Ernecoff NC, Wessell KL, Lin FC, Milowsky MI, Collichio FA, Wood WA, Rosenstein DL. Mortality Risk for Patients With Stage IV Cancer and Acute Illness Hospitalization. J Pain Symptom Manage 2021;61:797-804. [PMID: 33096216 DOI: 10.1016/j.jpainsymman.2020.10.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
331 Chardon ML, Pinto S, Slayton WB, Fisher RS, Janicke DM. Eating behaviors and dietary quality in childhood acute lymphoblastic leukemia survivors. Pediatr Blood Cancer 2021;68:e28811. [PMID: 33381920 DOI: 10.1002/pbc.28811] [Reference Citation Analysis]
332 Ciurea AM, Vere CC, Popp CG, Streba CT, Caliţa M, Pirici D, Cercelaru L, Schenker M, Gheonea DI, Pirici I. E-cadherin and aquaporin 1 co-expression analysis in hepatocellular carcinoma: a pilot study. Rom J Morphol Embryol 2021;62:427-34. [PMID: 35024730 DOI: 10.47162/RJME.62.2.08] [Reference Citation Analysis]
333 Cooper RM, Chung J, Hogan T, Haque R. Patterns of overall mortality by race/ethnicity and socioeconomic status in insured cancer patients in Southern California. Cancer Causes Control 2021;32:609-16. [PMID: 33783687 DOI: 10.1007/s10552-021-01414-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
334 Cheng B, Sethi I, Villalobos A, Wagstaff W, Schuster DM, Bercu Z, Brandon D, Kokabi N. Determination of tumour dose response threshold and implication on survival in patients with HCC treated with Y90 radiation segmentectomy: a simple semi-quantitative analysis. Nucl Med Commun 2021;42:892-8. [PMID: 33795611 DOI: 10.1097/MNM.0000000000001420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
335 He R, Wang Z, Shi W, Yu L, Xia H, Huang Z, Liu S, Zhao X, Xu Y, Yam JWP, Cui Y. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value. Biomed Pharmacother 2021;138:111529. [PMID: 34311529 DOI: 10.1016/j.biopha.2021.111529] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
336 Hang Y, Tang S, Tang W, Větvička D, Zhang C, Xie Y, Yu F, Yu A, Sil D, Li J, Singh RK, Oupický D. Polycation fluorination improves intraperitoneal siRNA delivery in metastatic pancreatic cancer. J Control Release 2021;333:139-50. [PMID: 33774121 DOI: 10.1016/j.jconrel.2021.03.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
337 Zhang L, Cai P, Hou J, Luo M, Li Y, Jiang X. Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation. Cancer Manag Res 2021;13:2785-96. [PMID: 33790652 DOI: 10.2147/CMAR.S300627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
338 Lehmann J, Cofala T, Tschuggnall M, Giesinger JM, Rumpold G, Holzner B. Machine learning in oncology—Perspectives in patient-reported outcome research. Onkologe 2021;27:150-5. [DOI: 10.1007/s00761-021-00916-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
339 Vemala RNG, Katti SV, Sirohi B, Manikandan D, Nandakumar G. Molecular Oncology in Management of Colorectal Cancer. Indian J Surg Oncol 2021;12:169-80. [PMID: 33994743 DOI: 10.1007/s13193-021-01289-6] [Reference Citation Analysis]
340 Haddad DN, Sandler KL, Henderson LM, Rivera MP, Aldrich MC. Disparities in Lung Cancer Screening: A Review. Ann Am Thorac Soc 2020;17:399-405. [PMID: 32017612 DOI: 10.1513/AnnalsATS.201907-556CME] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 17.5] [Reference Citation Analysis]
341 Huang Y, Chen X, Wang L, Wang T, Tang X, Su X. Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma. J Cancer 2021;12:2933-51. [PMID: 33854594 DOI: 10.7150/jca.52187] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
342 Kong FH, Ye QF, Miao XY, Liu X, Huang SQ, Xiong L, Wen Y, Zhang ZJ. Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma. Theranostics 2021;11:5464-90. [PMID: 33859758 DOI: 10.7150/thno.54822] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
343 Yang Z, Zhang L, Zhu H, Zhou K, Wang H, Wang Y, Su R, Guo D, Zhou L, Xu X, Song P, Zheng S, Xie H. Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour-associated fibroblast. J Cell Mol Med 2021;25:3511-23. [PMID: 33713546 DOI: 10.1111/jcmm.16434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
344 Wang X, Chen H, Jiang R, Hong X, Peng J, Chen W, Jiang J, Li J, Huang D, Dai H, Wang W, Lu J, Zhao Y, Wu W. Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenocarcinoma. Cancer Lett 2021;508:1-12. [PMID: 33713738 DOI: 10.1016/j.canlet.2021.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
345 Choe JH, Mazambani S, Kim TH, Kim JW. Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas. Cells 2021;10:606. [PMID: 33803326 DOI: 10.3390/cells10030606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
346 Xu S, Ling S, Shan Q, Ye Q, Zhan Q, Jiang G, Zhuo J, Pan B, Wen X, Feng T, Lu H, Wei X, Xie H, Zheng S, Xiang J, Shen Y, Xu X. Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma Therapy. Adv Sci (Weinh) 2021;8:2003042. [PMID: 33717848 DOI: 10.1002/advs.202003042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
347 Cabrera R, Singal AG, Colombo M, Kelley RK, Lee H, Mospan AR, Meyer T, Newell P, Parikh ND, Sangro B, Reddy KR, Watkins S, Zink RC, Di Bisceglie AM. A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC. Hepatol Commun 2021;5:538-47. [PMID: 33681685 DOI: 10.1002/hep4.1652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
348 Zhu C, Ho YJ, Salomao MA, Dapito DH, Bartolome A, Schwabe RF, Lee JS, Lowe SW, Pajvani UB. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features. J Hepatol 2021;74:613-26. [PMID: 33038431 DOI: 10.1016/j.jhep.2020.09.032] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
349 Sparano JA, Brawley OW. Deconstructing Racial and Ethnic Disparities in Breast Cancer. JAMA Oncol 2021;7:355-6. [PMID: 33475709 DOI: 10.1001/jamaoncol.2020.7113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
350 Lauko A, Lo A, Ahluwalia MS, Lathia JD. Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors. Semin Cancer Biol 2021:S1044-579X(21)00049-3. [PMID: 33640445 DOI: 10.1016/j.semcancer.2021.02.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
351 Jiang N, Zhang X, Qin D, Yang J, Wu A, Wang L, Sun Y, Li H, Shen X, Lin J, Kantawong F, Wu J. Identification of Core Genes Related to Progression and Prognosis of Hepatocellular Carcinoma and Small-Molecule Drug Predication. Front Genet 2021;12:608017. [PMID: 33708237 DOI: 10.3389/fgene.2021.608017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
352 Whelton SP, Berning P, Blumenthal RS, Marshall CH, Martin SS, Mortensen MB, Blaha MJ, Dzaye O. Multidisciplinary prevention and management strategies for colorectal cancer and cardiovascular disease. Eur J Intern Med 2021;87:3-12. [PMID: 33610416 DOI: 10.1016/j.ejim.2021.02.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
353 Haider A, Siddiqa A, Mehmood M, Adrish M. Ramucirumab-Induced Hepatocellular Carcinoma Rupture and Gastrointestinal Perforation. Am J Case Rep 2021;22:e929493. [PMID: 33597391 DOI: 10.12659/AJCR.929493] [Reference Citation Analysis]
354 Liang Z, Li X. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer. Autoimmunity 2021;54:76-87. [PMID: 33596760 DOI: 10.1080/08916934.2021.1887148] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
355 Olsen HE, Lynn GM, Valdes PA, Cerecedo Lopez CD, Ishizuka AS, Arnaout O, Bi WL, Peruzzi PP, Chiocca EA, Friedman GK, Bernstock JD. Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologies. Neurooncol Adv 2021;3:vdab027. [PMID: 33860227 DOI: 10.1093/noajnl/vdab027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
356 Li S, Xu W, Liao M, Zhou Y, Weng J, Ren L, Yu J, Liao W, Huang Z. The Significance of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in the Early Postoperative Recurrence Monitoring and Prognosis Prediction of AFP-Negative Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:23-33. [PMID: 33604313 DOI: 10.2147/JHC.S286213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
357 Colnot J, Zefkili S, Gschwind R, Huet C. Out-of-field doses from radiotherapy using photon beams: A comparative study for a pediatric renal treatment. J Appl Clin Med Phys 2021;22:94-106. [PMID: 33547766 DOI: 10.1002/acm2.13182] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
358 Mukherjee TK, Malik P, Hoidal JR. The emerging role of estrogen related receptorα in complications of non-small cell lung cancers. Oncol Lett 2021;21:258. [PMID: 33664821 DOI: 10.3892/ol.2021.12519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
359 Lu L, Jiang J, Zhan M, Zhang H, Wang QT, Sun SN, Guo XK, Yin H, Wei Y, Li SY, Liu JO, Li Y, He YW. Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies. Hepatology 2021;73:821-32. [PMID: 32767586 DOI: 10.1002/hep.31502] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
360 Demir T, Lee SS, Kaseb AO. Systemic therapy of liver cancer. Adv Cancer Res 2021;149:257-94. [PMID: 33579425 DOI: 10.1016/bs.acr.2020.12.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 9.5] [Reference Citation Analysis]
361 Yang L, Park J, Marjanovic M, Chaney EJ, Spillman DR Jr, Phillips H, Boppart SA. Intraoperative Label-Free Multimodal Nonlinear Optical Imaging for Point-of-Procedure Cancer Diagnostics. IEEE J Sel Top Quantum Electron 2021;27:6801412. [PMID: 33746497 DOI: 10.1109/jstqe.2021.3054578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
362 Wu W, Yang J, Li D, Huang Q, Zhao F, Feng X, Yan H, Lyu J. Competitive Risk Analysis of Prognosis in Patients With Cecum Cancer: A Population-Based Study. Cancer Control 2021;28:1073274821989316. [PMID: 33491489 DOI: 10.1177/1073274821989316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
363 Fountzilas C, Evans R, Alaklabi S, Iyer R. Immunotherapy in hepatocellular cancer. Adv Cancer Res 2021;149:295-320. [PMID: 33579426 DOI: 10.1016/bs.acr.2020.12.002] [Reference Citation Analysis]
364 Miller DR, Averbukh L, Virk G, Jafri M, Tadros M. The Value of Family History in Colorectal Screening Decisions for Oldest Old Geriatric Populations. Cureus 2021;13:e12815. [PMID: 33628681 DOI: 10.7759/cureus.12815] [Reference Citation Analysis]
365 Chinh K, Mosher CE, Brown LF, Beck-Coon KA, Kroenke K, Johns SA. Psychological Processes and Symptom Outcomes in Mindfulness-Based Stress Reduction for Cancer Survivors: A Pilot Study. Mindfulness (N Y) 2020;11:905-16. [PMID: 33456623 DOI: 10.1007/s12671-019-01299-0] [Reference Citation Analysis]
366 Kuzminac IZ, Jakimov DS, Bekić SS, Ćelić AS, Marinović MA, Savić MP, Raičević VN, Kojić VV, Sakač MN. Synthesis and anticancer potential of novel 5,6-oxygenated and/or halogenated steroidal d-homo lactones. Bioorg Med Chem 2021;30:115935. [PMID: 33340938 DOI: 10.1016/j.bmc.2020.115935] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
367 Hryhorenko L, Samoilenko A. A., Romaniuta I. A.. EPIDEMIOLOGY, PROGNOSIS AND RISK FACTORS FOR DEVELOPMENT OF ONCOLOGICAL DISEASES AS EARLY DIAGNOSTIC OF DENTAL PROBLEMS IN THE CHILDREN. RS Global - World Science 2021. [DOI: 10.31435/rsglobal_ws/30012021/7399] [Reference Citation Analysis]
368 Wang LL, Liao C, Li XQ, Dai R, Ren QW, Shi HL, Wang XP, Feng XS, Chao X. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma. Med Sci Monit 2021;27:e927624. [PMID: 33436534 DOI: 10.12659/MSM.927624] [Reference Citation Analysis]
369 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7-33. [PMID: 33433946 DOI: 10.3322/caac.21654] [Cited by in Crossref: 6065] [Cited by in F6Publishing: 6715] [Article Influence: 3032.5] [Reference Citation Analysis]
370 Landy R, Young CD, Skarzynski M, Cheung LC, Berg CD, Rivera MP, Robbins HA, Chaturvedi AK, Katki HA. Using Prediction-Models to Reduce Persistent Racial/Ethnic Disparities in Draft 2020 USPSTF Lung-Cancer Screening Guidelines. J Natl Cancer Inst 2021:djaa211. [PMID: 33399825 DOI: 10.1093/jnci/djaa211] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 14.0] [Reference Citation Analysis]
371 Kabashima A, Shimada S, Shimokawa M, Akiyama Y, Tanabe M, Tanaka S. Molecular and immunological paradigms of hepatocellular carcinoma: Special reference to therapeutic approaches. J Hepatobiliary Pancreat Sci 2021;28:62-75. [PMID: 33259135 DOI: 10.1002/jhbp.874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
372 Fani Pakdel A, Hatami A, Salek R, Taghizadeh-Kermani A, Javadinia SA, Ghorbani A. Effects of a polyherbal formulation on the quality of life and survival of patients with common upper gastrointestinal cancers: A randomized placebo-controlled trial. Avicenna J Phytomed 2021;11:566-75. [PMID: 34804894 DOI: 10.22038/AJP.2021.18132] [Reference Citation Analysis]
373 Morino M, Arezzo A, Forcignanò E. The Medrobotics Platform for Transanal Surgery. Innovative Endoscopic and Surgical Technology in the GI Tract 2021. [DOI: 10.1007/978-3-030-78217-7_29] [Reference Citation Analysis]
374 Vennelaganti S, Cuatrecasas M, Vennalaganti P, Kennedy KF, Srinivasan S, Patil DT, Plesec T, Lanas A, Hörndler C, Andraws N, Cherian R, Mathur S, Hassan C, Repici A, Klotz D, Musulen E, Risio M, Castells A, Gupta N, Sharma P. Interobserver Agreement Among Pathologists in the Differentiation of Sessile Serrated From Hyperplastic Polyps. Gastroenterology 2021;160:452-454.e1. [PMID: 32950521 DOI: 10.1053/j.gastro.2020.09.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
375 Craig AJ, Wang XW. Molecular Carcinogenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma. Hepatitis B Virus and Liver Disease 2021. [DOI: 10.1007/978-981-16-3615-8_6] [Reference Citation Analysis]
376 Zhang W, Hu Z, Tian J, Fang C. A narrative review of near-infrared fluorescence imaging in hepatectomy for hepatocellular carcinoma. Ann Transl Med 2021;9:171. [PMID: 33569473 DOI: 10.21037/atm-20-5341] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
377 Begum S, Zubair M, Alamri MM, Husain FM, Fatima F, Oves M, Ansari MA, Hassan I. Diabetic Foot Complications in Asia and European Continents. Diabetic Foot Ulcer 2021. [DOI: 10.1007/978-981-15-7639-3_1] [Reference Citation Analysis]
378 Nault JC, Villanueva A. Biomarkers for Hepatobiliary Cancers. Hepatology 2021;73 Suppl 1:115-27. [PMID: 32045030 DOI: 10.1002/hep.31175] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 34.0] [Reference Citation Analysis]
379 Diab S, Raiyat M, Gerogiorgis DI. Flow synthesis kinetics for lomustine, an anti-cancer active pharmaceutical ingredient. React Chem Eng 2021;6:1819-1828. [DOI: 10.1039/d1re00184a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
380 Gerson Cwilich R, Zentella Dehesa A, Murrieta González H, Campos Alvarado LD, García López EA, Camacho Limas CP, Regalado Porras GO, Lázaro León JM, Olivares Beltrán GM, Serrano Olvera JA, Villalobos Prieto A, Villegas Osorno DA, Shveid Gerson D, Noguez Ramos A. Sensibilidad in vitro a quimioterapia como posible herramienta de medicina personalizada en pacientes con cáncer y ascitis maligna. Iniciativa del Centro Médico ABC. Anales Médicos de la Asociación Médica del Centro Médico ABC 2021;66:238-248. [DOI: 10.35366/102923] [Reference Citation Analysis]
381 Liu Y, Yang W, VoPham T, Ma Y, Simon TG, Gao X, Chan AT, Meyerhardt JA, Giovannucci EL, Zhang X. Plant-Based and Animal-Based Low-Carbohydrate Diets and Risk of Hepatocellular Carcinoma Among US Men and Women. Hepatology 2021;73:175-85. [PMID: 32222996 DOI: 10.1002/hep.31251] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
382 Marchese V, Rock K, York T, Creath R, Gray V. Neuromuscular mechanisms that contribute to gross motor performance in survivors of childhood acute lymphoblastic leukemia. J Pediatr Rehabil Med 2021;14:415-23. [PMID: 33935120 DOI: 10.3233/PRM-200784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
383 Petrović AZ, Ćoćić DC, Bockfeld D, Živanović M, Milivojević N, Virijević K, Janković N, Scheurer A, Vraneš M, Bogojeski JV. Biological activity of bis(pyrazolylpyridine) and terpiridine Os( ii ) complexes in the presence of biocompatible ionic liquids. Inorg Chem Front 2021;8:2749-70. [DOI: 10.1039/d0qi01540g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
384 Carter TM, Strassle PD, Ollila DW, Stitzenberg KB, Meyers MO, Maduekwe UN. Does acral lentiginous melanoma subtype account for differences in patterns of care in Black patients? Am J Surg 2021;221:706-11. [PMID: 33461732 DOI: 10.1016/j.amjsurg.2020.12.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
385 Jogi S, Varanai R, Bantu SS, Manne A. Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelines. Oncol Rev 2020;14:515. [PMID: 33425223 DOI: 10.4081/oncol.2020.515] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
386 Tung RT, Heyns J. Incidental Findings of Malignancy of the Chest by Single Photon Emission Computed Tomography Myocardial Perfusion Imaging (SPECT-CT MPI): One Year Follow-Up Report. Kans J Med 2020;13:280-4. [PMID: 33312410 DOI: 10.17161/kjm.vol13.13822] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
387 Ugarte-Alvarez O, Muñoz-López P, Moreno-Vargas LM, Prada-Gracia D, Mateos-Chávez AA, Becerra-Báez EI, Luria-Pérez R. Cell-Permeable Bak BH3 Peptide Induces Chemosensitization of Hematologic Malignant Cells. J Oncol 2020;2020:2679046. [PMID: 33312200 DOI: 10.1155/2020/2679046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
388 Cunningham J, Thuijsman F, Peeters R, Viossat Y, Brown J, Gatenby R, Staňková K. Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer. PLoS One 2020;15:e0243386. [PMID: 33290430 DOI: 10.1371/journal.pone.0243386] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
389 Forjaz G, Barnholtz-Sloan JS, Kruchko C, Siegel R, Negoita S, Ostrom QT, Dickie L, Ruhl J, Van Dyke A, Patil N, Cioffi G, Miller KD, Waite K, Mariotto AB. An updated histology recode for the analysis of primary malignant and nonmalignant brain and other central nervous system tumors in the Surveillance, Epidemiology, and End Results Program. Neurooncol Adv 2021;3:vdaa175. [PMID: 33506208 DOI: 10.1093/noajnl/vdaa175] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
390 Schwarze V, Marschner C, Völckers W, de Figueiredo GN, Rübenthaler J, Clevert DA. The diagnostic performance of contrast-enhanced ultrasound (CEUS) for evaluating hepatocellular carcinoma (HCC) juxtaposed to MRI findings; a retrospective single-center analysis of 292 patients. Clin Hemorheol Microcirc 2020;76:155-60. [PMID: 32925017 DOI: 10.3233/CH-209213] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
391 Khan I, Steeg PS. Endocytosis: a pivotal pathway for regulating metastasis. Br J Cancer 2021;124:66-75. [PMID: 33262521 DOI: 10.1038/s41416-020-01179-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
392 Bakula B, Rašić Ž, Jurčić D, Lucijanić M, Rašić F. CORRELATION BETWEEN THE LEVEL OF COLORECTAL ANASTOMOSIS AND ANORECTAL FUNCTION. Acta Clin Croat 2020;59:703-11. [PMID: 34285441 DOI: 10.20471/acc.2020.59.04.17] [Reference Citation Analysis]
393 Saxena V, Mehta N. Current Transplant Criteria for Hepatocellular Carcinoma—Overuse or Underuse. Curr Hepatology Rep 2020;19:470-477. [DOI: 10.1007/s11901-020-00555-5] [Reference Citation Analysis]
394 Sonbare DJ, Bandi R, Sharma V, Cacciarelli T, Shaikh OS. Spontaneous Regression of Advanced Hepatocellular Carcinoma. Case Rep Gastroenterol 2020;14:491-6. [PMID: 33250687 DOI: 10.1159/000508847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
395 Lee J. Associations between Physical Activity and Liver Cancer Risks and Mortality: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2020;17:E8943. [PMID: 33271947 DOI: 10.3390/ijerph17238943] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
396 Rothkamm K, Christiansen S, Rieckmann T, Horn M, Frenzel T, Brinker A, Schumacher U, Stein A, Petersen C, Burdak-Rothkamm S. Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-rays. Cancer Lett 2020;493:179-88. [PMID: 32891715 DOI: 10.1016/j.canlet.2020.08.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
397 Gomez-Puerto D, Mirallas O, Vidal-González J, Vargas V. Hepatocellular carcinoma with tumor thrombus extends to the right atrium and portal vein: A case report. World J Hepatol 2020;12:1128-35. [PMID: 33312435 DOI: 10.4254/wjh.v12.i11.1128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
398 Gurses SA, Banskar S, Stewart C, Trimoski B, Dziarski R, Gupta D. Nod2 protects mice from inflammation and obesity-dependent liver cancer. Sci Rep 2020;10:20519. [PMID: 33239685 DOI: 10.1038/s41598-020-77463-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
399 Wu L, Li H, Chen S, Wu X, Chen X, Wang F. Catalpol inhibits the proliferation, migration and metastasis of HCC cells by regulating miR‑140‑5p expression. Mol Med Rep 2021;23:29. [PMID: 33179108 DOI: 10.3892/mmr.2020.11667] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
400 Hernandez S, Simoni-Nieves A, Gerardo-Ramírez M, Torres S, Fucho R, Gonzalez J, Castellanos-Tapia L, Hernández-Pando R, Tejero-Barrera E, Bucio L, Souza V, Miranda-Labra R, Fernández-Checa JC, Marquardt JU, Gomez-Quiroz LE, García-Ruiz C, Gutiérrez-Ruiz MC. GDF11 restricts aberrant lipogenesis and changes in mitochondrial structure and function in human hepatocellular carcinoma cells. J Cell Physiol 2021;236:4076-90. [PMID: 33174245 DOI: 10.1002/jcp.30151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
401 Prince D, Liu K, Xu W, Chen M, Sun JY, Lu XJ, Ji J. Management of patients with intermediate stage hepatocellular carcinoma. Ther Adv Med Oncol 2020;12:1758835920970840. [PMID: 33224278 DOI: 10.1177/1758835920970840] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
402 Arumugam M, Sonkusare S, Goripalli S, Shivappa P, Shetty P, Kumari N S. Vitamin D receptor Fok1 polymorphism and invasive ovarian carcinoma risk - A case-control study. Gene 2021;768:145291. [PMID: 33157205 DOI: 10.1016/j.gene.2020.145291] [Reference Citation Analysis]
403 Skobeltcin A, Ryabova A, Maklygina YS, Loschenov V. Tumorigenesis and metastasis scheme from photodynamic therapy perspective. 2020 International Conference Laser Optics (ICLO) 2020. [DOI: 10.1109/iclo48556.2020.9285734] [Reference Citation Analysis]
404 Tailor TD, Tong BC, Gao J, Henderson LM, Choudhury KR, Rubin GD. Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population. Chest 2020;158:2200-10. [DOI: 10.1016/j.chest.2020.05.592] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
405 Liu H, Zhang C. Paeonol induces antitumor effects in hepatocellular carcinoma cells through survivin via the cyclooxygenase-2/prostaglandin E2 signaling pathway. Transl Cancer Res 2020;9:7183-95. [PMID: 35117322 DOI: 10.21037/tcr-20-322A] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
406 Yang W, Sui J, Ma Y, Simon TG, Petrick JL, Lai M, McGlynn KA, Campbell PT, Giovannucci EL, Chan AT, Zhang X. High Dietary Intake of Vegetable or Polyunsaturated Fats Is Associated With Reduced Risk of Hepatocellular Carcinoma. Clin Gastroenterol Hepatol 2020;18:2775-2783.e11. [PMID: 31927110 DOI: 10.1016/j.cgh.2020.01.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
407 Wei T, Zhang XF, Bagante F, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Pawlik TM. Long-term outcomes after curative resection of HCV-positive versus non-hepatitis related hepatocellular carcinoma: an international multi-institutional analysis. HPB (Oxford) 2020;22:1549-56. [PMID: 31987739 DOI: 10.1016/j.hpb.2020.01.003] [Reference Citation Analysis]
408 Du J, Zhu Z, Xu L, Chen X, Li X, Lan T, Li W, Yuan K, Zeng Y. ARHGEF11 promotes proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma through activation of β-catenin pathway. Aging (Albany NY) 2020;12:20235-53. [PMID: 33122451 DOI: 10.18632/aging.103772] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
409 Martos-Benítez FD, Soler-Morejón CD, Lara-Ponce KX, Orama-Requejo V, Burgos-Aragüez D, Larrondo-Muguercia H, Lespoir RW. Critically ill patients with cancer: A clinical perspective. World J Clin Oncol 2020; 11(10): 809-835 [PMID: 33200075 DOI: 10.5306/wjco.v11.i10.809] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
410 Wang L, Chen Y, Zhang N, Chen W, Zhang Y, Gao R. QIMCMDA: MiRNA-Disease Association Prediction by q-Kernel Information and Matrix Completion. Front Genet 2020;11:594796. [PMID: 33193744 DOI: 10.3389/fgene.2020.594796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
411 Ahmed S, Gordon L, Dueck DA, Souied O, Haider K. Current status of systemic therapy in hepatocellular cancer. Dig Liver Dis 2020:S1590-8658(20)30933-6. [PMID: 34756361 DOI: 10.1016/j.dld.2020.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
412 Hung P, Zahnd WE, Brandt HM, Adams SA, Wang S, Eberth JM. Cervical cancer treatment initiation and survival: The role of residential proximity to cancer care. Gynecol Oncol 2021;160:219-26. [PMID: 33081985 DOI: 10.1016/j.ygyno.2020.10.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
413 Bercow AS, Nitecki R, Haber H, Gockley AA, Hinchcliff E, James K, Melamed A, Diver E, Kamdar MM, Feldman S, Growdon WB. Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer. Int J Gynecol Cancer 2021;31:66-72. [PMID: 33046575 DOI: 10.1136/ijgc-2020-001812] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
414 Chen C, Stock C, Hoffmeister M, Brenner H. Self-Reported Lower Gastrointestinal Endoscopy Use and Changes in Colorectal Cancer Mortality Rates in European Countries. Clin Transl Gastroenterol 2020;11:e00243. [PMID: 33031193 DOI: 10.14309/ctg.0000000000000243] [Reference Citation Analysis]
415 Zhao Z, He B, Cai Q, Zhang P, Peng X, Zhang Y, Xie H, Wang X. A model of twenty-three metabolic-related genes predicting overall survival for lung adenocarcinoma. PeerJ 2020;8:e10008. [PMID: 33024640 DOI: 10.7717/peerj.10008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
416 Jobani BM, Mohebi E, Najafzadeh N. In Vitro Anticancer Effects of All-trans Retinoic Acid in Combination with Dacarbazine against CD117+ Melanoma Cells. Drug Res (Stuttg) 2020;70:563-9. [DOI: 10.1055/a-1240-0072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
417 Fan X, Yuan H, Zhao S, Yang X, Shi R, Wang J, Zhao H. Epigenetic age acceleration of early stage hepatocellular carcinoma tightly associated with hepatitis B virus load, immunoactivation, and improved survival. Cancer Biol Ther 2020;21:899-906. [PMID: 32914683 DOI: 10.1080/15384047.2020.1804284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
418 Singh B, Spence R, Steele ML, Hayes S, Toohey K. Exercise for Individuals With Lung Cancer: A Systematic Review and Meta-Analysis of Adverse Events, Feasibility, and Effectiveness. Semin Oncol Nurs 2020;36:151076. [PMID: 33008682 DOI: 10.1016/j.soncn.2020.151076] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
419 Xie F, You Y, Huang J, Guan C, Chen Z, Fang M, Yao F, Han J. Association between physical activity and digestive-system cancer: An updated systematic review and meta-analysis. J Sport Health Sci 2021;10:4-13. [PMID: 33010525 DOI: 10.1016/j.jshs.2020.09.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
420 Xu J, Yan B, Zhang L, Zhou L, Zhang J, Yu W, Dong X, Yao L, Shan L. Theabrownin Induces Apoptosis and Tumor Inhibition of Hepatocellular Carcinoma Huh7 Cells Through ASK1-JNK-c-Jun Pathway. Onco Targets Ther 2020;13:8977-87. [PMID: 32982289 DOI: 10.2147/OTT.S254693] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
421 Niu PH, Zhao LL, Wu HL, Zhao DB, Chen YT. Artificial intelligence in gastric cancer: Application and future perspectives. World J Gastroenterol 2020; 26(36): 5408-5419 [PMID: 33024393 DOI: 10.3748/wjg.v26.i36.5408] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 44] [Article Influence: 14.7] [Reference Citation Analysis]
422 Hu X, Bao M, Huang J, Zhou L, Zheng S. Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma. Front Oncol 2020;10:541479. [PMID: 33102213 DOI: 10.3389/fonc.2020.541479] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
423 Xie F, Sun L, Pang Y, Xu G, Jin B, Xu H, Lu X, Xu Y, Du S, Wang Y, Feng S, Sang X, Zhong S, Wang X, Sun W, Zhao H, Zhang H, Yang H, Huang P, Mao Y. Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine. Biomaterials 2021;265:120416. [PMID: 33007612 DOI: 10.1016/j.biomaterials.2020.120416] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
424 Reaman G, Karres D, Ligas F, Lesa G, Casey D, Ehrlich L, Norga K, Pazdur R. Accelerating the Global Development of Pediatric Cancer Drugs: A Call to Coordinate the Submissions of Pediatric Investigation Plans and Pediatric Study Plans to the European Medicines Agency and US Food and Drug Administration. J Clin Oncol 2020;38:4227-30. [PMID: 32946356 DOI: 10.1200/JCO.20.02152] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
425 Batai K, Hooker S, Kittles RA. Leveraging genetic ancestry to study health disparities. Am J Phys Anthropol 2021;175:363-75. [PMID: 32935870 DOI: 10.1002/ajpa.24144] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
426 Raybould AL, Sanoff H. Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date. J Hepatocell Carcinoma 2020;7:133-42. [PMID: 32984090 DOI: 10.2147/JHC.S224938] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
427 Ahmadi M, Amiri S, Pecic S, Machaj F, Rosik J, Łos MJ, Alizadeh J, Mahdian R, da Silva Rosa SC, Schaafsma D, Shojaei S, Madrakian T, Zeki AA, Ghavami S. Pleiotropic effects of statins: A focus on cancer. Biochim Biophys Acta Mol Basis Dis 2020;1866:165968. [PMID: 32927022 DOI: 10.1016/j.bbadis.2020.165968] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 17.0] [Reference Citation Analysis]
428 Labeur TA, Hofsink Q, Takkenberg RB, van Delden OM, Mathôt RAA, Schinner R, Malfertheiner P, Amthauer H, Schütte K, Basu B, Kuhl C, Mayerle J, Ricke J, Klümpen HJ. The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trial. Acta Oncol 2020;59:1028-35. [PMID: 32366155 DOI: 10.1080/0284186X.2020.1759826] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
429 Nguyen PT, Kanno K, Pham QT, Kikuchi Y, Kakimoto M, Kobayashi T, Otani Y, Kishikawa N, Miyauchi M, Arihiro K, Ito M, Tazuma S. Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma. J Cancer Res Clin Oncol 2020;146:3255-68. [PMID: 32870388 DOI: 10.1007/s00432-020-03374-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
430 Luizaga CTM, Ribeiro KB, Fonseca LAM, Eluf Neto J. Trends in prostate cancer mortality in the state of São Paulo, 2000 to 2015. Rev Saude Publica 2020;54:87. [PMID: 32876300 DOI: 10.11606/s1518-8787.2020054001948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
431 Kong W, Gao M, Jin Y, Huang W, Huang Z, Xie Z. Prognostic model of patients with liver cancer based on tumor stem cell content and immune process. Aging (Albany NY) 2020;12:16555-78. [PMID: 32852285 DOI: 10.18632/aging.103832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
432 Yammine K, Hayek F, Assi C. A meta-analysis of mortality after minor amputation among patients with diabetes and/or peripheral vascular disease. J Vasc Surg 2020;72:2197-207. [PMID: 32835790 DOI: 10.1016/j.jvs.2020.07.086] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
433 Tanabe K, Ikeda M, Hayashi M, Matsuo K, Yasaka M, Machida H, Shida M, Katahira T, Imanishi T, Hirasawa T, Sato K, Yoshida H, Mikami M. Comprehensive Serum Glycopeptide Spectra Analysis Combined with Artificial Intelligence (CSGSA-AI) to Diagnose Early-Stage Ovarian Cancer. Cancers (Basel) 2020;12:E2373. [PMID: 32825730 DOI: 10.3390/cancers12092373] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
434 Chen Y, Sadasivan SM, She R, Datta I, Taneja K, Chitale D, Gupta N, Davis MB, Newman LA, Rogers CG, Paris PL, Li J, Rybicki BA, Levin AM. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival. BMC Med Genomics 2020;13:116. [PMID: 32819446 DOI: 10.1186/s12920-020-00765-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
435 Tyuryumina EY, Neznanov AA, Turumin JL. A Mathematical Model to Predict Diagnostic Periods for Secondary Distant Metastases in Patients with ER/PR/HER2/Ki-67 Subtypes of Breast Cancer. Cancers (Basel) 2020;12:E2344. [PMID: 32825078 DOI: 10.3390/cancers12092344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
436 Fu S, Wu CF, Wang M, Lairson DR. Cost Effectiveness of Transplant, Conventional Chemotherapy, and Novel Agents in Multiple Myeloma: A Systematic Review. Pharmacoeconomics 2019;37:1421-49. [PMID: 31392666 DOI: 10.1007/s40273-019-00828-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
437 Bianconi D, Herac M, Posch F, Schmeidl M, Unseld M, Kieler M, Brettner R, Müllauer L, Riedl J, Gerger A, Scheithauer W, Prager G. Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC. Ther Adv Med Oncol 2020;12:1758835920928635. [PMID: 32922518 DOI: 10.1177/1758835920928635] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
438 Pasquinelli MM, Tammemägi MC, Kovitz KL, Durham ML, Deliu Z, Rygalski K, Liu L, Koshy M, Finn P, Feldman LE. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities. J Thorac Oncol 2020;15:1738-47. [PMID: 32822843 DOI: 10.1016/j.jtho.2020.08.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
439 Wang J, Wei W, Tang Q, Lu L, Luo Z, Li W, Lu Y, Pu J. Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti-Lag-3 via reducing FGL1 expression. Cancer Med 2020;9:7125-36. [PMID: 32810392 DOI: 10.1002/cam4.3151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
440 Dymova MA, Taskaev SY, Richter VA, Kuligina EV. Boron neutron capture therapy: Current status and future perspectives. Cancer Commun (Lond) 2020;40:406-21. [PMID: 32805063 DOI: 10.1002/cac2.12089] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 17.3] [Reference Citation Analysis]
441 Cao MD, Song YC, Yang ZM, Wang DW, Lin YM, Lu HD. Identification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on Bioinformatic and Experimental Analysis. Onco Targets Ther 2020;13:8095-107. [PMID: 32884293 DOI: 10.2147/OTT.S256617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
442 Wang M, Wei K, Qian B, Feiler S, Lemekhova A, Büchler MW, Hoffmann K. HSP70-eIF4G Interaction Promotes Protein Synthesis and Cell Proliferation in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E2262. [PMID: 32823513 DOI: 10.3390/cancers12082262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
443 Gianì F, Vella V, Tumino D, Malandrino P, Frasca F. The Possible Role of Cancer Stem Cells in the Resistance to Kinase Inhibitors of Advanced Thyroid Cancer. Cancers (Basel) 2020;12:E2249. [PMID: 32796774 DOI: 10.3390/cancers12082249] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
444 Maginador G, Lixandrão ME, Bortolozo HI, Vechin FC, Sarian LO, Derchain S, Telles GD, Zopf E, Ugrinowitsch C, Conceição MS. Aerobic Exercise-Induced Changes in Cardiorespiratory Fitness in Breast Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis. Cancers (Basel) 2020;12:E2240. [PMID: 32796499 DOI: 10.3390/cancers12082240] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
445 Xu LX, He MH, Dai ZH, Yu J, Wang JG, Li XC, Jiang BB, Ke ZF, Su TH, Peng ZW, Guo Y, Chen ZB, Chen SL, Peng S, Kuang M. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma. Ann Oncol. 2019;. [PMID: 30916311 DOI: 10.1093/annonc/mdz103] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 14.7] [Reference Citation Analysis]
446 Mazloom A, Ghalehsari N, Gazivoda V, Nimkar N, Paul S, Gregos P, Rateshwar J, Khan U. Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies. J Clin Med 2020;9:E2533. [PMID: 32781500 DOI: 10.3390/jcm9082533] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
447 Langston AA, Quest TE, Abernethy ER, Campbell GP, Owonikoko TK, Pentz RD. Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer. Oncologist 2020;25:e1586-8. [PMID: 32744382 DOI: 10.1634/theoncologist.2020-0442] [Reference Citation Analysis]
448 Koureas M, Kirgou P, Amoutzias G, Hadjichristodoulou C, Gourgoulianis K, Tsakalof A. Target Analysis of Volatile Organic Compounds in Exhaled Breath for Lung Cancer Discrimination from Other Pulmonary Diseases and Healthy Persons. Metabolites 2020;10:E317. [PMID: 32756521 DOI: 10.3390/metabo10080317] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
449 Low EE, Demb J, Liu L, Earles A, Bustamante R, Williams CD, Provenzale D, Kaltenbach T, Gawron AJ, Martinez ME, Gupta S. Risk Factors for Early-Onset Colorectal Cancer. Gastroenterology 2020;159:492-501.e7. [PMID: 31926997 DOI: 10.1053/j.gastro.2020.01.004] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 22.0] [Reference Citation Analysis]
450 Palumbo C, Pecoraro A, Rosiello G, Luzzago S, Deuker M, Stolzenbach F, Tian Z, Shariat SF, Simeone C, Briganti A, Saad F, Berruti A, Antonelli A, Karakiewicz PI. Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years. Cancer Epidemiology 2020;67:101762. [DOI: 10.1016/j.canep.2020.101762] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
451 Patel SH, Ebrahimi S, Northfelt DW, Mathews TE, Omar FM, Martinez ED, DeWees TA, Okamoto JM. Understanding American Indian Perceptions Toward Radiation Therapy. Cancer Control 2020;27:1073274820945991. [PMID: 32735143 DOI: 10.1177/1073274820945991] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
452 Uc PY, Miranda J, Raya-Sandino A, Alarcón L, Roldán ML, Ocadiz-Delgado R, Cortés-Malagón EM, Chávez-Munguía B, Ramírez G, Asomoza R, Shoshani L, Gariglio P, González-Mariscal L. E7 oncoprotein from human papillomavirus 16 alters claudins expression and the sealing of epithelial tight junctions. Int J Oncol 2020;57:905-24. [PMID: 32945372 DOI: 10.3892/ijo.2020.5105] [Reference Citation Analysis]
453 Wang Y, Li B, Ren F, Song Z, Ouyang L, Liu K. Survival After Minimally Invasive vs. Open Radical Hysterectomy for Cervical Cancer: A Meta-Analysis. Front Oncol 2020;10:1236. [PMID: 32903313 DOI: 10.3389/fonc.2020.01236] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
454 Johnson AL, Medina HN, Schlumbrecht MP, Reis I, Kobetz EN, Pinheiro PS. The role of histology on endometrial cancer survival disparities in diverse Florida. PLoS One 2020;15:e0236402. [PMID: 32701999 DOI: 10.1371/journal.pone.0236402] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
455 Novinson D, Puckett M, Townsend J, Tortolero-Luna G, Patterson JR, Gelb CA, Stewart SL. Increasing Awareness of Uterine Cancer Risks and Symptoms by Using Campaign Materials from Inside Knowledge: Get the Facts About Gynecologic Cancer. J Cancer Educ 2019;34:1190-7. [PMID: 30229402 DOI: 10.1007/s13187-018-1427-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
456 Grassi T, Mariani A, Cibula D, Soliman PT, Suman VJ, Weaver AL, Pedra Nobre S, Weigelt B, Glaser GE, Cappuccio S, Abu-Rustum NR. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial). Int J Gynecol Cancer 2020;30:1627-32. [PMID: 32699021 DOI: 10.1136/ijgc-2020-001698] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
457 Suzuki L, Nieboer D, van Lanschot JJ, Spaander MC, Looijenga LH, Biermann K. Effect of neoadjuvant chemoradiotherapy on p53 and SOX2 protein expression in esophageal adenocarcinoma. Biomark Med 2020;14:785-93. [PMID: 32677456 DOI: 10.2217/bmm-2020-0135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
458 Zhang B, Guo K, Zheng X, Sun L, Shen M, Ruan S. Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy. Front Oncol 2020;10:1154. [PMID: 32766153 DOI: 10.3389/fonc.2020.01154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
459 Thorsness SL, Freites-Martinez A, Marchetti MA, Navarrete-Dechent C, Lacouture ME, Tonorezos ES. Nonmelanoma Skin Cancer in Childhood and Young Adult Cancer Survivors Previously Treated With Radiotherapy. J Natl Compr Canc Netw 2019;17:237-43. [PMID: 30865918 DOI: 10.6004/jnccn.2018.7096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
460 Zgodic A, Zahnd WE, Miller DP Jr, Studts JL, Eberth JM. Predictors of Lung Cancer Screening Utilization in a Population-Based Survey. J Am Coll Radiol 2020;17:1591-601. [PMID: 32681828 DOI: 10.1016/j.jacr.2020.06.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
461 Ma Y, Yang W, Li T, Liu Y, Simon TG, Sui J, Wu K, Giovannucci EL, Chan AT, Zhang X. Meat intake and risk of hepatocellular carcinoma in two large US prospective cohorts of women and men. Int J Epidemiol 2019;48:1863-71. [PMID: 31302687 DOI: 10.1093/ije/dyz146] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
462 Zhao B, Wang Y, Wang Y, Chen W, Zhou L, Liu PH, Kong Z, Dai C, Wang Y, Ma W. Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses. Aging (Albany NY) 2020;12:14244-70. [PMID: 32669477 DOI: 10.18632/aging.103455] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
463 Liang JY, Wang DS, Lin HC, Chen XX, Yang H, Zheng Y, Li YH. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. Int J Biol Sci 2020;16:2430-41. [PMID: 32760210 DOI: 10.7150/ijbs.45050] [Cited by in Crossref: 213] [Cited by in F6Publishing: 230] [Article Influence: 71.0] [Reference Citation Analysis]
464 Abdolali F, Kapur J, Jaremko JL, Noga M, Hareendranathan AR, Punithakumar K. Automated thyroid nodule detection from ultrasound imaging using deep convolutional neural networks. Computers in Biology and Medicine 2020;122:103871. [DOI: 10.1016/j.compbiomed.2020.103871] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
465 Rice LW, Cedars MI, Sadovsky Y, Siddiqui NY, Teal SB, Wright JD, Zorbas A, Del Carmen MG. Increasing NIH funding for academic departments of obstetrics and gynecology: a call to action. Am J Obstet Gynecol 2020;223:79.e1-8. [PMID: 32272090 DOI: 10.1016/j.ajog.2020.03.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
466 Wu Y, Min J, Ge C, Shu J, Tian D, Yuan Y, Zhou D. Interleukin 22 in Liver Injury, Inflammation and Cancer. Int J Biol Sci 2020;16:2405-13. [PMID: 32760208 DOI: 10.7150/ijbs.38925] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
467 Ogawa E, Nomura H, Nakamuta M, Furusyo N, Kajiwara E, Dohmen K, Kawano A, Ooho A, Azuma K, Takahashi K, Satoh T, Koyanagi T, Ichiki Y, Kuniyoshi M, Yanagita K, Amagase H, Morita C, Sugimoto R, Kato M, Shimoda S, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group. Development of Hepatocellular Carcinoma by Patients Aged 75-84 with Chronic Hepatitis C Treated with Direct-acting Antivirals. J Infect Dis 2020:jiaa359. [PMID: 32584386 DOI: 10.1093/infdis/jiaa359] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
468 Scott JM, Stene G, Edvardsen E, Jones LW. Performance Status in Cancer: Not Broken, But Time for an Upgrade? J Clin Oncol 2020;38:2824-9. [PMID: 32584631 DOI: 10.1200/JCO.20.00721] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
469 Valentini V, Boldrini L, Mariani S, Massaccesi M. Role of radiation oncology in modern multidisciplinary cancer treatment. Mol Oncol 2020;14:1431-41. [PMID: 32418368 DOI: 10.1002/1878-0261.12712] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
470 Voute M, Morel V, Joly D, Villatte C, Martin E, Durando X, Pereira B, Pickering G. Predicting Pain Trajectories in the One Year Following Breast Cancer Diagnosis-An Observational Study. J Clin Med 2020;9:E1907. [PMID: 32570868 DOI: 10.3390/jcm9061907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
471 Hashim D, Genden E, Posner M, Hashibe M, Boffetta P. Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Ann Oncol 2019;30:744-56. [PMID: 30840052 DOI: 10.1093/annonc/mdz084] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 17.7] [Reference Citation Analysis]
472 Ward EM, Sherman RL, Henley SJ, Jemal A, Siegel DA, Feuer EJ, Firth AU, Kohler BA, Scott S, Ma J, Anderson RN, Benard V, Cronin KA. Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20-49 Years. J Natl Cancer Inst 2019;111:1279-97. [PMID: 31145458 DOI: 10.1093/jnci/djz106] [Cited by in Crossref: 154] [Cited by in F6Publishing: 170] [Article Influence: 51.3] [Reference Citation Analysis]
473 Douglas EH, Rhoads A, Thomas A, Aloi J, Suhl J, Lycan T Jr, Oleson J, Conway KM, Klubo-Gwiezdzinska J, Lynch CF, Romitti PA. Incidence and Survival in Reproductive-Aged Women with Differentiated Thyroid Cancer: United States SEER 18 2000-2016. Thyroid 2020;30:1781-91. [PMID: 32394796 DOI: 10.1089/thy.2020.0152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
474 Rossetti M, Brannetti S, Mocenigo M, Marini B, Ippodrino R, Porchetta A. Harnessing Effective Molarity to Design an Electrochemical DNA‐based Platform for Clinically Relevant Antibody Detection. Angew Chem Int Ed 2020;59:14973-8. [DOI: 10.1002/anie.202005124] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
475 Rossetti M, Brannetti S, Mocenigo M, Marini B, Ippodrino R, Porchetta A. Harnessing Effective Molarity to Design an Electrochemical DNA‐based Platform for Clinically Relevant Antibody Detection. Angew Chem 2020;132:15083-8. [DOI: 10.1002/ange.202005124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
476 Cahaney C, Stefancin P, Coulehan K, Parker RI, Preston T, Goldstein J, Hogan L, Duong TQ. Anatomical brain MRI study of pediatric cancer survivors treated with chemotherapy: Correlation with behavioral measures. Magn Reson Imaging 2020;72:8-13. [PMID: 32526251 DOI: 10.1016/j.mri.2020.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
477 Myers DJ, Hoppin P, Jacobs M, Clapp R, Kriebel D. Cancer rates not explained by smoking: a county-level analysis. Environ Health 2020;19:64. [PMID: 32505184 DOI: 10.1186/s12940-020-00613-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
478 Rencsok EM, Bazzi LA, McKay RR, Huang FW, Friedant A, Vinson J, Peisch S, Zarif JC, Simmons S, Hawthorne K, Villanti P, Kantoff PW, Heath E, George DJ, Mucci LA. Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions. Cancer Epidemiol Biomarkers Prev 2020;29:1374-80. [PMID: 32503813 DOI: 10.1158/1055-9965.EPI-19-1616] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
479 Youn JI, Park SM, Park S, Kim G, Lee HJ, Son J, Hong MH, Ghaderpour A, Baik B, Islam J, Choi JW, Lee EY, Kim HR, Seo SU, Paik S, Yoon HI, Jung I, Xin CF, Jin HT, Cho BC, Seong SY, Ha SJ, Kim HR. Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer. Sci Rep 2020;10:9050. [PMID: 32493990 DOI: 10.1038/s41598-020-65666-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
480 Lv L, Zhao Y, Wei Q, Zhao Y, Yi Q. Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma. Cancer Cell Int 2020;20:210. [PMID: 32514254 DOI: 10.1186/s12935-020-01298-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
481 Dang H, Yeo YH, Yasuda S, Huang CF, Iio E, Landis C, Jun DW, Enomoto M, Ogawa E, Tsai PC, Le A, Liu M, Maeda M, Nguyen B, Ramrakhiani N, Henry L, Cheung R, Tamori A, Kumada T, Tanaka Y, Yu ML, Toyoda H, Nguyen MH. Cure With Interferon-Free Direct-Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma From Both East and West. Hepatology 2020;71:1910-22. [PMID: 31610027 DOI: 10.1002/hep.30988] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 15.3] [Reference Citation Analysis]
482 von Felden J, Villanueva A. Role of Molecular Biomarkers in Liver Transplantation for Hepatocellular Carcinoma. Liver Transpl 2020;26:823-31. [PMID: 32061009 DOI: 10.1002/lt.25731] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
483 Islami F, Siegel RL, Jemal A. The changing landscape of cancer in the USA — opportunities for advancing prevention and treatment. Nat Rev Clin Oncol 2020;17:631-49. [DOI: 10.1038/s41571-020-0378-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
484 Manzo A, Carillio G, Montanino A, Sforza V, Palumbo G, Esposito G, Costanzo R, Sandomenico C, La Manna C, Martucci N, La Rocca A, De Luca G, Piccirillo MC, De Cecio R, Botti G, Totaro G, Muto P, Picone C, Normanno N, Morabito A. The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancer. Expert Opin Drug Saf 2020;19:775-83. [PMID: 32400223 DOI: 10.1080/14740338.2020.1767584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
485 Erdmann F, Frederiksen LE, Bonaventure A, Mader L, Hasle H, Robison LL, Winther JF. Childhood cancer: Survival, treatment modalities, late effects and improvements over time. Cancer Epidemiol 2021;71:101733. [PMID: 32461035 DOI: 10.1016/j.canep.2020.101733] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 15.3] [Reference Citation Analysis]
486 Palumbo C, Pecoraro A, Knipper S, Rosiello G, Luzzago S, Deuker M, Tian Z, Shariat SF, Simeone C, Briganti A, Saad F, Berruti A, Antonelli A, Karakiewicz PI. Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology. Eur Urol Focus 2021;7:644-52. [PMID: 32456993 DOI: 10.1016/j.euf.2020.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
487 Li JL, Li KZ, Xie MZ, Tang YP, Tang YL, Hu B. Clinical Significance and Prognostic Value of miR-28-5p in Colon Cancer. Dis Markers 2020;2020:3159831. [PMID: 32566038 DOI: 10.1155/2020/3159831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
488 Chang Z, Ji G, Huang R, Chen H, Gao Y, Wang W, Sun X, Zhang J, Zheng J, Wei Q. PIWI-interacting RNAs piR-13643 and piR-21238 are promising diagnostic biomarkers of papillary thyroid carcinoma. Aging (Albany NY) 2020;12:9292-310. [PMID: 32428871 DOI: 10.18632/aging.103206] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
489 Hensley MK, Donnelly JP, Carlton EF, Prescott HC. Epidemiology and Outcomes of Cancer-Related Versus Non-Cancer-Related Sepsis Hospitalizations. Crit Care Med 2019;47:1310-6. [PMID: 31356477 DOI: 10.1097/CCM.0000000000003896] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
490 Swoboda CM, Walker DM, Huerta TR. Likelihood of Smoking Among Cancer Survivors: An Updated Health Information National Trends Survey Analysis. Nicotine Tob Res 2019;21:1636-43. [PMID: 30843035 DOI: 10.1093/ntr/ntz007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
491 Babatunde OA, Eberth JM, Felder T, Moran R, Truman S, Hebert JR, Zhang J, Adams SA. Social Determinants of Racial Disparities in Breast Cancer Mortality Among Black and White Women. J Racial Ethn Health Disparities 2021;8:147-56. [PMID: 32385849 DOI: 10.1007/s40615-020-00766-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
492 Adjei Boakye E, Wang M, Sharma A, Jenkins WD, Osazuwa-peters N, Chen B, Lee M, Schootman M. Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers. J Cancer Res Clin Oncol 2020;146:1765-79. [DOI: 10.1007/s00432-020-03232-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
493 Fischer I, Milton C, Wallace H. Toxicity testing is evolving! Toxicol Res (Camb) 2020;9:67-80. [PMID: 32440338 DOI: 10.1093/toxres/tfaa011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
494 Orhan A, Vogelsang RP, Andersen MB, Madsen MT, Hölmich ER, Raskov H, Gögenur I. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis. Eur J Cancer 2020;132:71-84. [PMID: 32334338 DOI: 10.1016/j.ejca.2020.03.013] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 18.3] [Reference Citation Analysis]
495 Wood J, Yasmin-Karim S, Mueller R, Viswanathan AN, Ngwa W. Single Radiotherapy Fraction with Local Anti-CD40 Therapy Generates Effective Abscopal Responses in Mouse Models of Cervical Cancer. Cancers (Basel) 2020;12:E1026. [PMID: 32331490 DOI: 10.3390/cancers12041026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
496 Luo Y, Mei D, Gong J, Zuo M, Guo X. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymphovascular Space Invasion in Endometrial Carcinoma. J Magn Reson Imaging 2020;52:1257-62. [PMID: 32315482 DOI: 10.1002/jmri.27142] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
497 Bruegl AS, Joshi S, Batman S, Weisenberger M, Munro E, Becker T. Gynecologic cancer incidence and mortality among American Indian/Alaska Native women in the Pacific Northwest, 1996-2016. Gynecol Oncol 2020;157:686-92. [PMID: 32305303 DOI: 10.1016/j.ygyno.2020.03.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
498 Yang L, He Y, Zhang Z, Wang W. Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer. Biomed Res Int 2020;2020:4139320. [PMID: 32337246 DOI: 10.1155/2020/4139320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
499 Ma X, Zhou L, Zheng S. Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma. PeerJ 2020;8:e8930. [PMID: 32296612 DOI: 10.7717/peerj.8930] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
500 Kim-Wanner SZ, Assenov Y, Nair MB, Weichenhan D, Benner A, Becker N, Landwehr K, Kuner R, Sültmann H, Esteller M, Koch I, Lindner M, Meister M, Thomas M, Bieg M, Klingmüller U, Schlesner M, Warth A, Brors B, Seifried E, Bönig H, Plass C, Risch A, Muley T. Genome-Wide DNA Methylation Profiling in Early Stage I Lung Adenocarcinoma Reveals Predictive Aberrant Methylation in the Promoter Region of the Long Noncoding RNA PLUT: An Exploratory Study. J Thorac Oncol 2020;15:1338-50. [PMID: 32272161 DOI: 10.1016/j.jtho.2020.03.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
501 Gunn C, Maschke A, Bickmore T, Kennedy M, Hopkins MF, Fishman MDC, Paasche-Orlow MK, Warner ET. Acceptability of an Interactive Computer-Animated Agent to Promote Patient-Provider Communication About Breast Density: a Mixed Method Pilot Study. J Gen Intern Med 2020;35:1069-77. [PMID: 31919723 DOI: 10.1007/s11606-019-05622-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
502 Lin C, Wu J, Ding S, Goh C, Andriani L, Shen K, Zhu L. Impact of Prior Cancer History on the Clinical Outcomes in Advanced Breast Cancer: A Propensity Score-Adjusted, Population-Based Study. Cancer Res Treat 2020;52:552-62. [PMID: 31801318 DOI: 10.4143/crt.2019.210] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
503 Labgaa I, Taffé P, Martin D, Clerc D, Schwartz M, Kokudo N, Denys A, Halkic N, Demartines N, Melloul E. Comparison of Partial Hepatectomy and Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Liver Cancer 2020;9:138-47. [PMID: 32399428 DOI: 10.1159/000505093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
504 Reaman G, Stancato L, Vassal G, Maris JM. Crossing Oceans: Preclinical Collaboration to Improve Pediatric Drug Development. Am Soc Clin Oncol Educ Book 2020;40:1-8. [PMID: 32207673 DOI: 10.1200/EDBK_278893] [Reference Citation Analysis]
505 Xie LT, Gu JH, Chai WL, Chen RD, Zhao QY, Kong DX, Jiang TA. Pre-operative Detection of Liver Fibrosis in Hepatocellular Carcinoma Patients Using 2D Shear Wave Elastography: Where to Measure? Ultrasound Med Biol 2020;46:1412-23. [PMID: 32217029 DOI: 10.1016/j.ultrasmedbio.2020.02.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
506 Park J, Look KA. Health Care Expenditure Burden of Cancer Care in the United States. Inquiry 2019;56:46958019880696. [PMID: 31583928 DOI: 10.1177/0046958019880696] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
507 Robles AJ, Kurmasheva RT, Bandyopadhyay A, Phelps DA, Erickson SW, Lai Z, Kurmashev D, Chen Y, Smith MA, Houghton PJ. Evaluation of Eribulin Combined with Irinotecan for Treatment of Pediatric Cancer Xenografts. Clin Cancer Res 2020;26:3012-23. [PMID: 32184294 DOI: 10.1158/1078-0432.CCR-19-1822] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
508 Henley SJ, Ward EM, Scott S, Ma J, Anderson RN, Firth AU, Thomas CC, Islami F, Weir HK, Lewis DR, Sherman RL, Wu M, Benard VB, Richardson LC, Jemal A, Cronin K, Kohler BA. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer. 2020;126:2225-2249. [PMID: 32162336 DOI: 10.1002/cncr.32802] [Cited by in Crossref: 340] [Cited by in F6Publishing: 355] [Article Influence: 113.3] [Reference Citation Analysis]
509 Peres LC, Cushing-Haugen KL, Köbel M, Harris HR, Berchuck A, Rossing MA, Schildkraut JM, Doherty JA. Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage. J Natl Cancer Inst 2019;111:60-8. [PMID: 29718305 DOI: 10.1093/jnci/djy071] [Cited by in Crossref: 180] [Cited by in F6Publishing: 197] [Article Influence: 60.0] [Reference Citation Analysis]
510 Rowland JH, Gallicchio L, Mollica M, Saiontz N, Falisi AL, Tesauro G. Survivorship Science at the NIH: Lessons Learned From Grants Funded in Fiscal Year 2016. J Natl Cancer Inst 2019;111:109-17. [PMID: 30657942 DOI: 10.1093/jnci/djy208] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
511 Liu H, Zang L, Zhao J, Wang Z, Li L. Paeoniflorin inhibits cell viability and invasion of liver cancer cells via inhibition of Skp2. Oncol Lett 2020;19:3165-72. [PMID: 32256812 DOI: 10.3892/ol.2020.11424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
512 Zhang H, Pei Y, Zhang X, Zhu L, Hou L, Chang J, Zhang Z. Engineering of an intelligent cascade nanoreactor for sequential improvement of microenvironment and enhanced tumor phototherapy. Applied Materials Today 2020;18:100494. [DOI: 10.1016/j.apmt.2019.100494] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
513 Gaines S, van Praagh JB, Williamson AJ, Jacobson RA, Hyoju S, Zaborin A, Mao J, Koo HY, Alpert L, Bissonnette M, Weichselbaum R, Gilbert J, Chang E, Hyman N, Zaborina O, Shogan BD, Alverdy JC. Western Diet Promotes Intestinal Colonization by Collagenolytic Microbes and Promotes Tumor Formation After Colorectal Surgery. Gastroenterology 2020;158:958-970.e2. [PMID: 31655031 DOI: 10.1053/j.gastro.2019.10.020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
514 Moore JX, Han Y, Appleton C, Colditz G, Toriola AT. Determinants of Mammographic Breast Density by Race Among a Large Screening Population. JNCI Cancer Spectr 2020;4:pkaa010. [PMID: 32373777 DOI: 10.1093/jncics/pkaa010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
515 Kong S, Lee JK, Kang D, Kim I, Shim YM, Park W, Choi D, Cho J. Effectiveness of wearable activity tracker to reinforce leisure time physical activity among breast cancer patients: a randomized controlled trial (Preprint).. [DOI: 10.2196/preprints.18425] [Reference Citation Analysis]
516 Kong S, Lee JK, Kang D, Kim I, Shim YM, Park W, Choi D, Cho J. Effectiveness of wearable activity tracker to reinforce leisure time physical activity among breast cancer patients: a randomized controlled trial (Preprint).. [DOI: 10.2196/preprints.18452] [Reference Citation Analysis]
517 Massa ST, Osazuwa-Peters N, Adjei Boakye E, Walker RJ, Ward GM. Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors. JAMA Otolaryngol Head Neck Surg 2019;145:239-49. [PMID: 30789634 DOI: 10.1001/jamaoto.2018.3982] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 17.7] [Reference Citation Analysis]
518 Zheng G, Chattopadhyay S, Sundquist K, Sundquist J, Försti A, Hemminki A, Hemminki K. Association between tumor characteristics and second primary cancers with cutaneous melanoma survival: A nationwide cohort study. Pigment Cell Melanoma Res 2020;33:625-32. [PMID: 32012479 DOI: 10.1111/pcmr.12868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
519 Maskarinec G, Ju D, Shvetsov YB, Horio D, Chan O, Loo LWM, Hernandez BY. Breast tumor tissue inflammation but not lobular involution is associated with survival among breast cancer patients in the Multiethnic Cohort. Cancer Epidemiol 2020;65:101685. [PMID: 32058311 DOI: 10.1016/j.canep.2020.101685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
520 DeFeo BM, Kaste SC, Li Z, Brinkman TM, Neel MD, Srivastava DK, Hudson MM, Robison LL, Karol SE, Ness KK. Long-Term Functional Outcomes Among Childhood Survivors of Cancer Who Have a History of Osteonecrosis. Phys Ther 2020;100:509-22. [PMID: 32044966 DOI: 10.1093/ptj/pzz176] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
521 Yang W, Ma Y, Liu Y, Smith-Warner SA, Simon TG, Chong DQ, Qi Q, Meyerhardt JA, Giovannucci EL, Chan AT, Zhang X. Association of Intake of Whole Grains and Dietary Fiber With Risk of Hepatocellular Carcinoma in US Adults. JAMA Oncol 2019;5:879-86. [PMID: 30789662 DOI: 10.1001/jamaoncol.2018.7159] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
522 Brown JC, Caan BJ, Prado CM, Weltzien E, Xiao J, Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA. Body Composition and Cardiovascular Events in Patients With Colorectal Cancer: A Population-Based Retrospective Cohort Study. JAMA Oncol 2019;5:967-72. [PMID: 31095251 DOI: 10.1001/jamaoncol.2019.0695] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
523 Mulder FI, Bosch FTM, van Es N. Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand? Cancers (Basel) 2020;12:E367. [PMID: 32033438 DOI: 10.3390/cancers12020367] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
524 Carrasco R, Ramirez MC, Nes K, Schuster A, Aguayo R, Morales M, Ramos C, Hasson D, Sotomayor CG, Henriquez P, Cortés I, Erazo M, Salas C, Gormaz JG. Prevention of doxorubicin-induced Cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning based on Docosahexaenoic Acid (DHA) and carvedilol direct antioxidant effects: study protocol for a pilot, randomized, double-blind, controlled trial (CarDHA trial). Trials 2020;21:137. [PMID: 32019575 DOI: 10.1186/s13063-019-3963-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
525 Hu J, Shen J, Sun J. CDK4/RB/E2Fs axis as potential therapeutic target of endometrial cancer. Biomed Pharmacother 2020;125:109870. [PMID: 32032891 DOI: 10.1016/j.biopha.2020.109870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
526 Walsh N, Zhang H, Hyland PL, Yang Q, Mocci E, Zhang M, Childs EJ, Collins I, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Brennan P, Canzian F, Duell EJ, Gallinger S, Giles GG, Goggins M, Goodman GE, Goodman PJ, Hung RJ, Kooperberg C, Kurtz RC, Malats N, LeMarchand L, Neale RE, Olson SH, Scelo G, Shu XO, Van Den Eeden SK, Visvanathan K, White E, Zheng W, Albanes D, Andreotti G, Babic A, Bamlet WR, Berndt SI, Borgida A, Boutron-Ruault MC, Brais L, Brennan P, Bueno-de-Mesquita B, Buring J, Chaffee KG, Chanock S, Cleary S, Cotterchio M, Foretova L, Fuchs C, M Gaziano JM, Giovannucci E, Goggins M, Hackert T, Haiman C, Hartge P, Hasan M, Helzlsouer KJ, Herman J, Holcatova I, Holly EA, Hoover R, Hung RJ, Janout V, Klein EA, Kurtz RC, Laheru D, Lee IM, Lu L, Malats N, Mannisto S, Milne RL, Oberg AL, Orlow I, Patel AV, Peters U, Porta M, Real FX, Rothman N, Sesso HD, Severi G, Silverman D, Strobel O, Sund M, Thornquist MD, Tobias GS, Wactawski-Wende J, Wareham N, Weiderpass E, Wentzensen N, Wheeler W, Yu H, Zeleniuch-Jacquotte A, Kraft P, Li D, Jacobs EJ, Petersen GM, Wolpin BM, Risch HA, Amundadottir LT, Yu K, Klein AP, Stolzenberg-Solomon RZ; PanScan and PanC4 consortia. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. J Natl Cancer Inst 2019;111:557-67. [PMID: 30541042 DOI: 10.1093/jnci/djy155] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
527 Baek S, Lee SS, Kim JH, Kim SH, Lim J, Lee JS, Kim M. Pancreatic Cancer in a Young Male in His Twenties. Korean J Med 2020;95:50-55. [DOI: 10.3904/kjm.2020.95.1.50] [Reference Citation Analysis]
528 Fair D, Potter SL, Venkatramani R. Challenges and solutions to the study of rare childhood tumors. Curr Opin Pediatr 2020;32:7-12. [PMID: 31789973 DOI: 10.1097/MOP.0000000000000857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
529 Jung JO, Nienhüser H, Schleussner N, Schmidt T. Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach. Int J Mol Sci 2020;21:E951. [PMID: 32023907 DOI: 10.3390/ijms21030951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
530 Schullian P, Johnston EW, Putzer D, Eberle G, Laimer G, Bale R. Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study. Int J Hyperthermia 2019;36:876-85. [PMID: 31462110 DOI: 10.1080/02656736.2019.1648886] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
531 Hooker K, Mejía ST, Phibbs S, Tan EJ, Stevens J. Effects of Age Discrimination on Self-perceptions of Aging and Cancer Risk Behaviors. Gerontologist 2019;59:S28-37. [PMID: 31100138 DOI: 10.1093/geront/gny183] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
532 Ritwik P, Chrisentery-singleton TE. Oral and dental considerations in pediatric cancers. Cancer Metastasis Rev 2020;39:43-53. [DOI: 10.1007/s10555-020-09842-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
533 Wang S, Ma H, Li X, Mo X, Zhang H, Yang L, Deng Y, Yan Y, Yang G, Liu X, Sun H. DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection. Aging (Albany NY) 2020;12:1171-85. [PMID: 31977318 DOI: 10.18632/aging.102675] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
534 Zheng G, Chattopadhyay S, Sundquist K, Sundquist J, Försti A, Hemminki A, Hemminki K. Second Primary Cancers in Melanoma Patients Critically Shorten Survival. Clin Epidemiol 2020;12:105-12. [PMID: 32158273 DOI: 10.2147/CLEP.S230149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
535 Jurrius P, Green T, Garmo H, Young M, Cariati M, Gillett C, Mera A, Harries M, Grigoriadis A, Pinder S, Holmberg L, Purushotham A. Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the "ATRESS" phenomenon. Breast 2020;50:39-48. [PMID: 31981910 DOI: 10.1016/j.breast.2020.01.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
536 Khan S, Zaki H. Crosstalk between NLRP12 and JNK during Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E496. [PMID: 31941025 DOI: 10.3390/ijms21020496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
537 Freisling H, Viallon V, Lennon H, Bagnardi V, Ricci C, Butterworth AS, Sweeting M, Muller D, Romieu I, Bazelle P, Kvaskoff M, Arveux P, Severi G, Bamia C, Kühn T, Kaaks R, Bergmann M, Boeing H, Tjønneland A, Olsen A, Overvad K, Dahm CC, Menéndez V, Agudo A, Sánchez MJ, Amiano P, Santiuste C, Gurrea AB, Tong TYN, Schmidt JA, Tzoulaki I, Tsilidis KK, Ward H, Palli D, Agnoli C, Tumino R, Ricceri F, Panico S, Picavet HSJ, Bakker M, Monninkhof E, Nilsson P, Manjer J, Rolandsson O, Thysell E, Weiderpass E, Jenab M, Riboli E, Vineis P, Danesh J, Wareham NJ, Gunter MJ, Ferrari P. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med 2020;18:5. [PMID: 31918762 DOI: 10.1186/s12916-019-1474-7] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 25.3] [Reference Citation Analysis]
538 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7-30. [PMID: 31912902 DOI: 10.3322/caac.21590] [Cited by in Crossref: 11224] [Cited by in F6Publishing: 12312] [Article Influence: 3741.3] [Reference Citation Analysis]
539 Bandera EV, Demissie K, Qin B, Llanos AAM, Lin Y, Xu B, Pawlish K, Plascak JJ, Tsui J, Omilian AR, McCann W, Yao S, Ambrosone CB, Hong CC. The Women's Circle of Health Follow-Up Study: a population-based longitudinal study of Black breast cancer survivors in New Jersey. J Cancer Surviv 2020;14:331-46. [PMID: 31907766 DOI: 10.1007/s11764-019-00849-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
540 Jiang Y, Cheng W, Li L, Zhou L, Liang Y, Zhang W, Chen W, Wang S, Zhao H, Chen G, Zhou W, Ji G, Zhang Y, Hoffman RM, Wang M, Jia L. Effective targeting of the ubiquitin-like modifier NEDD8 for lung adenocarcinoma treatment. Cell Biol Toxicol 2020;36:349-64. [PMID: 31907687 DOI: 10.1007/s10565-019-09503-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
541 Zheng H, Qin Z, Qiu X, Zhan M, Wen F, Xu T. Cost-effectiveness analysis of ramucirumab treatment for patients with hepatocellular carcinoma who progressed on sorafenib with α-fetoprotein concentrations of at least 400 ng/ml. Journal of Medical Economics 2020;23:347-52. [DOI: 10.1080/13696998.2019.1707211] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
542 Sjöblom O, Turnbull-smith S, Minn H, Keyriläinen J. Comparison of Cost and Time Effectiveness Between CT- and MRI-Based Radiotherapy Workflow for Prostate Cancer. Communications in Computer and Information Science 2020. [DOI: 10.1007/978-3-030-57847-3_4] [Reference Citation Analysis]
543 Gutierrez C. Outcomes After Cardiopulmonary Resuscitation in the Cancer Patient. Oncologic Critical Care 2020. [DOI: 10.1007/978-3-319-74588-6_71] [Reference Citation Analysis]
544 Gugnin A, Bagatelya Z, Nechipay A, Korzheva I, Afanasieva V, Amirov M, Bako R. Colonic stenting is a more effective treatment of the malignant colonic obstruction compare with emergency surgery. Dok gastroenterol 2020;9:16. [DOI: 10.17116/dokgastro2020904116] [Reference Citation Analysis]
545 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin 2020;70:7-30. [DOI: 10.3322/caac.21590] [Cited by in Crossref: 12148] [Article Influence: 4049.3] [Reference Citation Analysis]
546 Pinheiro PS, Callahan KE, Kobetz EN. Disaggregated Hispanic Groups and Cancer: Importance, Methodology, and Current Knowledge. Advancing the Science of Cancer in Latinos 2020. [DOI: 10.1007/978-3-030-29286-7_2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
547 Malakorn S, Sammour T, Chang GJ. Robotic Pelvic Exenteration. Minimally Invasive Surgical Techniques for Cancers of the Gastrointestinal Tract 2020. [DOI: 10.1007/978-3-030-18740-8_29] [Reference Citation Analysis]
548 Preisser F, Graefen M, Thederan I, Haese A, Huland H. Prostatakarzinom: Epidemiologie und Risikofaktoren. Uroonkologie 2020. [DOI: 10.1007/978-3-662-54652-9_50-1] [Reference Citation Analysis]
549 Cheng L, Lopez-beltran A, Maclennan GT, Montironi R, Bostwick DG. Neoplasms of the Urinary Bladder. Urologic Surgical Pathology 2020. [DOI: 10.1016/b978-0-323-54941-7.00006-2] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
550 Amukotuwa S, Bell LC, Thomas DL. Applications of Quantitative Perfusion and Permeability in the Brain. Advances in Magnetic Resonance Technology and Applications 2020. [DOI: 10.1016/b978-0-12-817057-1.00017-2] [Reference Citation Analysis]
551 Jhingran A, Russell AH, Seiden MV, Duska LR, Goodman A, Lee SL, Digumarthy SR, Fuller AF. Cancers of the Cervix, Vulva, and Vagina. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00084-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
552 Chou CW, Lin CH, Hsiao TH, Lo CC, Hsieh CY, Huang CC, Sher YP. Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis. Sci Rep. 2019;9:20403. [PMID: 31892709 DOI: 10.1038/s41598-019-56532-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
553 Lakomy DS, Urbauer DL, Westin SN, Lin LL. Phase I study of the PARP inhibitor talazoparib with radiation therapy for locally recurrent gynecologic cancers. Clin Transl Radiat Oncol 2020;21:56-61. [PMID: 31993510 DOI: 10.1016/j.ctro.2019.12.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
554 Onal C, Sari SY, Yildirim BA, Yavas G, Gultekin M, Guler OC, Akyurek S, Yildiz F. A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma. J Gynecol Oncol 2019;30:e28. [PMID: 30887753 DOI: 10.3802/jgo.2019.30.e28] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
555 Houghton PJ, Kurmasheva RT. Challenges and Opportunities for Childhood Cancer Drug Development. Pharmacol Rev 2019;71:671-97. [PMID: 31558580 DOI: 10.1124/pr.118.016972] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
556 Sun H, Huang H, Ji S, Chen X, Xu Y, Zhu F, Wu J. The Efficacy of Cognitive Behavioral Therapy to Treat Depression and Anxiety and Improve Quality of Life Among Early-Stage Breast Cancer Patients. Integr Cancer Ther 2019;18:1534735419829573. [PMID: 30791739 DOI: 10.1177/1534735419829573] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
557 Mizuno R, Kawada K, Sakai Y. Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer. Int J Mol Sci 2019;20:E6254. [PMID: 31835815 DOI: 10.3390/ijms20246254] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 13.8] [Reference Citation Analysis]
558 Yang L, He Y, Zhang Z, Wang W. Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas. PeerJ 2019;7:e8245. [PMID: 31844595 DOI: 10.7717/peerj.8245] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
559 Metzger K, Horn D, Pfeiffer T, Moratin J, Kansy K, Ristow O, Engel M, Hoffmann J, Freier K, Schaible A, Freudlsperger C. Is panendoscopy a necessary staging procedure in patients with lacking risk factors and oral squamous cell carcinoma? J Craniomaxillofac Surg 2019;47:1968-72. [PMID: 31810847 DOI: 10.1016/j.jcms.2019.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
560 Xue J, Cao Z, Cheng Y, Wang J, Liu Y, Yang R, Li H, Jiang W, Li G, Zhao W, Zhang X. Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression. Cancer Lett 2020;471:12-26. [PMID: 31811908 DOI: 10.1016/j.canlet.2019.11.043] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
561 Albujja MH, Vasudevan R, Alghamdi S, Pei CP, Bin Mohd Ghani KA, Ranneh Y, Ismail PB. A review of studies examining the association between genetic biomarkers (short tandem repeats and single-nucleotide polymorphisms) and risk of prostate cancer: the need for valid predictive biomarkers. Prostate Int 2020;8:135-45. [PMID: 33425790 DOI: 10.1016/j.prnil.2019.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
562 Mangana J, Dimitriou F, Braun R, Ludwig S, Dummer R, Barysch MJ. Single-center real-life experience with low-dose ipilimumab monotherapy in adjuvant setting for patients with stage III melanoma. Melanoma Research 2019;29:648-54. [DOI: 10.1097/cmr.0000000000000593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
563 Tailor TD, Tong BC, Gao J, Choudhury KR, Rubin GD. A Geospatial Analysis of Factors Affecting Access to CT Facilities: Implications for Lung Cancer Screening. Journal of the American College of Radiology 2019;16:1663-8. [DOI: 10.1016/j.jacr.2019.06.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
564 Gudkov A, Yermolov P. The prospects of creating of microwave radiothermography based on monolithic integrated circuits. ITM Web Conf 2019;30:13001. [DOI: 10.1051/itmconf/20193013001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
565 Duan XH, Li H, Ren JZ, Han XW, Chen PF, Li FY, Huang GH, Ju SG. Hepatic Arterial Chemoembolization With Arsenic Trioxide Eluting CalliSpheres Microspheres Versus Lipiodol Emulsion: Pharmacokinetics And Intratumoral Concentration In A Rabbit Liver Tumor Model. Cancer Manag Res 2019;11:9979-88. [PMID: 32063723 DOI: 10.2147/CMAR.S199188] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
566 Liu Z, Tao H. Small nucleolar RNA host gene 3 facilitates cell proliferation and migration in oral squamous cell carcinoma via targeting nuclear transcription factor Y subunit gamma. J Cell Biochem 2020;121:2150-8. [PMID: 31762107 DOI: 10.1002/jcb.29421] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
567 An MW, Tang J, Grothey A, Sargent DJ, Ou FS, Mandrekar SJ. Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials. Contemp Clin Trials Commun 2020;17:100492. [PMID: 31872158 DOI: 10.1016/j.conctc.2019.100492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
568 Konen J, Murphy S, Berkman A, Ahern TP, Sowden M. Intraoperative Ultrasound Guidance With an Ultrasound-Visible Clip: A Practical and Cost-effective Option for Breast Cancer Localization. J Ultrasound Med 2020;39:911-7. [PMID: 31737930 DOI: 10.1002/jum.15172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
569 Shao YH, Tsai K, Kim S, Wu YJ, Demissie K. Exposure to Tomographic Scans and Cancer Risks. JNCI Cancer Spectr 2020;4:pkz072. [PMID: 32337490 DOI: 10.1093/jncics/pkz072] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
570 Wong CR, Lim JK. Increasing contribution of non-alcoholic fatty liver disease to hepatocellular carcinoma incidence and mortality in U.S. Medicare. Hepatobiliary Surg Nutr 2019;8:506-8. [PMID: 31673540 DOI: 10.21037/hbsn.2019.04.06] [Reference Citation Analysis]
571 Matsui T, Miyamoto K, Yamanaka K, Okai Y, Kaushik EP, Harada K, Wagoner M, Shinozawa T. Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicology and Applied Pharmacology 2019;383:114761. [DOI: 10.1016/j.taap.2019.114761] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
572 Labgaa I, Tabrizian P, Titano J, Kim E, Thung SN, Florman S, Schwartz M, Melloul E. Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma. HPB (Oxford) 2019;21:1497-504. [PMID: 31005494 DOI: 10.1016/j.hpb.2019.03.360] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
573 Zhao X, Zhang C, Wei X, Shi L, Dai S, Jia J, Wei S, Wang Y, Wang Y, Cheng J, Zhao L. CARLo-5 as an oncogenic gene in endometrial carcinoma. Environ Mol Mutagen 2020;61:256-65. [PMID: 31661565 DOI: 10.1002/em.22340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
574 Hall BM, Geraci TC, Machan JT, Milman S, Adams CA, Cioffi W, Ng T, Monaghan S. Lack of Lymphocyte Recovery After Esophagectomy Predicts Overall and Recurrence-Free Survival. J Surg Res 2020;246:379-83. [PMID: 31676146 DOI: 10.1016/j.jss.2019.09.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
575 Williams MS, Young C, McKinney S, Simon Hawkins OS, Roberson C, Udemgba C, Rogers DB, Wells J, Lake DA, Davis D, Young T, Donnell D, Herring BJ. Making Breast Screening Convenient: a Community-Based Breast Screening Event During a Historically Black University's Homecoming Festivities. J Cancer Educ 2020;35:832-5. [PMID: 31654322 DOI: 10.1007/s13187-019-01600-8] [Reference Citation Analysis]
576 Teng L, Wang K, Liu Y, Ma Y, Chen W, Bi L. Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions. Biomed Res Int 2019;2019:1742341. [PMID: 31886176 DOI: 10.1155/2019/1742341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
577 Bytnar JA, Lin J, Shriver CD, Zhu K. Racial differences in brain cancer characteristics and survival: an analysis of SEER data. Cancer Causes Control 2019;30:1283-91. [PMID: 31641915 DOI: 10.1007/s10552-019-01239-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
578 Travassos XL, Avila SL, Grubisic S, Linhares A, Ida N. Electromagnetic Field Exposure Assessment in a Multi Source Telecommunication Environment: Application to Nonoccupational Exposure in Public Spaces. Wireless Pers Commun 2020;110:2213-25. [DOI: 10.1007/s11277-019-06838-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
579 Malmgren JA, Calip GS, Atwood MK, Mayer M, Kaplan HG. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011. Cancer 2020;126:390-9. [PMID: 31639221 DOI: 10.1002/cncr.32531] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
580 Han X, Yabroff KR, Ward E, Brawley OW, Jemal A. Comparison of Insurance Status and Diagnosis Stage Among Patients With Newly Diagnosed Cancer Before vs After Implementation of the Patient Protection and Affordable Care Act. JAMA Oncol 2018;4:1713-20. [PMID: 30422152 DOI: 10.1001/jamaoncol.2018.3467] [Cited by in Crossref: 102] [Cited by in F6Publishing: 104] [Article Influence: 25.5] [Reference Citation Analysis]
581 Al-Oqail MM, Al-Sheddi ES, Farshori NN, Al-Massarani SM, Al-Turki EA, Ahmad J, Al-Khedhairy AA, Siddiqui MA. Corn Silk (Zea mays L.) Induced Apoptosis in Human Breast Cancer (MCF-7) Cells via the ROS-Mediated Mitochondrial Pathway. Oxid Med Cell Longev 2019;2019:9789241. [PMID: 31781357 DOI: 10.1155/2019/9789241] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
582 Ho L, Li W, Cheung AT, Ho E, Lam K, Chiu SY, Chan G, Chung J. Relationships among hope, psychological well-being and health-related quality of life in childhood cancer survivors. J Health Psychol 2021;26:1528-37. [PMID: 31621412 DOI: 10.1177/1359105319882742] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
583 Chen M, Wang D, Zhao Y, Lu DM, Li HX, Liu JJ, Li H. Preoperative color Doppler ultrasonography predicts early recurrence in AFP-positive hepatocellular carcinoma. Oncol Lett 2019;18:4703-11. [PMID: 31611979 DOI: 10.3892/ol.2019.10825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
584 Simoni-Nieves A, Gerardo-Ramírez M, Pedraza-Vázquez G, Chávez-Rodríguez L, Bucio L, Souza V, Miranda-Labra RU, Gomez-Quiroz LE, Gutiérrez-Ruiz MC. GDF11 Implications in Cancer Biology and Metabolism. Facts and Controversies. Front Oncol 2019;9:1039. [PMID: 31681577 DOI: 10.3389/fonc.2019.01039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
585 Zenger S, Gurbuz B, Can U, Bilgic C, Sobutay E, Postgil Yilmaz S, Balik E, Yalti T, Kapran Y, Bugra D. Clinicopathological importance of colorectal medullary carcinoma. Eur Surg 2019;51:308-14. [DOI: 10.1007/s10353-019-00613-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
586 Pasquinelli MM, Kovitz KL, Koshy M, Menchaca MG, Liu L, Winn R, Feldman LE. Outcomes From a Minority-Based Lung Cancer Screening Program vs the National Lung Screening Trial. JAMA Oncol 2018;4:1291-3. [PMID: 30073301 DOI: 10.1001/jamaoncol.2018.2823] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
587 Homan SG, Yun S, Bouras A, Schmaltz C, Gwanfogbe P, Lucht J. Breast Cancer Population Screening Program Results in Early Detection and Reduced Treatment and Health Care Costs for Medicaid. J Public Health Manag Pract 2021;27:70-9. [PMID: 31592983 DOI: 10.1097/PHH.0000000000001041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
588 Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS. Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014. JAMA Oncol 2018;4:1254-62. [PMID: 29931168 DOI: 10.1001/jamaoncol.2018.1789] [Cited by in Crossref: 226] [Cited by in F6Publishing: 242] [Article Influence: 56.5] [Reference Citation Analysis]
589 Matsushita Y, Smith B, Delannoy M, Trujillo MA, Chianchiano P, McMillan R, Kamiyama H, Liang H, Thompson ED, Hruban RH, Matsui W, Wood LD, Roberts NJ, Eshleman JR. Biphenotypic Differentiation of Pancreatic Cancer in 3-Dimensional Culture. Pancreas 2019;48:1225-31. [PMID: 31593010 DOI: 10.1097/MPA.0000000000001390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
590 Pillon M, Sperotto F, Zattarin E, Cattelan M, Carraro E, Contin AE, Massano D, Pece F, Putti MC, Messina C, Pettenazzo A, Amigoni A. Predictors of mortality after admission to pediatric intensive care unit in oncohematologic patients without history of hematopoietic stem cell transplantation: A single-center experience. Pediatr Blood Cancer 2019;66:e27892. [PMID: 31250548 DOI: 10.1002/pbc.27892] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
591 Čizmarević U, Hanžič N, Polanec B, Rupreht M. Unusual Presentation of Hepatocellular Carcinoma and Rare Metastasis to the Masticatory Space. Cureus 2019;11:e5802. [PMID: 31728249 DOI: 10.7759/cureus.5802] [Reference Citation Analysis]
592 Kalidindi Y, Segel J, Jung J. Impact of Hospice on Spending and Utilization Among Patients With Lung Cancer in Medicare. Am J Hosp Palliat Care 2020;37:286-93. [PMID: 31564110 DOI: 10.1177/1049909119878446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
593 Chemaitilly W, Liu Q, van Iersel L, Ness KK, Li Z, Wilson CL, Brinkman TM, Klosky JL, Barnes N, Clark KL, Howell RM, Smith SA, Krasin MJ, Metzger ML, Armstrong GT, Bishop MW, van Santen HM, Pui CH, Srivastava DK, Yasui Y, Hudson MM, Robison LL, Green DM, Sklar CA. Leydig Cell Function in Male Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study. J Clin Oncol 2019;37:3018-31. [PMID: 31557085 DOI: 10.1200/JCO.19.00738] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
594 Wood DE, Kazerooni EA, Baum SL, Eapen GA, Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Makani SS, Massion PP, Mazzone P, Merritt RE, Meyers BF, Midthun DE, Pipavath S, Pratt C, Reddy C, Reid ME, Rotter AJ, Sachs PB, Schabath MB, Schiebler ML, Tong BC, Travis WD, Wei B, Yang SC, Gregory KM, Hughes M. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16:412-441. [PMID: 29632061 DOI: 10.6004/jnccn.2018.0020] [Cited by in Crossref: 245] [Cited by in F6Publishing: 286] [Article Influence: 61.3] [Reference Citation Analysis]
595 Liang Z, Pan Q, Zhang Z, Huang C, Yan Z, Zhang Y, Li J. MicroRNA‑125a‑5p controls the proliferation, apoptosis, migration and PTEN/MEK1/2/ERK1/2 signaling pathway in MCF‑7 breast cancer cells. Mol Med Rep 2019;20:4507-14. [PMID: 31702027 DOI: 10.3892/mmr.2019.10704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
596 Davidson NE. Incident Cancer in Cancer Survivors-When Cancer Lurks in the Background. JAMA Oncol 2018;4:836-7. [PMID: 29167860 DOI: 10.1001/jamaoncol.2017.4167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
597 Lowery CD, Blosser W, Dowless M, Renschler M, Perez LV, Stephens J, Pytowski B, Wasserstrom H, Stancato LF, Falcon B. Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy. Oncotarget 2019;10:5523-33. [PMID: 31565186 DOI: 10.18632/oncotarget.27148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
598 Felix AS, Brinton LA. Cancer Progress and Priorities: Uterine Cancer. Cancer Epidemiol Biomarkers Prev 2018;27:985-94. [PMID: 30181320 DOI: 10.1158/1055-9965.EPI-18-0264] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
599 Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL. Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014. JAMA Oncol 2018;4:317-23. [PMID: 29192307 DOI: 10.1001/jamaoncol.2017.3846] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 21.8] [Reference Citation Analysis]
600 Pulley JM, Jerome RN, Ogletree ML, Bernard GR, Lavieri RR, Zaleski NM, Hong CC, Shirey-Rice JK, Arteaga CL, Mayer IA, Holroyd KJ, Cook RS. Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program. Target Oncol 2018;13:61-8. [PMID: 29218624 DOI: 10.1007/s11523-017-0542-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
601 Shobab L, Gomes-lima C, Zeymo A, Feldman R, Jonklaas J, Wartofsky L, Burman KD. Clinical, Pathological, and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer. Thyroid 2019;29:1262-8. [DOI: 10.1089/thy.2019.0075] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
602 Peres LC, Hebert JR, Qin B, Guertin KA, Bandera EV, Shivappa N, Camacho TF, Chyn D, Alberg AJ, Barnholtz-Sloan JS, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Schildkraut JM. Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous Ovarian Carcinoma. J Nutr 2019;149:1606-16. [PMID: 31152675 DOI: 10.1093/jn/nxz098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
603 Shih AR, Uruga H, Bozkurtlar E, Chung J, Hariri LP, Minami Y, Wang H, Yoshizawa A, Muzikansky A, Moreira AL, Mino‐kenudson M. Problems in the reproducibility of classification of small lung adenocarcinoma: an international interobserver study. Histopathology 2019;75:649-59. [DOI: 10.1111/his.13922] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
604 Zalzman M, Meltzer WA, Portney BA, Brown RA, Gupta A. The Role of Ubiquitination and SUMOylation in Telomere Biology. Curr Issues Mol Biol 2020;35:85-98. [PMID: 31422934 DOI: 10.21775/cimb.035.085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
605 Spiegelberg L, van Hoof SJ, Biemans R, Lieuwes NG, Marcus D, Niemans R, Theys J, Yaromina A, Lambin P, Verhaegen F, Dubois LJ. Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity. Radiother Oncol. 2019;141:247-255. [PMID: 31431383 DOI: 10.1016/j.radonc.2019.06.034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
606 Alcedo KP, Guerrero A, Basrur V, Fu D, Richardson ML, McLane JS, Tsou CC, Nesvizhskii AI, Welling TH, Lebrilla CB, Otey CA, Kim HJ, Omary MB, Snider NT. Tumor-Selective Altered Glycosylation and Functional Attenuation of CD73 in Human Hepatocellular Carcinoma. Hepatol Commun 2019;3:1400-14. [PMID: 31592495 DOI: 10.1002/hep4.1410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
607 Vera-Ramirez L. Cell-intrinsic survival signals. The role of autophagy in metastatic dissemination and tumor cell dormancy. Semin Cancer Biol 2020;60:28-40. [PMID: 31400500 DOI: 10.1016/j.semcancer.2019.07.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
608 Wang Z, Yang MQ, Lei L, Fei LR, Zheng YW, Huang WJ, Li ZH, Liu CC, Xu HT. Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis. Cancer Manag Res 2019;11:7485-97. [PMID: 31496806 DOI: 10.2147/CMAR.S218926] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
609 Onol FF, P Ganapathi H, Rogers T, Palmer K, Coughlin G, Samavedi S, Coelho R, Jenson C, Sandri M, Rocco B, Patel V. Changing clinical trends in 10 000 robot-assisted laparoscopic prostatectomy patients and impact of the 2012 US Preventive Services Task Force's statement against PSA screening. BJU Int 2019;124:1014-21. [PMID: 31301265 DOI: 10.1111/bju.14866] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
610 Ma Y, Yang W, Simon TG, Smith-Warner SA, Fung TT, Sui J, Chong D, VoPham T, Meyerhardt JA, Wen D, Giovannucci EL, Chan AT, Zhang X. Dietary Patterns and Risk of Hepatocellular Carcinoma Among U.S. Men and Women. Hepatology 2019;70:577-86. [PMID: 30506561 DOI: 10.1002/hep.30362] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
611 Shulman DS, DuBois SG. Winning the RACE: Expanding pediatric cancer drug approvals. Pediatr Blood Cancer 2019;66:e27705. [PMID: 30854771 DOI: 10.1002/pbc.27705] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
612 Trabert B, Coburn SB, Mariani A, Yang HP, Rosenberg PS, Gierach GL, Wentzensen N, Cronin KA, Sherman ME. Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries. J Natl Cancer Inst 2018;110:750-7. [PMID: 29281053 DOI: 10.1093/jnci/djx263] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
613 Singhal S, Rolfo C, Maksymiuk AW, Tappia PS, Sitar DS, Russo A, Akhtar PS, Khatun N, Rahnuma P, Rashiduzzaman A, Ahmed Bux R, Huang G, Ramjiawan B. Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study. Cancers (Basel) 2019;11:E1069. [PMID: 31362354 DOI: 10.3390/cancers11081069] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
614 Francois RA, Zhang A, Husain K, Wang C, Hutchinson S, Kongnyuy M, Batra SK, Coppola D, Sebti SM, Malafa MP. Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIPs. Cancer Cell Int 2019;19:189. [PMID: 31367187 DOI: 10.1186/s12935-019-0876-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
615 Johnson HM, Irish W, Muzaffar M, Vohra NA, Wong JH. Quantifying the relationship between age at diagnosis and breast cancer-specific mortality. Breast Cancer Res Treat 2019;177:713-22. [DOI: 10.1007/s10549-019-05353-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
616 Frenette CT, Isaacson AJ, Bargellini I, Saab S, Singal AG. A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk. Mayo Clin Proc Innov Qual Outcomes 2019;3:302-10. [PMID: 31485568 DOI: 10.1016/j.mayocpiqo.2019.04.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
617 Griffin KT, Mille MM, Pelletier C, Gopalakrishnan M, Jung JW, Lee C, Kalapurakal J, Pyakuryal A, Lee C. Conversion of computational human phantoms into DICOM-RT for normal tissue dose assessment in radiotherapy patients. Phys Med Biol 2019;64:13NT02. [PMID: 31158829 DOI: 10.1088/1361-6560/ab2670] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
618 Du Z, Hopp H, Ingles SA, Huff C, Sheng X, Weaver B, Stern M, Hoffmann TJ, John EM, Van Den Eeden SK, Strom S, Leach RJ, Thompson IM Jr, Witte JS, Conti DV, Haiman CA. A genome-wide association study of prostate cancer in Latinos. Int J Cancer 2020;146:1819-26. [PMID: 31226226 DOI: 10.1002/ijc.32525] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
619 Warner ET, Lathan CS. Race and sex differences in patient provider communication and awareness of lung cancer screening in the health information National Trends Survey, 2013-2017. Prev Med 2019;124:84-90. [PMID: 31054908 DOI: 10.1016/j.ypmed.2019.05.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
620 Sun J, Ji G, Xie J, Jiao Z, Zhang H, Chen J. Six-transmembrane epithelial antigen of the prostate 1 is associated with tumor invasion and migration in endometrial carcinomas. J Cell Biochem 2019;120:11172-89. [PMID: 30714206 DOI: 10.1002/jcb.28393] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
621 Ishida E, Lee J, Campbell JS, Chakravarty PD, Katori Y, Ogawa T, Johnson L, Mukhopadhyay A, Faquin WC, Lin DT, Wirth LJ, Pierce RH, Pai SI. Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model. Cancer Immunol Immunother 2019;68:1273-86. [PMID: 31243491 DOI: 10.1007/s00262-019-02357-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
622 Fredheim OM, Skurtveit S, Handal M, Hjellvik V. A complete national cohort study of prescriptions of analgesics and benzodiazepines to cancer survivors in Norway 10 years after diagnosis. Pain 2019;160:852-9. [PMID: 30531310 DOI: 10.1097/j.pain.0000000000001459] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
623 Schildkraut JM, Peres LC, Bethea TN, Camacho F, Chyn D, Cloyd EK, Bandera EV, Beeghly-Fadiel A, Lipworth L, Joslin CE, Davis FG, Moorman PG, Myers E, Ochs-Balcom HM, Setiawan VW, Pike MC, Wu AH, Rosenberg L. Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women. Cancer Causes Control 2019;30:967-78. [PMID: 31236792 DOI: 10.1007/s10552-019-01199-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
624 Cunningham JJ. A call for integrated metastatic management. Nat Ecol Evol 2019;3:996-8. [DOI: 10.1038/s41559-019-0927-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
625 Subedi P, Nembrini S, An Q, Zhu Y, Peng H, Yeh F, Cole SA, Rhoades DA, Lee ET, Zhao J. Telomere length and cancer mortality in American Indians: the Strong Heart Study. Geroscience 2019;41:351-61. [PMID: 31230193 DOI: 10.1007/s11357-019-00080-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
626 Fuh KC, Java JJ, Chan JK, Kapp DS, Monk BJ, Burger RA, Young RC, Alberts DS, McGuire WP, Markman M, Bell J, Ozols RF, Armstrong DK, Aghajanian C, Bookman MA, Mannel RS. Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients. Gynecol Oncol 2019;154:420-5. [PMID: 31229298 DOI: 10.1016/j.ygyno.2019.05.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
627 Cavalheri V, Burtin C, Formico VR, Nonoyama ML, Jenkins S, Spruit MA, Hill K. Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. Cochrane Database Syst Rev 2019;6:CD009955. [PMID: 31204439 DOI: 10.1002/14651858.CD009955.pub3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
628 Yang W, Sui J, Ma Y, Simon TG, Chong D, Meyerhardt JA, Willett WC, Giovannucci EL, Chan AT, Zhang X. A prospective study of dairy product intake and the risk of hepatocellular carcinoma in U.S. men and women. Int J Cancer 2020;146:1241-9. [PMID: 31116416 DOI: 10.1002/ijc.32423] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
629 Yu L, Sabatino SA, White MC. Rural-Urban and Racial/Ethnic Disparities in Invasive Cervical Cancer Incidence in the United States, 2010-2014. Prev Chronic Dis 2019;16:E70. [PMID: 31172917 DOI: 10.5888/pcd16.180447] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
630 Miceli J, Geller D, Tsung A, Hecht CL, Wang Y, Pathak R, Cheng H, Marsh W, Antoni M, Penedo F, Burke L, Ell K, Shen S, Steel J. Illness perceptions and perceived stress in patients with advanced gastrointestinal cancer. Psychooncology 2019;28:1513-9. [PMID: 31090125 DOI: 10.1002/pon.5108] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
631 Gerardo-ramírez M, Lazzarini-lechuga R, Hernández-rizo S, Jiménez-salazar JE, Simoni-nieves A, García-ruiz C, Fernández-checa JC, Marquardt JU, Coulouarn C, Gutiérrez-ruiz MC, Pérez-aguilar B, Gomez-quiroz LE. GDF11 exhibits tumor suppressive properties in hepatocellular carcinoma cells by restricting clonal expansion and invasion. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019;1865:1540-54. [DOI: 10.1016/j.bbadis.2019.03.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
632 Schnitzbauer V, Gerken M, Benz S, Völkel V, Draeger T, Fürst A, Klinkhammer-Schalke M. Laparoscopic and open surgery in rectal cancer patients in Germany: short and long-term results of a large 10-year population-based cohort. Surg Endosc 2020;34:1132-41. [PMID: 31147825 DOI: 10.1007/s00464-019-06861-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
633 You X, Wu J, Wang Y, Liu Q, Chen D, Zhao X, Zhou Y, Wu X, Wang D. Single vs. double purse-string anastomosis during laparoscopic low anterior rectal resection (SINGLE-DOUBLE trial): study protocol for a randomized controlled trial. Trials 2019;20:292. [PMID: 31138321 DOI: 10.1186/s13063-019-3411-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
634 Holman DM, Freeman MB, Shoemaker ML. Trends in Melanoma Incidence Among Non-Hispanic Whites in the United States, 2005 to 2014. JAMA Dermatol 2018;154:361-2. [PMID: 29387875 DOI: 10.1001/jamadermatol.2017.5541] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
635 Weir HK, Stewart SL, Allemani C, White MC, Thomas CC, White A, Coleman MP; CONCORD Working Group (US Members). Population-based cancer survival (2001 to 2009) in the United States: Findings from the CONCORD-2 study. Cancer 2017;123 Suppl 24:4963-8. [PMID: 29205309 DOI: 10.1002/cncr.31028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
636 Hains-Monfette G, Atoui S, Needham Dancause K, Bernard P. Device-Assessed Physical Activity and Sedentary Behaviors in Canadians with Chronic Disease(s): Findings from the Canadian Health Measures Survey. Sports (Basel) 2019;7:E113. [PMID: 31100779 DOI: 10.3390/sports7050113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
637 Lourembam RM, Yadav AS, Kundu GC, Mazumder PB. Curcuma zedoaria (christm.) roscoe inhibits proliferation of MDA-MB231 cells via caspase-cascade apoptosis. Orient Pharm Exp Med 2019;19:235-41. [DOI: 10.1007/s13596-019-00374-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
638 Recio-Boiles A, Hammad H, Howell K, Kalb BT, Nfonsam VN, Scott AJ, Babiker HM, Elquza E. Locally Advanced Rectal Cancer Evaluation by Magnetic Resonance Imaging after Neoadjuvant Therapy on Decision Making: Cancer Center Experience and Literature Review. J Gastrointest Cancer 2020;51:254-9. [PMID: 31054106 DOI: 10.1007/s12029-019-00246-5] [Reference Citation Analysis]
639 Daddiouaissa D, Amid A, Kabbashi NA, Fuad FA, Elnour A, Epandy MAS. Antiproliferative activity of ionic liquid-graviola fruit extract against human breast cancer (MCF-7) cell lines using flow cytometry techniques. Journal of Ethnopharmacology 2019;236:466-73. [DOI: 10.1016/j.jep.2019.03.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
640 Shen W, Qiu Y, Li J, Wu C, Liu Z, Zhang X, Hu X, Liao Y, Wang H. IL-25 promotes cisplatin resistance of lung cancer cells by activating NF-κB signaling pathway to increase of major vault protein. Cancer Med 2019;8:3491-501. [PMID: 31044552 DOI: 10.1002/cam4.2213] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
641 Shih AR, Kradin RL. Malignant mesothelioma in Lynch syndrome: A report of two cases and a review of the literature. Am J Ind Med 2019;62:448-52. [PMID: 31033031 DOI: 10.1002/ajim.22968] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
642 Sui J, Yang W, Ma Y, Li TY, Simon TG, Meyerhardt JA, Liang G, Giovannucci EL, Chan AT, Zhang X. A Prospective Study of Nut Consumption and Risk of Primary Hepatocellular Carcinoma in the U.S. Women and Men. Cancer Prev Res (Phila) 2019;12:367-74. [PMID: 31040153 DOI: 10.1158/1940-6207.CAPR-18-0511] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
643 Ng DWL, Kwong A, Suen D, Chan M, Or A, Ng SS, Foo CC, Fielding BF, Lam WW. Fear of cancer recurrence among Chinese cancer survivors: Prevalence and associations with metacognition and neuroticism. Psycho‐Oncology 2019;28:1243-51. [DOI: 10.1002/pon.5073] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
644 Kaushal R, Das CJ, Singh P, Dogra PN, Kumar R. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsies increase the rate of cancer detection in populations with a low incidence of prostate cancer. Investig Clin Urol 2019;60:156-61. [PMID: 31098422 DOI: 10.4111/icu.2019.60.3.156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
645 Tsiakanikas P, Kontos CK, Kerimis D, Papadopoulos IN, Scorilas A. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease. Clin Chem Lab Med 2018;56:990-1000. [PMID: 29688883 DOI: 10.1515/cclm-2017-0430] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
646 Ye L, Mayerle J, Ziesch A, Reiter FP, Gerbes AL, De Toni EN. The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma. Cell Death Discov 2019;5:86. [PMID: 30962952 DOI: 10.1038/s41420-019-0165-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
647 Lange N, Dufour JF. Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk? Dig Dis Sci 2019;64:903-9. [PMID: 30863952 DOI: 10.1007/s10620-019-05515-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
648 Portal D, Hofstetter L, Eshed I, Dan-Lantsman C, Sella T, Urban D, Onn A, Bar J, Segal G. L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients. Cancer Manag Res 2019;11:2579-88. [PMID: 31114324 DOI: 10.2147/CMAR.S195869] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
649 Odahowski CL, Zahnd WE, Eberth JM. Challenges and Opportunities for Lung Cancer Screening in Rural America. Journal of the American College of Radiology 2019;16:590-5. [DOI: 10.1016/j.jacr.2019.01.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
650 Sun L, Yuan Y, Chen J, Ma C, Xu Y. Brahma related gene 1 (BRG1) regulates breast cancer cell migration and invasion by activating MUC1 transcription. Biochemical and Biophysical Research Communications 2019;511:536-43. [DOI: 10.1016/j.bbrc.2019.02.088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
651 Antunes P, Esteves D, Nunes C, Joaquim A, Pimentel FL, Fonseca-Moutinho J. Health-related quality of life and physical fitness in breast cancer patients: the impact of a supervised physical exercise program in women with no exercise experience. Psychol Health Med 2019;24:1038-46. [PMID: 30929464 DOI: 10.1080/13548506.2019.1597978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
652 Neel DV, Shulman DS, DuBois SG. Timing of first-in-child trials of FDA-approved oncology drugs. Eur J Cancer 2019;112:49-56. [PMID: 30928805 DOI: 10.1016/j.ejca.2019.02.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
653 Virk GS, Jafri M, Ashley C. Colonoscopy and colorectal cancer rates among octogenarians and nonagenarians: nationwide study of US veterans.Clin Interv Aging. 2019;14:609-614. [PMID: 30988602 DOI: 10.2147/CIA.S192497] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
654 Li Y, Du L, Wu C, Yu B, Zhang H, An F. Peptide Sequence-Dominated Enzyme-Responsive Nanoplatform for Anticancer Drug Delivery. CTMC 2019;19:74-97. [DOI: 10.2174/1568026619666190125144621] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
655 Minlikeeva AN, Cannioto R, Jensen A, Kjaer SK, Jordan SJ, Diergaarde B, Szender JB, Odunsi K, Almohanna H, Mayor P, Starbuck K, Zsiros E, Bandera EV, Cramer DW, Doherty JA, DeFazio A, Edwards R, Goode EL, Goodman MT, Høgdall E, Matsuo K, Mizuno M, Nagle CM, Ness RB, Paddock LE, Pearce CL, Risch HA, Rossing MA, Terry KL, Wu AH, Modugno F, Webb PM, Moysich KB; Australian Ovarian Cancer Study Group., Ovarian Cancer Association Consortium. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium. Cancer Causes Control 2019;30:537-47. [PMID: 30905014 DOI: 10.1007/s10552-019-01157-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
656 Zhong S, Zhang Y, Yin X, Di W. CDK7 inhibitor suppresses tumor progression through blocking the cell cycle at the G2/M phase and inhibiting transcriptional activity in cervical cancer. Onco Targets Ther 2019;12:2137-47. [PMID: 30962695 DOI: 10.2147/OTT.S195655] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
657 Jawitz OK, Adam MA, Turner MC, Gilmore BF, Migaly J. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection. Surgery 2019;165:1193-8. [PMID: 30904173 DOI: 10.1016/j.surg.2019.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
658 Dandachi D, Ostrom QT, Chong I, Serpa JA, Giordano TP, Kruchko C, Barnholtz-Sloan JS, Fowler N, Colen RR, Morón FE. Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data. Cancer Causes Control 2019;30:477-88. [PMID: 30888569 DOI: 10.1007/s10552-019-01144-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
659 Onoue K, Nishio M, Yakami M, Aoyama G, Nakagomi K, Iizuka Y, Kubo T, Emoto Y, Akasaka T, Satoh K, Yamamoto H, Isoda H, Togashi K. CT temporal subtraction improves early detection of bone metastases compared to SPECT. Eur Radiol 2019;29:5673-81. [PMID: 30888486 DOI: 10.1007/s00330-019-06107-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
660 Chang CC, Bi KW, Lin HJ, Su YC, Wang WL, Lin CY, Ting CF, Sun MF, Huang ST. Conventional Western Treatment Associated With Chinese Herbal Medicine Ameliorates the Incidence of Head and Neck Cancer Among Patients With Esophageal Cancer. Integr Cancer Ther 2019;18:1534735419834353. [PMID: 30866690 DOI: 10.1177/1534735419834353] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
661 Duan Z, Chinn D, Tu MJ, Zhang QY, Huynh J, Chen J, Mack P, Yu AM, Kim EJ. Novel Synergistic Combination of Mitotic Arrest and Promotion of Apoptosis for Treatment of Pancreatic Adenocarcinoma. Transl Oncol 2019;12:683-92. [PMID: 30844579 DOI: 10.1016/j.tranon.2019.01.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
662 Reilly NM, Novara L, Di Nicolantonio F, Bardelli A. Exploiting DNA repair defects in colorectal cancer. Mol Oncol. 2019;13:681-700. [PMID: 30714316 DOI: 10.1002/1878-0261.12467] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 14.3] [Reference Citation Analysis]
663 Crumley S, Kurnit K, Hudgens C, Fellman B, Tetzlaff MT, Broaddus R. Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes. Mod Pathol 2019;32:396-404. [PMID: 30291344 DOI: 10.1038/s41379-018-0148-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
664 Bolivar AM, Luthra R, Mehrotra M, Chen W, Barkoh BA, Hu P, Zhang W, Broaddus RR. Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients. Mod Pathol 2019;32:405-14. [PMID: 30315273 DOI: 10.1038/s41379-018-0158-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 8.3] [Reference Citation Analysis]
665 Hughey CC, James FD, Wang Z, Goelzer M, Wasserman DH. Dysregulated transmethylation leading to hepatocellular carcinoma compromises redox homeostasis and glucose formation. Mol Metab 2019;23:1-13. [PMID: 30850319 DOI: 10.1016/j.molmet.2019.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
666 Jayasekara H, English DR, Hodge AM, Room R, Hopper JL, Milne RL, Giles GG, Macinnis RJ. Lifetime alcohol intake and pancreatic cancer incidence and survival: findings from the Melbourne Collaborative Cohort Study. Cancer Causes Control 2019;30:323-31. [DOI: 10.1007/s10552-019-01146-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
667 Martins-Filho SN, Alves VAF, Wakamatsu A, Maeda M, Craig AJ, Assato AK, Villacorta-Martin C, D'Avola D, Labgaa I, Carrilho FJ, Thung SN, Villanueva A. A phenotypical map of disseminated hepatocellular carcinoma suggests clonal constraints in metastatic sites. Histopathology. 2019;74:718-730. [PMID: 30636011 DOI: 10.1111/his.13809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
668 Higgins A, Khan Z, Coddington CC, Hashmi SK, Hefazi M, Alkhateeb H, Litzow MR, Hogan WJ, Cathcart-Rake E, Thompson CA, Patnaik MM. Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant. Biol Blood Marrow Transplant 2019;25:1232-9. [PMID: 30772513 DOI: 10.1016/j.bbmt.2019.02.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
669 Al-Husseini MJ, Saad AM, Jazieh KA, Elmatboly AM, Rachid A, Gad MM, Ruhban IA, Hilal T. Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups. Int J Colorectal Dis 2019;34:285-92. [PMID: 30443675 DOI: 10.1007/s00384-018-3195-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
670 Ladd J. Oncology breakthroughs give new hope. Pharmacy Today 2019;25:17. [DOI: 10.1016/j.ptdy.2019.01.008] [Reference Citation Analysis]
671 Minarich MJ, Schwarz RE. A Simplified Two-Step Technique for Extended Lymphadenectomy During Resection of Gastroesophageal Malignancy: Early Results Compared to En Bloc Dissection. J Gastrointest Surg 2019;23:393-401. [PMID: 30603860 DOI: 10.1007/s11605-018-4056-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
672 Dunn A, Whitmire B, Batch A, Fernando L, Rittmueller L. High Spending Growth Rates For Key Diseases In 2000-14 Were Driven By Technology And Demographic Factors. Health Aff (Millwood) 2018;37:915-24. [PMID: 29863919 DOI: 10.1377/hlthaff.2017.1688] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
673 Ioannou LJ, Serpell J, Dean J, Bendinelli C, Gough J, Lisewski D, Miller JA, Meyer-Rochow W, Sidhu S, Topliss D, Walters D, Zalcberg J, Ahern S. Development of a binational thyroid cancer clinical quality registry: a protocol paper. BMJ Open 2019;9:e023723. [PMID: 30782713 DOI: 10.1136/bmjopen-2018-023723] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
674 Mizuno R, Kawada K, Itatani Y, Ogawa R, Kiyasu Y, Sakai Y. The Role of Tumor-Associated Neutrophils in Colorectal Cancer. Int J Mol Sci 2019;20:E529. [PMID: 30691207 DOI: 10.3390/ijms20030529] [Cited by in Crossref: 100] [Cited by in F6Publishing: 111] [Article Influence: 25.0] [Reference Citation Analysis]
675 Lu T, Yang X, Huang Y, Zhao M, Li M, Ma K, Yin J, Zhan C, Wang Q. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res 2019;11:943-53. [PMID: 30718965 DOI: 10.2147/CMAR.S187317] [Cited by in Crossref: 187] [Cited by in F6Publishing: 220] [Article Influence: 46.8] [Reference Citation Analysis]
676 Gkogkozotou VI, Gkiozos IC, Charpidou AG, Kotteas EA, Boura PG, Tsagouli SN, Syrigos KN. PET/CT and brain MRI role in staging NSCLC: prospective assessment of the accuracy, reliability and cost-effectiveness. Lung Cancer Manag 2018;7:LMT02. [PMID: 30643581 DOI: 10.2217/lmt-2018-0008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
677 Derbal Y. The Adaptive Complexity of Cancer. Biomed Res Int 2018;2018:5837235. [PMID: 30627563 DOI: 10.1155/2018/5837235] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
678 Zhang X, Dai F, Chen J, Xie X, Xu H, Bai C, Qiao W, Shen W. Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits. Cancer Biol Ther 2019;20:642-52. [PMID: 30621501 DOI: 10.1080/15384047.2018.1550567] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
679 Aqil F, Munagala R, Agrawal AK, Gupta R. Anticancer Phytocompounds. New Look to Phytomedicine. Elsevier; 2019. pp. 237-72. [DOI: 10.1016/b978-0-12-814619-4.00010-0] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
680 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2019. [DOI: 10.1007/978-3-319-96830-8_31] [Reference Citation Analysis]
681 Green BL, Davis JL, Rivers D, Buchanan KL, Yamoah K. Cancer Health Disparities. Fundamentals of Cancer Prevention 2019. [DOI: 10.1007/978-3-030-15935-1_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
682 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34. [PMID: 30620402 DOI: 10.3322/caac.21551] [Cited by in Crossref: 13274] [Cited by in F6Publishing: 13817] [Article Influence: 3318.5] [Reference Citation Analysis]
683 Huang H, Kovacs ME, Y. Aguilera K, Brekken RA. Collagen Signaling in Cancer. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. Elsevier; 2019. pp. 89-108. [DOI: 10.1016/b978-0-12-816435-8.00007-9] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
684 Li J, Cheng D, Zhu M, Yu H, Pan Z, Liu L, Geng Q, Pan H, Yan M, Yao M. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer. Theranostics 2019;9:179-95. [PMID: 30662561 DOI: 10.7150/thno.29545] [Cited by in Crossref: 55] [Cited by in F6Publishing: 62] [Article Influence: 13.8] [Reference Citation Analysis]
685 Khoobchandani M, Katti KK, Karikachery AR, Thipe VC, Bloebaum PLR, Katti KV. Targeted Phytochemical-Conjugated Gold Nanoparticles in Cancer Treatment. EcoProduction 2019. [DOI: 10.1007/978-3-319-92399-4_3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
686 Sforzini L, Nettis MA, Mondelli V, Pariante CM. Inflammation in cancer and depression: a starring role for the kynurenine pathway. Psychopharmacology (Berl) 2019;236:2997-3011. [PMID: 30806743 DOI: 10.1007/s00213-019-05200-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
687 Halim AB. Pharmaceutical crisis. Biomarkers, Diagnostics and Precision Medicine in the Drug Industry 2019. [DOI: 10.1016/b978-0-12-816121-0.00001-5] [Reference Citation Analysis]
688 Chude-okonkwo U, Malekian R, Maharaj BT. Communication Engineering Meets Medical Science: The Advanced Targeted Nanomedical Solution. Advanced Targeted Nanomedicine 2019. [DOI: 10.1007/978-3-030-11003-1_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
689 Satram-hoang S, Stein A, Cortazar P, Momin F, Reyes C. Increased Mortality Risk among Early Stage Hormone Receptor Positive Breast Cancer Patients Who Did Not Receive Adjuvant or Neoadjuvant Therapy. JCT 2019;10:1-20. [DOI: 10.4236/jct.2019.101001] [Reference Citation Analysis]
690 Roca-Lema D, Martinez-Iglesias O, Fernández de Ana Portela C, Rodríguez-Blanco A, Valladares-Ayerbes M, Díaz-Díaz A, Casas-Pais A, Prego C, Figueroa A. In Vitro Anti-proliferative and Anti-invasive Effect of Polysaccharide-rich Extracts from Trametes Versicolor and Grifola Frondosa in Colon Cancer Cells. Int J Med Sci 2019;16:231-40. [PMID: 30745803 DOI: 10.7150/ijms.28811] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
691 Sher T, Gertz MA. Plasma Cell Disorders. Concise Guide to Hematology 2019. [DOI: 10.1007/978-3-319-97873-4_34] [Reference Citation Analysis]
692 Gutierrez C. Outcomes After Cardiopulmonary Resuscitation in the Cancer Patient. Oncologic Critical Care 2019. [DOI: 10.1007/978-3-319-74698-2_71-1] [Reference Citation Analysis]
693 Saini S, Maker AV, Burman KD, Prabhakar BS. Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer. Biochim Biophys Acta Rev Cancer 2019;1872:188262. [PMID: 30605717 DOI: 10.1016/j.bbcan.2018.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
694 Caswell-Jin JL, Plevritis SK, Tian L, Cadham CJ, Xu C, Stout NK, Sledge GW, Mandelblatt JS, Kurian AW. Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review. JNCI Cancer Spectr 2018;2:pky062. [PMID: 30627694 DOI: 10.1093/jncics/pky062] [Cited by in Crossref: 119] [Cited by in F6Publishing: 126] [Article Influence: 23.8] [Reference Citation Analysis]
695 Lowery CD, Dowless M, Renschler M, Blosser W, VanWye AB, Stephens JR, Iversen PW, Lin AB, Beckmann RP, Krytska K, Cole KA, Maris JM, Hawkins DS, Rubin BP, Kurmasheva RT, Houghton PJ, Gorlick R, Kolb EA, Kang MH, Reynolds CP, Erickson SW, Teicher BA, Smith MA, Stancato LF. Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models. Clin Cancer Res 2019;25:2278-89. [PMID: 30563935 DOI: 10.1158/1078-0432.CCR-18-2728] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 8.6] [Reference Citation Analysis]
696 Linden HM, Peterson LM, Fowler AM. Clinical Potential of Estrogen and Progesterone Receptor Imaging. PET Clin 2018;13:415-22. [PMID: 30100079 DOI: 10.1016/j.cpet.2018.02.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
697 Yao Q, Kou L, Tu Y, Zhu L. MMP-Responsive 'Smart' Drug Delivery and Tumor Targeting. Trends Pharmacol Sci 2018;39:766-81. [PMID: 30032745 DOI: 10.1016/j.tips.2018.06.003] [Cited by in Crossref: 127] [Cited by in F6Publishing: 138] [Article Influence: 25.4] [Reference Citation Analysis]
698 Griffiths C, Jimenez E, Chalas E. Causal effect of obesity on gynecologic malignancies. Curr Probl Cancer 2019;43:145-50. [PMID: 30497850 DOI: 10.1016/j.currproblcancer.2018.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
699 Ramey SJ, Rich BJ, Kwon D, Mellon EA, Wolfson A, Portelance L, Yechieli R. Demographic disparities in delay of definitive chemoradiation for anal squamous cell carcinoma: a nationwide analysis. J Gastrointest Oncol 2018;9:1109-26. [PMID: 30603130 DOI: 10.21037/jgo.2018.08.07] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
700 Cao B, Bray F, Ilbawi A, Soerjomataram I. Effect on longevity of one-third reduction in premature mortality from non-communicable diseases by 2030: a global analysis of the Sustainable Development Goal health target. The Lancet Global Health 2018;6:e1288-96. [DOI: 10.1016/s2214-109x(18)30411-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
701 [DOI: 10.1109/iccsdet.2018.8821188] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
702 Yang C, Sriranjan V, Abou-Setta AM, Poluha W, Walker JR, Singh H. Anxiety Associated with Colonoscopy and Flexible Sigmoidoscopy: A Systematic Review. Am J Gastroenterol 2018;113:1810-8. [PMID: 30385831 DOI: 10.1038/s41395-018-0398-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
703 Yang T, Chen H, Tang H, Li D, Wei P. A powerful and data-adaptive test for rare-variant-based gene-environment interaction analysis. Stat Med 2019;38:1230-44. [PMID: 30460711 DOI: 10.1002/sim.8037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
704 Kim YA, Cho H, Lee N, Jung SY, Sim SH, Park IH, Lee S, Lee ES, Kim HJ. Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database. Cancer Med 2018;7:6084-92. [PMID: 30453386 DOI: 10.1002/cam4.1886] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
705 Sakin A, Arici S, Secmeler S, Can O, Geredeli C, Yasar N, Demir C, Demir OG, Cihan S. Prognostic significance of primary tumor localization in stage II and III colon cancer. World J Gastrointest Oncol 2018; 10(11): 410-420 [PMID: 30487952 DOI: 10.4251/wjgo.v10.i11.410] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
706 Buscariollo DL, Cronin AM, Borstelmann NA, Punglia RS. Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women. Breast Cancer Res Treat 2019;173:709-17. [PMID: 30406869 DOI: 10.1007/s10549-018-5006-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
707 Ashton JR, Gottlin EB, Patz EF Jr, West JL, Badea CT. A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer. PLoS One 2018;13:e0206950. [PMID: 30408128 DOI: 10.1371/journal.pone.0206950] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
708 Ashley CW, Da Cruz Paula A, Kumar R, Mandelker D, Pei X, Riaz N, Reis-Filho JS, Weigelt B. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression. Gynecol Oncol 2019;152:11-9. [PMID: 30415991 DOI: 10.1016/j.ygyno.2018.10.032] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
709 Ji J, Sundquist J, Sundquist K. Use of terbinafine and risk of death in patients with prostate cancer: A population‐based cohort study. Int J Cancer 2019;144:1888-95. [DOI: 10.1002/ijc.31901] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
710 Gallaway MS, Henley SJ, Steele CB, Momin B, Thomas CC, Jamal A, Trivers KF, Singh SD, Stewart SL. Surveillance for Cancers Associated with Tobacco Use - United States, 2010-2014. MMWR Surveill Summ 2018;67:1-42. [PMID: 30383737 DOI: 10.15585/mmwr.ss6712a1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
711 Guo B, Liao C, Fang Y, Li S, Li X, Lu Z, Chen Y. Ruthenium complex delivery using liposomes to improve bioactivity against HeLa cells via the mitochondrial pathway. Nanomedicine 2018;13:2851-66. [DOI: 10.2217/nnm-2018-0236] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
712 Morgan MA, Papanicolaou N. Voiding cystourethrography after prostatectomy: spectrum of appearances. Abdom Radiol (NY) 2018;43:3060-7. [PMID: 29556701 DOI: 10.1007/s00261-018-1564-6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
713 De B, Rhome R, Jairam V, Özbek U, Holcombe RF, Buckstein M, Ang C. Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States. Gastric Cancer 2018;21:889-99. [PMID: 29691758 DOI: 10.1007/s10120-018-0826-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
714 Felix AS, Cohn DE, Brasky TM, Zaino R, Park K, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Randall ME, Brinton LA. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study. Am J Obstet Gynecol 2018;219:459.e1-459.e11. [PMID: 30096321 DOI: 10.1016/j.ajog.2018.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
715 Dasari A, Grothey A, Kopetz S. Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies. J Clin Oncol. 2018;36:JCO2018789032. [PMID: 30376428 DOI: 10.1200/jco.2018.78.9032] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
716 Maskarinec G, Shvetsov YB, Conroy SM, Haiman CA, Setiawan VW, Le Marchand L. Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort. Breast Cancer Res Treat 2019;173:637-45. [PMID: 30367331 DOI: 10.1007/s10549-018-5025-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
717 Gadalla SM, Widemann BC. Editorial: US Cancer Statistics of Survival: Achievements, Challenges, and Future Directions. J Natl Cancer Inst 2017;109. [PMID: 28954287 DOI: 10.1093/jnci/djx070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
718 Umesh C. Gupta, Subhas C. Gupta, Shayle S. Gupta. The Under appreciated Role of Lifestyle and Nutrition in Cancer Prevention, Genesis, and Treatment. J Can Res Updates 2018;7:119-133. [DOI: 10.30683/1929-2279.2018.07.04.3] [Reference Citation Analysis]
719 Warnecke RB, Campbell RT, Vijayasiri G, Barrett RE, Rauscher GH. Multilevel Examination of Health Disparity: The Role of Policy Implementation in Neighborhood Context, in Patient Resources, and in Healthcare Facilities on Later Stage of Breast Cancer Diagnosis. Cancer Epidemiol Biomarkers Prev 2019;28:59-66. [PMID: 30352817 DOI: 10.1158/1055-9965.EPI-17-0945] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
720 Saini S, Tulla K, Maker AV, Burman KD, Prabhakar BS. Therapeutic advances in anaplastic thyroid cancer: a current perspective. Mol Cancer 2018;17:154. [PMID: 30352606 DOI: 10.1186/s12943-018-0903-0] [Cited by in Crossref: 82] [Cited by in F6Publishing: 94] [Article Influence: 16.4] [Reference Citation Analysis]
721 Zhang Y, Wang G. MicroRNA-183 inhibits A375 human melanoma cell migration and invasion by targeting Ezrin and MMP-9. Oncol Lett 2019;17:548-54. [PMID: 30655800 DOI: 10.3892/ol.2018.9603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
722 Townsend JS, Sitaker M, Rose JM, Rohan EA, Gardner A, Moore AR. Capacity Building for and Implementation of Policy, Systems, and Environmental Change: Results from a Survey of the National Comprehensive Cancer Control Program. Popul Health Manag 2019;22:330-8. [PMID: 30332328 DOI: 10.1089/pop.2018.0082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
723 Stewart SL, Hayes NS, Moore AR, Ii RB, Brown PM, Wanliss E. Combating Cancer Through Public Health Practice in the United States: An In-Depth Look at the National Comprehensive Cancer Control Program. Public Health - Emerging and Re-emerging Issues 2018. [DOI: 10.5772/intechopen.78582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
724 Kazdal D, Longuespée R, Dietz S, Casadonte R, Schwamborn K, Volckmar A, Kriegsmann J, Kriegsmann K, Fresnais M, Stenzinger A, Sültmann H, Warth A, Kriegsmann M. Digital PCR After MALDI–Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma. Prot Clin Appl 2018;13:1800034. [DOI: 10.1002/prca.201800034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
725 Ye Y, Otahal P, Marwick TH, Wills KE, Neil AL, Venn AJ. Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: An Australian population-based study. Cancer 2019;125:442-52. [PMID: 30311655 DOI: 10.1002/cncr.31806] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
726 Zheng G, Chattopadhyay S, Försti A, Sundquist K, Hemminki K. Familial risks of second primary cancers and mortality in ovarian cancer patients. Clin Epidemiol 2018;10:1457-66. [PMID: 30349393 DOI: 10.2147/CLEP.S174173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
727 Sauer CM, Dong J, Celi LA, Ramazzotti D. Improved Survival of Cancer Patients Admitted to the Intensive Care Unit between 2002 and 2011 at a U.S. Teaching Hospital. Cancer Res Treat 2019;51:973-81. [PMID: 30309220 DOI: 10.4143/crt.2018.360] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
728 Chao A, Lin CY, Wu RC, Lee YS, Lee LY, Tsai CL, Yang LY, Liu H, Chen SJ, Wang TH, Lai CH. The combination of everolimus and terameprocol exerts synergistic antiproliferative effects in endometrial cancer: molecular role of insulin-like growth factor binding protein 2. J Mol Med (Berl) 2018;96:1251-66. [PMID: 30298385 DOI: 10.1007/s00109-018-1699-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
729 Brenner H, Chen C. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer. 2018;119:785-792. [PMID: 30287914 DOI: 10.1038/s41416-018-0264-x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 125] [Article Influence: 23.8] [Reference Citation Analysis]
730 Planchard D, Popat S, Kerr K, Novello S, Smit E, Faivre-finn C, Mok T, Reck M, Van Schil P, Hellmann M, Peters S. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2018;29:iv192-237. [DOI: 10.1093/annonc/mdy275] [Cited by in Crossref: 985] [Cited by in F6Publishing: 1118] [Article Influence: 197.0] [Reference Citation Analysis]
731 Kim G, Kurnit KC, Djordjevic B, Singh C, Munsell MF, Wang WL, Lazar AJ, Zhang W, Broaddus R. Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association. Mod Pathol 2018;31:1553-9. [PMID: 29795437 DOI: 10.1038/s41379-018-0080-0] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 12.8] [Reference Citation Analysis]
732 Alsayid M, Singh MH, Issaka R, Laleau V, Day L, Lee J, Allison J, Somsouk M. Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light. Clin Gastroenterol Hepatol 2018;16:1593-1597.e1. [PMID: 29660528 DOI: 10.1016/j.cgh.2018.04.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
733 Mausbach BT, Bos T, Irwin SA. Mental health treatment dose and annual healthcare costs in patients with cancer and major depressive disorder. Health Psychol 2018;37:1035-40. [PMID: 30265046 DOI: 10.1037/hea0000670] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
734 Zhang LJ, Li XQ, Wang CD, Zhuang L, Gong Q, Li SJ, Liu X, Dong H, Wang XC. The Correlation of Visfatin and Its Gene Polymorphism with Non-Small Cell Lung Cancer. Cancer Biother Radiopharm 2018;33:460-5. [PMID: 30256660 DOI: 10.1089/cbr.2018.2526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
735 Doroudi M, Pinsky PF, Marcus PM. Lung Cancer Mortality in the Lung Screening Study Feasibility Trial. JNCI Cancer Spectr 2018;2:pky042. [PMID: 31360863 DOI: 10.1093/jncics/pky042] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
736 Kitahata Y, Hirono S, Kawai M, Okada K, Miyazawa M, Shimizu A, Kobayashi R, Ueno M, Hayami S, Shimokawa T, Kouda K, Tajima F, Yamaue H. Intensive perioperative rehabilitation improves surgical outcomes after pancreaticoduodenectomy. Langenbecks Arch Surg 2018;403:711-8. [DOI: 10.1007/s00423-018-1710-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
737 Feng J, Gu X, Liu L, Lu M, Ma X, Cao Y, Jiang R, Wang B, Zhao Q. Prognostic Role of MicroRNA-497 In Cancer Patients: A Meta-analysis. J Cancer 2018;9:3334-42. [PMID: 30271494 DOI: 10.7150/jca.25514] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
738 Hendler R, Zhang Y. Probiotics in the Treatment of Colorectal Cancer. Medicines (Basel). 2018;5. [PMID: 30205429 DOI: 10.3390/medicines5030101] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 9.8] [Reference Citation Analysis]
739 Berry MF, Canchola AJ, Gensheimer MF, Gomez SL, Cheng I. Factors Associated With Treatment of Clinical Stage I Non–Small-cell Lung Cancer: A Population-based Analysis. Clinical Lung Cancer 2018;19:e745-58. [DOI: 10.1016/j.cllc.2018.05.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
740 Rejane DSR, Alfredo JMS. Cancer survival in Brazil: Estimate through the mortality to incidence ratio. J Public Health Epidemiol 2018;10:295-302. [DOI: 10.5897/jphe2018.1027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
741 McCarthy CJ, Kilcoyne A, Li X, Cahalane AM, Liu B, Arellano RS, Uppot RN, Gee MS. Radiation Dose and Risk Estimates of CT-Guided Percutaneous Liver Ablations and Factors Associated with Dose Reduction. Cardiovasc Intervent Radiol 2018;41:1935-42. [PMID: 30132100 DOI: 10.1007/s00270-018-2066-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
742 Townsend JS, Puckett M, Gelb CA, Whiteside M, Thorsness J, Stewart SL. Improving Knowledge and Awareness of Human Papillomavirus-Associated Gynecologic Cancers: Results from the National Comprehensive Cancer Control Program/Inside Knowledge Collaboration. J Womens Health (Larchmt) 2018;27:955-64. [PMID: 30129896 DOI: 10.1089/jwh.2018.7289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
743 Gasparri ML, Besharat ZM, Farooqi AA, Khalid S, Taghavi K, Besharat RA, Sabato C, Papadia A, Panici PB, Mueller MD, Ferretti E. MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance. J Cancer Res Clin Oncol 2018;144:2313-8. [PMID: 30109500 DOI: 10.1007/s00432-018-2737-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
744 Del Core MA, Ahn J, Lewis RB, Raspovic KM, Lalli TAJ, Wukich DK. The Evaluation and Treatment of Diabetic Foot Ulcers and Diabetic Foot Infections. Foot & Ankle Orthopaedics 2018;3:247301141878886. [DOI: 10.1177/2473011418788864] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
745 Brown MT, Cowart LW. Evaluating the effectiveness of faith-based breast health education. Health Education Journal 2018;77:571-85. [DOI: 10.1177/0017896918778308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
746 D'Avola D, Villacorta-Martin C, Martins-Filho SN, Craig A, Labgaa I, von Felden J, Kimaada A, Bonaccorso A, Tabrizian P, Hartmann BM, Sebra R, Schwartz M, Villanueva A. High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma. Sci Rep. 2018;8:11570. [PMID: 30068984 DOI: 10.1038/s41598-018-30047-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 10.2] [Reference Citation Analysis]
747 Anderski J, Mahlert L, Mulac D, Langer K. Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer. European Journal of Pharmaceutics and Biopharmaceutics 2018;129:1-9. [DOI: 10.1016/j.ejpb.2018.05.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
748 Liao C, Xu D, Liu X, Fang Y, Yi J, Li X, Guo B. Iridium (III) complex-loaded liposomes as a drug delivery system for lung cancer through mitochondrial dysfunction. Int J Nanomedicine 2018;13:4417-31. [PMID: 30104875 DOI: 10.2147/IJN.S170035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
749 Best AF, Haozous EA, Berrington de Gonzalez A, Chernyavskiy P, Freedman ND, Hartge P, Thomas D, Rosenberg PS, Shiels MS. Premature mortality projections in the USA through 2030: a modelling study. Lancet Public Health. 2018;3:e374-e384. [PMID: 30037721 DOI: 10.1016/s2468-2667(18)30114-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
750 Schwarz RE. Clinical trends and effects on quality metrics for surgical gastroesophageal cancer care. Transl Gastroenterol Hepatol 2018;3:43. [PMID: 30148228 DOI: 10.21037/tgh.2018.06.07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
751 Pinheiro PS, Callahan KE, Boscoe FP, Balise RR, Cobb TR, Lee DJ, Kobetz E. Cancer Site-Specific Disparities in New York, Including the 1945-1965 Birth Cohort's Impact on Liver Cancer Patterns. Cancer Epidemiol Biomarkers Prev 2018;27:917-27. [PMID: 30026296 DOI: 10.1158/1055-9965.EPI-18-0194] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
752 Salem DA, Maric I, Yuan CM, Liewehr DJ, Venzon DJ, Kochenderfer J, Stetler-Stevenson M. Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma. Leuk Res 2018;71:106-11. [PMID: 30053652 DOI: 10.1016/j.leukres.2018.07.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
753 Dumas G, Bigé N, Lemiale V, Azoulay E. Patients immunodéprimés, quel pathogène pour quel déficit immunitaire ? (en dehors de l’infection à VIH). Méd Intensive Réa 2018;27:344-366. [DOI: 10.3166/rea-2018-0056] [Reference Citation Analysis]
754 Zheng H, Pomyen Y, Hernandez MO, Li C, Livak F, Tang W, Dang H, Greten TF, Davis JL, Zhao Y, Mehta M, Levin Y, Shetty J, Tran B, Budhu A, Wang XW. Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma. Hepatology 2018;68:127-40. [PMID: 29315726 DOI: 10.1002/hep.29778] [Cited by in Crossref: 164] [Cited by in F6Publishing: 173] [Article Influence: 32.8] [Reference Citation Analysis]
755 Tait RC, Zoberi K, Ferguson M, Levenhagen K, Luebbert RA, Rowland K, Salsich GB, Herndon C. Persistent Post-Mastectomy Pain: Risk Factors and Current Approaches to Treatment. J Pain. 2018;19:1367-1383. [PMID: 29966772 DOI: 10.1016/j.jpain.2018.06.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 13.0] [Reference Citation Analysis]
756 Hu X, Wu LW, Zhang ZY, Chen ML, Li YL, Zhang C. The anti-tumor effect of regorafenib in lung squamous cell carcinoma in vitro. Biochem Biophys Res Commun 2018;503:1123-9. [PMID: 29944884 DOI: 10.1016/j.bbrc.2018.06.129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
757 Yang Y, Alderman C, Sehlaoui A, Xiao Y, Wang W. MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers. Can J Gastroenterol Hepatol 2018;2018:9740357. [PMID: 30046565 DOI: 10.1155/2018/9740357] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
758 Félix AJ, Ciudad CJ, Noé V. Functional pharmacogenomics and toxicity of PolyPurine Reverse Hoogsteen hairpins directed against survivin in human cells. Biochem Pharmacol 2018;155:8-20. [PMID: 29940174 DOI: 10.1016/j.bcp.2018.06.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
759 Cho WK, Park W, Choi DH, Cha H, Nam SJ, Kim SW, Lee JE, Yu J, Im YH, Ahn JS, Park YH, Kim JY. Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy? J Breast Cancer 2018;21:206-12. [PMID: 29963117 DOI: 10.4048/jbc.2018.21.2.206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
760 Mizuno R, Kawada K, Sakai Y. The Molecular Basis and Therapeutic Potential of Let-7 MicroRNAs against Colorectal Cancer. Can J Gastroenterol Hepatol 2018;2018:5769591. [PMID: 30018946 DOI: 10.1155/2018/5769591] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
761 Moore JX, Royston KJ, Langston ME, Griffin R, Hidalgo B, Wang HE, Colditz G, Akinyemiju T. Mapping hot spots of breast cancer mortality in the United States: place matters for Blacks and Hispanics. Cancer Causes Control 2018;29:737-50. [PMID: 29922896 DOI: 10.1007/s10552-018-1051-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
762 Ji J, Sundquist J, Sundquist K. Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients. Nat Commun 2018;9:2367. [PMID: 29915319 DOI: 10.1038/s41467-018-04814-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
763 Njatcha C, Farooqui M, Kornberg A, Johnson DE, Grandis JR, Siegfried JM. STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung Cancer. Mol Cancer Ther 2018;17:1917-26. [PMID: 29891486 DOI: 10.1158/1535-7163.MCT-17-1194] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
764 Moulder DE, Hatoum D, Tay E, Lin Y, McGowan EM. The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer? Cancers (Basel) 2018;10:E189. [PMID: 29890631 DOI: 10.3390/cancers10060189] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]